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Perineuronal nets (PNNs) first appear in the brain during early postnatal development and 
increase until they are fully expressed in adulthood, often tracking the end of critical windows of 
synaptic plasticity1, 2. The experience-dependent development of PNNs in the brain is thought to 
function as a molecular brake on plasticity during the closure of these critical windows 3, 4. PNNs 
are typically associated with inhibitory neurons throughout the brain; however, I characterized a 
dense localization of PNNs surrounding a population of excitatory pyramidal neurons in 
hippocampal area CA2. I found that PNNs in CA2 function to restrict plasticity at CA2 synapses 
in mice 14-18 days old (P14-18). I also identified a novel window of plasticity in area CA2, P8-
11, an age prior to the maturation of PNNs in CA2.  
PNNs are reportedly altered in several neurodevelopmental disorders such as temporal 
lobe epilepsy (TLE) and Rett syndrome. I found that PNNs are precociously increased and 
develop prematurely in a Rett mouse model. Moreover, PNNs appear to be at least one 
mechanism restricting plasticity prematurely in CA2 of the Rett model mouse. Finally, because 
PNNs are regulated by pathological activity, I characterized PNNs in a TLE mouse model. PNNs 
were attenuated in CA2 by age P45, but were unchanged at younger ages after the onset of 
seizures (P21). To further examine how activity regulates PNNs in CA2, we chemogenetically 
increased or decreased CA2 activity for five days and found that PNNs are inversely regulated 
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by activity in CA2. Overall, these findings reveal a critical function for PNNs in restricting 
plasticity in CA2 and identify a novel window of plasticity in the hippocampus that may be 
critical for understanding the severe hippocampal-dependent learning deficits associated with 
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CHAPTER I- INTRODUCTION 
Synaptic plasticity 
The cellular basis of learning and memory has long been attributed to long-lasting 
changes in synaptic function. The most well-characterized example of such synaptic plasticity is 
long-term potentiation and depression (LTP or LTD respectively) of excitatory synaptic 
transmission.  LTP is the persistent strengthening of excitatory currents in the postsynaptic cell 
in response to a high frequency electrical stimulation or a postsynaptic depolarization paired with 
a lower frequency stimulation. This phenomenon was initially theorized by Donald Hebb, who 
proposed that persistent neuronal activity can strengthen neighboring cells via “some growth 
process or metabolic change”- now referred to at Hebbian plasticity 5. It wasn’t until about 20 
years later when an electrophysiological readout of plasticity was first characterized in the rabbit 
hippocampus 6, 7. Many mechanisms have since been proposed to explain LTP, many of which 
require the postsynaptic calcium and ionotropic glutamatergic receptors NMDA (N-methyl-D-
aspartate) and AMPA (α-amino-3-hydroxy-5-methyl-4-isoaxazole propionic acid). Regulation of 
synaptic plasticity is integral for refining circuit development and learning, especially during 
critical windows of plasticity in the developing brain, such as ocular dominance plasticity in the 
visual system.  
Synaptic plasticity is thought to play a critical role in both the activity-dependent 
refinement of neuronal circuits during development 8 and in learning in the mature brain 9. Early 
studies of experience-dependent plasticity in development revealed that plasticity is more robust 
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in immature sensory cortical regions compared to adult 10-13. For example, LTP is readily 
inducible in layer IV somatosensory neurons (by stimulation of thalamic inputs) in young rat 
slices (P3-7) but resistant in older slices (P8-14) 14. Likewise, the ability to induce LTD is also 
downregulated with age 15, 16. This age-restriction of thalamocortical plasticity was found in 
several other brain regions, such as visual and auditory cortices, at different age windows. 
However, most investigators presumed initially that the restriction of plasticity in the adult was 
permanent in these areas. We now understand there to be many factors regulating cortical 
plasticity in the mature brain, eg. neuromodulators such as acetylcholine 17. Overall, significant 
progress has been made in identifying the molecular switches that occur during critical windows 
of plasticity, however the precise mechanisms underlying plasticity in distinct regions of the 
developing brain versus the mature brain remain unclear. 
 
Critical period plasticity: a brief overview  
The concept of critical periods in brain development has been an area of study for 
decades 18, 19. A critical period, or sensitive window, in behavior and neural development refers 
to a window in postnatal development when experience is required for normal development and 
is vulnerable to abnormal experience. For example, early studies of sensitive windows of 
learning identified chick imprinting as an experience-dependent behavior in early postnatal 
development 20, 21.  Similarly, experience of trauma or stress during early childhood development 
has profound effects on cognitive and neural circuit development 22-26. Another way to study how 
experience can change brain circuitry is the development of sensory systems. For example, the 
development of vision and underlying visual system circuitry is dependent on activity from the 
eye 27. Normal maturation of visual cortical circuits requires normal visual experience during 
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postnatal life 19, 28. This form of experience-dependent learning is by far the most well-studied 
and is known as ‘the critical period’. The study of the visual system during sensitive versus non-
sensitive stages of development has provided insight into the onset, duration and closure of the 
sensitivity, and the underlying mechanisms regulating these different stages of plasticity.  
The critical period was first characterized at the neuronal level more than 50 years ago by 
Hubel and Wiesel while recording activity of primary visual cortex (V1) neurons in response to 
visual stimuli 25. They discovered that visual deprivation of one eye by lid suture (monocular 
deprivation; MD) causes a shift favoring responses to stimulation of the open eye. Referred to as 
ocular dominance plasticity (OD) 19, 25, 29, this shift was found to occur only during a temporary 
developmental window when synapses are highly sensitive to disruptions of activity; upon 
structural and physiological maturity, synapses become much less sensitive to such manipulation 
1. This period of heightened sensitivity to MD lasts between 4-5 week of age in cats 19, up to 4- 5 
weeks in rodents 30, and during the first year of life in human 31. During the critical period, long-
term changes in visual input, like MD, cause a shift in neural response, or a strengthening and 
weakening of synapses of visual cortical neurons. To explain this adaption of cortical neurons, a 
theory was proposed by Bienenstock, Cooper, and Munro (BCM) theory 32. They provide a 
mathematic framework for how synapse strength is altered by the length and degree of activity 
changes during the critical period. 
In OD plasticity, visually depriving one eye with an eye-lid suture shifts the responses of 
visual cortical neurons to the open eye and deprived eye responses eventually cease to respond 19, 
29, 33. Three distinct processes occur during OD shift toward deprived-eye; a rapid weakening of 
the deprived-eye cortical responses via LTD, a strengthening of open eye responses via LTP, and 
a delayed threshold shift from depression to potentiation after long-term deprivation, also known 
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as ‘modification threshold’ 35, 36. These data demonstrate a bidirectional threshold shift between 
LTD and LTP 36. Importantly, the depression of cortical responses of the deprived-eye requires 
weak sensory input (retinal activity) because ablation of retinal activity, eg. via intravitreal 
injection of tetrodotoxin, is sufficient to prevent the depression of cortical response 19, 34, 37. OD 
is rapidly shifted when MD occurs around 4 weeks old and is detectable within 1 day of darkness 
34. Also, a brief re-exposure to light can rapidly reverse these effects 35, 38, 39. This critical period 
is observed in other species 40-42.  
The shift in OD in visual cortex after MD is necessarily assessed at the functional level. 
However, activity-dependent plasticity of the component structures has also been observed. For 
example, MD of kittens during the critical period caused dramatic anatomical changes in the 
visual system, such as reduced horizontal connections 43, decreased thalamic afferents to the 
deprived eye 33, 44, and shrinkage of the geniculate neurons themselves 19, 25, 45. Dendritic spines 
also become pruned on V1 pyramidal neurons of the deprived eye, while thalamic axons from 
the open eye progressively expand 44, 46-48. These structural changes are absent and spines are 
more stable during adulthood 49. Although the mechanisms underlying the loss of dendritic 
spines associated with MD during the critical period are unknown, the changes have been linked 
to the regulation of the extracellular matrix, perhaps by release of tissue-type plasminogen 
activator (tPA), during the critical period but not in adulthood 46, 47. Long-term studies following 
dendritic spines in vivo corroborate these findings, showing that spines extend and retract over 
hours during early development, while the majority are stable for days/ months (~96%) in 
adulthood 50-52, 53.  However, whether and how LTD-like mechanisms trigger this plasticity 
during critical periods is still unknown. 
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Many cellular mechanisms have been reported to mediate this form of plasticity. For 
example, experience-dependent molecular changes in NMDA subunit expression and subsequent 
modification of NMDAR function are thought to regulate changes in synaptic strength 39, 54-56 
and AMAPR trafficking 57-60. Moreover, synaptic scaling has been proposed as a mechanism of 
activity-dependent synaptic changes 46, 47, 61, 62. The depression of synaptic strength in response 
to deprivation has also been explained by enhanced intracortical inhibition and described as a 
long-term potentiation of inhibition 63, 64. More recent studies have focused on molecular factors 
such as calcium-regulating enzymes (eg. calcium/ calmodulin-dependent protein kinase II 
(CaMKII)), molecular breaks (eg. the extracellular matrix (ECM) or prototoxins such as Lynx1 
(Ly6/ neurotixin1)) and molecular triggers (eg. Otx2 or BDNF (orthodenticle homeobox 2 
homeoprotein) (brain-derived neurotrophic factor)) 65-68. Much effort has been directed toward 
understanding the mechanisms underlying this and other critical periods that have since been 
identified in other brain regions and across species 69, 70.  
Taken together, the onset, duration and closure of critical period plasticity are regulated 
by numerous physiological and molecular factors throughout postnatal development. The focus 
of this thesis is on the role of the extracellular matrix in regulating synaptic plasticity in the 
hippocampus during early postnatal development. In principle, the characteristics of synaptic 
plasticity observed in the visual critical period should resemble those of synapses in the 
hippocampus 32, 71, 72. However, a critical period in the hippocampus has yet to be defined, as 
synaptic plasticity, particularly LTP, in the hippocampus persists into adulthood. A few studies, 
though, have implicated the hippocampus in modulating a sensitive window for fear learning in 
early postnatal development 73-75.   
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Hippocampal Plasticity during Development 
The anatomical regions of the hippocampus are fully distinguishable by the first postnatal 
week of life in rodent 76. While anatomy is not necessarily a readout of functional maturity, it can 
still be a useful indicator 77. Early studies found that LTP at CA3-CA1 synapses emerges in the 
second postnatal week in the rodent and in the third week in DG 78-80. Moreover, excitatory 
neurotransmission in the hippocampus matures around P14 in the rodent 81, while inhibitory 
transmission develops around P9 in CA1/ P5 in CA3, and matures by P14-18 82-85. More 
recently, Yasuda and colleagues show CA1 LTP is indeed inducible in the neonatal rodent (<P9) 
and report that the underlying mechanisms regulating immature versus mature plasticity are 
distinct 86, 87. CAMKII is well-known to play a critical role in downstream signaling of LTP 
induction at adult CA1 synapses. They show that immature LTP induction does not require 
CaMKII (P7-9 hippocampal slices), but instead requires cyclic AMP-dependent protein kinase A 
(PKA) 87, 88. Other explanations for the developmental changes in hippocampal plasticity have 
been proposed 89, 90.  
The development of mature LTP in CA1 has been linked to the unsilencing of silent 
synapses during early postnatal development. Silent synapses are those that show NMDA 
receptor (NMDAR) but no AMPA receptor (AMPAR) response. In rodent hippocampal CA1 
neurons, the conversion of AMPA-silent synapses to AMPA-signaling synapses occurs around 
P12 when there is a developmental decline in the number of AMPA-silent synapses 86, 91-93. 
Several other mechanisms have been identified at this developmental switch: an increase in 
multivesicular release at CA3-CA1 synapses, increase in AMPAR signaling (increase in open 
probability/ single-channel conductance), and a change in the expression of AMPAR scaffolding 
proteins eg. SAP-102 to PSD-95 94-96. Also, there is a shift in AMPAR and NMDAR subunit 
7 
 
composition during the second and third postnatal weeks which reflects distinct LTP 
mechanisms regulating plasticity during development 97. 
AMPAR/ NMDAR subunit composition in development 
The glutamatergic NMDAR is a heterotetramer made up of two obligatory NR1 subunits 
and two variable NR2 subunits. NR2B composition switches from predominantly NR2B to 
NR2A in the cortex during development. This switch is activity-dependent (delayed by sensory 
deprivation experiments) and the timing appears to parallel critical periods of plasticity, eg. 
NR2A is expressed between P3-10 in the somatosensory cortex and between P12-30 in the visual 
cortex in rodent 98, 99. The subunit switch alters NMDA-mediated excitatory postsynaptic 
currents (EPSC) kinetics. NMDARs that are dominant in NR2B subunit have a prolonged ESPC, 
while NR2A-dominant have a truncated EPSC decay 99. The change in EPSC efficacy is 
proposed to underlie critical periods of plasticity 38, 39, 54, 55 14; however, the timing of visual 
critical period plasticity is surprisingly unaffected by the loss of NR2A subunit 30. Also, AMPAR 
GluR1 subunit is critically involved in mature LTP 100, while GluR2/4 subunits seem critical to 
early NMDAR and PKA-dependent LTP 101. 
GABA transmission: excitatory to inhibitory 
Lastly, the effects of inhibitory neurotransmission on synaptic activity notably switches 
during early postnatal development. GABA (γ-aminobutyric acid) is typically thought of as the 
primary inhibitory neurotransmitter in the adult brain that inhibits neuronal firing by either 
hyperpolarizing the membrane potential or by shunting excitatory input. However, early in 
development, GABA transmission is excitatory in that GABA signaling causes a large 
depolarizing postsynaptic potentials/ increase in intracellular calcium, and can trigger action 
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potentials 102. In the hippocampus, the developmental GABA switch from excitatory to inhibitory 
occurs around between P7 and P13 in rodent 103, 104. The switch indicates a change in the 
electrochemical gradient of chloride ions. In the adult brain, the reversal potential for GABA 
currents is very negative but more depolarized in the developing brain due to a higher 
intracellular chloride concentration at younger ages. This difference is attributed to a 
developmental increase in the K+-coupled Cl- transporter, which increases the rate of Cl- 
extrusion and a shift of EGABA to a more negative potential 105, 106.  
Taken together, many molecular and structural changes occur during critical windows in 
the brain that influence the regulation and function of plasticity throughout development. It has 
been hypothesized that early LTP may be important for the formation and refinement of synaptic 
contacts (by stabilizing single release site connections) and mature LTP might reflect activity-
dependent functions within a network of connections.  
 
A role for PNNs in limiting functional plasticity  
The extracellular matrix (ECM) is emerging as a key player in regulating plasticity 
throughout development in the central nervous system (CNS).  Recent discoveries in the field 
have led to an evolved theory called the ‘tetrapartite synapse’ that considers the pre and 
postsynaptic cell, astrocytes and the ECM in synaptic signaling 107. Perineuronal nets (PNNs) are 
a specialized form of the extracellular matrix localized around predominantly inhibitory neurons 
in the CNS. In the hippocampus, the matrix predominantly localizes around GABAergic 
interneurons, specifically those that are positive for parvalbumin (PV). However, we sought to 
characterize an unstudied concentration of PNNs surrounding a dense population of excitatory 
neurons in area CA2 108-112. PNNs first appear in early postnatal development, increase in 
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expression with age and are regulated by experience 1, 113, 114. The maturation of PNNs 
interestingly tracks the closure of critical windows of synaptic plasticity and therefore were 
hypothesized to play a role in dampening synaptic plasticity 115. Early studies discovered that 
PNN maturation requires normal experience during postnatal development in several brain 
regions including motor 116, visual 113, 117, 118 and somatosensory 114 systems. Furthermore, similar 
experiments performed in the adult mouse appeared to have little effect on PNN expression 114. 
These findings demonstrate that the formation of PNNs is dependent on neuronal activity in the 
developing brain, but is resistant to similar manipulations in adulthood.   
The composition of the extracellular space in the CNS differs from other tissues. Non- 
CNS ECM contains fibrous proteins such as collagen/ elastic and adhesive glycoproteins such as 
laminin/ fibronectin, whereas CNS ECM contains much less fibrous proteins and more 
glycosaminoglycan sugars (GAGs) 119, 120. The specialized CNS ECM, PNNs were first 
described in the 1890’s by both Camillo Golgi and Santiago Ramón y Cajal but it was not until 
the advent of more advanced histology and biochemical assays in the 1980’s that their 
composition was characterized 121. PNNs are composed of a complicated meshwork of molecular 
components that are organized into a scaffold around the ‘backbone’ polysaccharide hyaluronan. 
The majority of PNNs components are negatively charged proteoglycans known as chondroitin 
sulfate proteoglycans (CSPGs), bound to core proteins and a non-sulfated GAGs, tenascin-R 122-
125. It is believed that the PNN matrix is predominantly anchored to the cell membrane via 
hyaluronan docking to the hyalaronan synthase (HAS) receptor 126, 127.  
PNN components are typically synthesized by the cell they encompass. Briefly, the 
transcripts for the PNN core protein are trafficked from the nucleus to the rough endoplasmic 
reticulum where the protein is synthesized and transferred to the Golgi apparatus where the 
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protein is glycosylated (process by which carbohydrate chains are attached to the protein) and/or 
sulfated (process by which a sulfate group is added to the proteoglycan) 125. The molecules are 
then packaged into secretary vesicles and transported to the cell surface where they are released 
from the cytoplasm into the extracellular space. The synthesis of the CSPG can be stimulated by 
transforming growth factor B (TGFβ), and inhibitors of TGFβ are sufficient to suppress 
expression of several CSPGs 128, 129.  
Mechanisms of PNNs regulating synaptic plasticity in development 
The underlying mechanism(s) by which PNNs regulate plasticity are unclear. During 
development, the ECM is more permissive. The ECM is predominantly composed of hyaluronan 
during early development, which is a linear, non-branching GAG and thus allows for a soluble 
and spacious extracellular environment for axonal migration and motility 126, 130-133. As the brain 
matures, hyaluronan becomes bound to more complex GAGs and CSPGs such that the ECM 
ultimately becomes insoluble and structural plasticity is restricted. PNN mechanisms have been 
studied in both the context of structural and functional plasticity. After the early finding that 
dark-rearing cats delayed the development of PNNs, many groups worked to characterize the 
mechanisms behind experience-dependent maturation of PNNs in many other brains and across 
species 117.  
In 2002, Pizzorusso and colleagues demonstrated a direct association between PNNs in 
the visual cortex and the closure of critical period plasticity 134. Moreover, several PNN-
component knockout mouse models have implicated PNNs in regulating LTP and LTD at 
excitatory glutamatergic synapses in the hippocampus 135-138. Synaptic plasticity is generally 
thought to be induced by activity-dependent elevations in calcium in the postsynaptic cell, which 
ultimately triggers calcium-dependent intracellular signaling cascades that are required for the 
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induction of synaptic plasticity. PNN components might play a role in elevating postsynaptic 
calcium via several mechanisms, which are not mutually exclusive. PNNs may regulate AMPA 
receptor lateral motility between extrasynaptic sites and the active zone of the postsynaptic 
density. When PNNs are densely localized at the synapse, they may be acting as a physical 
barrier preventing trafficking of the AMPAR to the active zone 139, 140. In another theory, CSPGs 
carry a strong negative charge therefore PNNs may be acting as an ionic buffer of calcium or 
other cations that are associated with the induction/ maintenance of plasticity 140-142. For 
example, calcium diffusion is increased in rat hippocampal slices after degradation of PNNs with 
the enzyme chondroitinase (ChABC) 142. Cell-surface integrin proteins have also been implicated 
as a mechanism by which PNNs regulate plasticity 67, 143. β1 integrin signaling triggers NDMA 
receptor phosphorylation in CA1 neurons and increases the amplitude of NMDA receptor 
currents 144. Also, postnatal deletion of β1 protein impairs LTP in CA1 145. Evidence of a direct 
interaction between a PNN component and cell surface integrins is lacking, however the PNN-
degrading enzyme matrix metalloproteinase (MMP) directly binds and regulates several 
integrins, which could be an alternative PNN-associated signaling mechanisms regulating 
plasticity 146.  
L-type voltage voltage-dependent calcium channels (LVDCC) have also been implicated 
in ECM-mediated plasticity in the hippocampus. LVDCCs contribute to the influx of 
postsynaptic calcium after high-frequency stimulations and thus support LTP induction 147. 
LVDCC-dependent LTP cannot be induced in tenascin-C deficient mice in CA1 but can be 
partially rescued by pharmacological potentiation of LVDCC’s 136. Blocking LVDCC activation 
in a hippocampal culture system downregulates PNN expression 148. Furthermore, PNN 
degradation in an acute hippocampal slice reduced LVDCC calcium currents and abolished the 
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LVDCC-component of CA1 LTP. Exogenous bath perfusion of hyaluronan was able to rescue 
LVDCC currents and LTP, strongly linking PNNs and LVDCC in regulating LTP 149. However, 
evidence of a direct interaction between ECM molecules and LVDCCs is lacking and may 
suggest that several ECM molecules may be acting in a signaling complex 150.  
Finally, PNNs may limit plasticity by sequestering molecular factors that regulate 
plasticity. For example, Otx2 homeoprotein co-localizes with PNN+ PV neurons throughout the 
cortex, interacts with tenascin-R, and was found to trigger the onset of the visual critical period 
151 152. Infusion of Otx2 into the visual cortex during the critical period accelerated PNN 
development and functional onset of the critical period, while Otx2 infusion in adulthood 
degraded PNNs around PV neurons and reopened critical period plasticity 66, 152. PNNs also 
sequester growth-promoting or chemorepulsive proteins. For example, the chemorepulsive 
protein sema3a is strongly associated with PNNs in the adult rodent brain during postnatal 
development and its signaling receptors (PlexinA1/4) localize to the cell membrane of PNN+ 
neurons 153. ChABC treatment in vivo abolishes sema3a staining. Moreover CSPG-4 interacts 
with FGF-2 (fibroblast growth factor 2) and acts as a co-receptor to present FGF to its signaling 
receptor, a receptor tyrosine kinase, which ultimately leads to cell migration/ proliferation 
signaling 154. Interestingly, the only direct binding interactions between PNNs and a cell surface 
receptors (not including hyaluronan and its enzyme HAS) is with the receptor protein tyrosine 
phosphatase sigma (RPTP-sigma), which is a signaling inhibitor of neural regeneration 155. 
Taken together, PNNs appear to act either directly or indirectly to signal multiple guidance cues, 
such as chemorepulsion, and provides a likely mechanism by which PNNs restrict plasticity in 
the adult brain.  
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Disentangling the effects of PNN degradation in the brain 
 PNNs are endogenously degraded in the brain via extracellular proteolysis. This process 
is thought to be critical for synaptic remodeling and plasticity 156. The known ECM-degrading 
enzymes in the brain are MMPs (matrix metalloproteases), ADAMs (a disintegrin and 
metalloproteinase), and tPA. MMP-9 is the most well-characterized protease and is heavily 
implicated in activity-dependent structural and functional changes at the synapse. For example, 
MMP-9 is increased in response to neuronal activity by both aberrant increases in activity or by 
learning and memory tasks 157, 158. MMP-9 is also required for late-phase long-term potentiation 
in CA1 159. A possible mechanism by which MMP-9 may be acting to regulate plasticity is 
signaling through β1 integrin, as previously mentioned 160. Blocking β integrin signaling 
inhibited MMP-9-induced LTP in CA1 161. Several PNN-degrading proteases are well known to 
upregulate after brain insults, such as stroke or seizure, as well as in neurological disorders such 
as Alzheimer’s 162-165. In reference to critical period plasticity, a recent study showed that light 
reintroduction after dark exposure in adulthood increased MMP-9 and degraded PNNs in the 
visual cortex 166. Because dark exposure in adults reactivates critical period plasticity, the loss of 
PNNs may be a critical mechanism by which the adult brain shifts to a juvenile state 167.  
One study compared the effects of ChABC degradation of PNNs versus a mouse 
knockout of the PNN component tenascin-R. Both ChABC in vitro and tenascin-R KO was 
sufficient to attenuate CA1 LTP 137. Interestingly, the authors also found that LTD in CA1 was 
impaired by ChABC in acute hippocampal slices, but not in the tenascin-R KO. Conversely, 
short-term plasticity was unaffected by ChABC but increased in the tenascin-R KO mouse. The 
CA1 LTP deficit is also apparent in other PNN-component KO’s; for example, a brevican 
knockout mouse showed impaired LTP but no impairment in excitatory or inhibitory synaptic 
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transmission, as well as no learning and memory deficits 168. Lastly, LTP was minimally 
impaired in a neurocan KO mouse, suggesting that neurocan either plays a more subtle role in 
regulating plasticity or is redundant with other CSPGs 169.  
Degradation of PNNs in vivo with ChABC in the mouse amygdala abolished LTP at 
thalamo-amygdalar inputs in slice and impaired LTP of inhibitory neurons, which reflects loss of 
plasticity at glutamatergic inputs onto feedforward interneurons 170. However, ChABC treatment 
of mouse hippocampal cultures increased the excitability of hippocampal interneurons (note: 
cultures were harvested at P1-3, developed diffuse PNNs by 5 days in vitro, and fully matured by 
2 weeks) 148. Degradation of PNNs with ChABC in ex-vivo hippocampal slices increased sharp 
wave ripple (SWR) (extracellular recordings of SWR frequency in CA1 SR) 171. SWRs reflect 
excitatory events, typically initiated in CA3 and represents depolarization of CA1 dendrites 172. 
They tend to occur during rest/ slow-wave sleep and appear to be important for learning and 
memory consolidation. Because PV neurons are heavily implicated in modulating SWRs, the 
authors suggest that loss of PNNs around PV neurons impairs glutamatergic transmission onto 
PV neurons (in agreeance with the amygdala study 170), decreasing PV excitability, and 
ultimately increasing hippocampal excitability due to the loss of inhibition onto CA1 neurons. 
In 2002, Pizzorusso and colleagues demonstrated a direct association between PNNs in 
the visual cortex and the closure of critical period plasticity. They found that degradation of 
PNNs in vivo with the enzyme chondroitinase (ChABC) in the adult visual cortex ‘re-opens’ the 
critical period and reinstatement of ocular dominance plasticity 134. Similarly, CSPG 
development in the amygdala coincides with the developmental switch in fear memory 
regulation and have been implicated in the maintenance of fear memory in adulthood. Fear 
memory is more readily extinguished in young rats (P17) versus adult and it was recently found 
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that PNN degradation in the adult basolateral amygdala reopens a critical window for fear 
learning such that fear memories are more readily erased 173 170. These data suggest that PNNs 
may function to maintain erasure-resistant fear memories and loss of PNNs may render 
memories more susceptible to erasure by extinction learning. Similarly, PNN removal in the 
adult auditory cortex prevented consolidation of fear learning to tones 24-48 hours after 
conditioning, but not 30 minutes after 174. Interestingly, they also found PNNs are increased 4 
hours, but not 24-hours, after fear learning, overall suggesting that PNNs appear to be critical in 
long-term, but not short-term, memory consolidation. 
Lastly and most recently, degradation of PNNs in vivo in the visual cortex decreased 
inhibitory activity and increased gamma during a visual stimulus (recording single unit and 
population activity in awake, freely behaving animals) 175. MD in adult ChABC-treated mice 
caused an immediate potentiation of gamma activity, which was not observed in control adults, 
but was seen in juvenile mice after MD. This study provides compelling evidence that the loss of 
PNNs reinstates a ‘juvenile’ plasticity environment. Performing similar experiments, this group 
also found that PNNs are required for retrieval of visual fear memory in the secondary visual 
cortex 176. Taken together, these studies reveal a convincing role of PNNs regulating 
glutamatergic transmission, LTP and critical plasticity windows such as ocular dominance 
plasticity and fear learning.   
The focus of this thesis will be on the role of the specialized extracellular matrix, 
perineuronal nets (PNNs), in regulating a window of plasticity in hippocampal area CA2 during 




Plasticity resistance in hippocampal area CA2 
CA2 morphology and anatomy 
Hippocampal area CA2 was first described in by Ramón y Cajal and Lorente de Nó as a 
small region that was distinct in cytoarchitecture and connectivity 177, 178. The hippocampus 
consists of several subregions, namely the Cornu Ammonis (CA) regions and the dentate gyrus 
(DG). The CA regions, CA1, CA2, and CA3, are organized into a layer of pyramidal neurons 
with apical and basal dendrites extending into the stratum radiatum (SR) or stratum oriens (SO), 
respectively. The CA2 region is distinguishable from other hippocampal subregions by several 
features such as morphology, molecular profile, and its resistance to plasticity and injury.  
CA2 neurons are morphologically distinct in that their cell somas are typically larger than 
CA1 neurons and their dendrites lack thorny excrescences (postsynaptic specializations 
associated with mossy fibers and characteristic of CA3 pyramidal neurons) 178. Compared to the 
homologous and organized morphology of CA1 neurons, CA2 cells are heterogeneous based cell 
soma and dendritic anatomical analysis 179. CA2 neurons predominantly receive direct inputs 
from CA3 Schaffer collaterals, entorhinal cortex layer II, and more recently discovered, inputs 
from newborn DG granule neurons, extrahippocampal inputs from the supramammillary nucleus 
(SuM) and the paraventricular nucleus (PVN) of the hypothalamus, among others 180, 181 182-184. 
The absence of DG terminals has also been used as an anatomical identifier of CA2 neurons. 
Initially, the CA2/3 border was thought sit at the ending of DG axons, however many studies, 
across species, have since described DG inputs extending deep into CA1 178, 185, 186. Outside of 
these distinct anatomical and circuit properties, CA2 neurons also exhibit unique cell signaling 
pathways and respond distinctly several neuromodulators.  
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CA2 neurons have a higher mean firing rate than CA1 and CA3187, 188 A chronic loss of 
CA2 output leads to increased excitability in the recurrent CA3 network, which was found to 
result in widespread hyperexcitability during exploration and high frequency CA2 discharges 
during rest; overall implicating CA2 as a gateway for the spread of excitatory activity in the 
hippocampus 189.  
Plasticity (and the lack thereof) in CA2 
Most research on synaptic plasticity has been focused predominantly on mossy fiber 
synapses from DG to CA3 and on Schaeffer collateral synapses from CA3 to CA1 6, 190. 
Researchers initially became intrigued by CA2 because, unlike neurons in other hippocampal 
regions that  are vulnerable to damage from seizure, ischemia or traumatic insult, CA2 neurons 
are resistant to cell death from injury in human, as well as in rodent 191-195.  
CA3 Schaffer collateral (SC) synapses on CA2 dendrites are highly resistant to the 
induction of LTP such that high frequency stimulation or a pairing protocol (postsynaptic 
depolarization during stimulation) surprisingly fails to induce plasticity in CA2 neurons as they 
do in CA1 196. Although we have yet to fully understand the mechanisms behind this resistance 
to plasticity, a number of CA2-specific genes and extracellular matrix components are implicated 
in plasticity resistance 197. One or more of these mechanisms involve regulation of intracellular 
calcium levels. For example, LTP can be induced in CA2 by elevating intracellular calcium, 
either by blocking calcium extrusion in the postsynaptic cell using an inhibitor of the plasma 
membrane calcium ATPase (PMCA) or by elevating extracellular calcium to 10mM (182). 
Simons and colleagues also use calcium imaging to show that CA2 dendrites and spines have 
smaller rises in free calcium in response to action potential and have a significantly faster rate of 
calcium extrusion compared to neighboring CA1/3 neurons. These data, in, addition to the 
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enrichment of several other calcium/calmodulin-associated proteins in CA2, such as PCP4 
(purkinje cell protein 4), RGS14 (regulator of G-protein signaling 14), strongly suggests that 
robust calcium handling properties play an important function in limiting plasticity in CA2.  
RGS14 protein is also highly expressed in CA2 and is a suppressor of LTP. Mice lacking 
RGS14 express LTP at CA2 SR synapses and exhibit enhanced spatial and object recognition 
memory compared to wildtypes 198. Mechanistically, RGS14 is likely to act as a scaffolding 
protein that negatively regulates ERK/MAPK activation and inhibits signal transduction by 
driving G-protein α subunits into their inactive state 199.  However, recent data showing that 
RGS14 also binds several proteins linked to calcium signaling such as calmodulin and CaMKII, 
suggest that RGS14 may also be important in regulating both calcium and ERK pathways 200.  
RGS14 mRNA and protein are upregulated during postnatal development, with the protein first 
being detectable in rodent CA2 at P7 and maximally expressed in adulthood 201. Although 
RGS14 has been strongly implicated in both regulating CA2 plasticity, as well as mediating 
several hippocampal-dependent learning tasks, RGS14 is just one of many apparently redundant 
molecular brakes acting to restrict plasticity in CA2. 
Plasticity modulators in CA2 
CA2 plasticity is also regulated by several neuropeptides. Receptors for the social 
neuropeptides vasopressin and oxytocin are enriched in CA2. These neuropeptides play a role in 
modulating social behavior, aggression, and anxiety 202. Bath application of both agonists are 
able to induce a significant excitatory potentiation at CA2 SR synapses in hippocampal slices, 
but not at CA1 synapses 203.  This form of vasopressin-induced potentiation is dependent on 
NMDA receptors, calcium, and CaMKII. Vasopressin receptor 1b (Avpr1b- arginine vasopressin 
receptor 1b) knockout mice show decreased social aggression but no anxiety-like behaviors 204. 
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Although the Avpr1b-/- mouse is a global knockout, viral delivery of the Avpr1b receptor to 
dorsal CA2 neurons was sufficient to restore aggressive behavior 203. Moreover, vasopressin is 
endogenously released by neurons in PVN of the hypothalamus, a known direct CA2 input. A 
recent study found that optogenetic excitation of PVN neurons enhanced social memory and was 
subsequently blocked by an Avpr1b antagonist 205, strongly implicating CA2 in social memory 
function. A second peptide hormone, Substance P, originating from SuM inputs, also induces a 
similar NMDA-dependent potentiation in CA2 206. Though Substance P is considered to be an 
important neuropeptide in nociceptive processes, SuM inputs to the hippocampus have also been 
linked to stress 207.  
Lastly, CA2 synapses are also potentiated by the psychostimulant drug, caffeine, and 
other antagonists of the CA2-enriched receptor adenosine 1 (A1R) 208 209, 210. Unlike vasopressin-
induced potentiation, caffeine-induced potentiation is independent of NMDA receptors and 
CaMKII, but is blocked by inhibitors of adenylyl cyclase or PKA (Fig. 1). This mechanism of 
action was not surprising considering A1Rs are coupled to the Gi/o family of G proteins and, 
when activated by its agonist adenosine, normally inhibit adenylyl cyclases. Potentiation of CA2 
synapses by these neuromodulators implicate CA2 in multiple behaviors such as aggression and 
social memory, however the link between restricted plasticity in CA2 and regulation of these 
behaviors is still unclear.  
Plasticity of Inhibition in CA2 
Several inhibitory neuron cell-types are concentrated in CA2 relative to neighboring 
subregions and several groups have reported strong inhibitory drive onto CA2 neurons 211-214. 
Inhibitory neuron cell types, PV-, Reelin-, somatostatin-, and calbindin-positive are all more 
densely localized in CA2 compared to neighboring hippocampus subregions 215. Blocking 
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feedforward inhibition onto CA2 increases excitatory responses of CA2 neurons, suggesting that 
inhibitory input may be acting as a brake on CA2 cell firing to a larger degree than CA1 211. 
Also, similar to CA1, inhibitory synapses onto CA2 pyramidal neurons in SR are highly plastic 
in that they undergo LTD in response to high frequency stimulation, inhibitory LTD (iLTD) 212. 
This disinhibition of CA2 synapses in response to high frequency stimulation is sufficient to 
evoke action potential firing in CA2 212. Delta-opioid receptor (DOR) activation mediates this 
iLTD at CA2 inhibitory synapses, specifically at PV synapses, presumably by presynaptic 
reduction in neurotransmitter release 216. Similarly, another type of protocol, pairing activation of 
entorhinal cortex (EC) and Schaffer collateral (SC) inputs on CA2 pyramidal neurons, also 
results in a form of input-timing dependent plasticity (ITDP) that is a DOR-dependent iLTD 217. 
This ITDP/iLTD is distinct from that in CA1, which is mediated by endocannabinoid receptors 
on cholecystokinin-expressing interneurons 217, 218. Thus, because excitatory synapses in CA2 SR 
are normally resistant to plasticity, the authors suggest that iLTD at CA2 SR may function as a 
mechanism to gate CA2 excitatory output, essentially serving as a way of getting potentiation of 
CA2 neuron function in the absence of LTP-like processes at excitatory synapses.  Interestingly, 
a postmortem study of schizophrenic individuals reveal that non-pyramidal neurons are 40% 
lower in area CA2. This finding was replicated in a mouse model of 22q11.2 deletion syndrome, 
where it was also found that CA2 pyramidal neurons have a reduction in feedforward inhibition 
218, 219  Taken together, these data suggest that inhibitory drive on CA2 neurons is different from 
neighboring subregions and may represent a powerful gating mechanism of CA2 neuron firing.   
Function of CA2  
The hippocampus is integral in many forms of learning and memory, such as episodic/ 
contextual memory, spatial/ temporal cognition and fear learning, among others. However, 
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recent interest has focused on the function of area CA2. Several studies have recently implicated 
CA2 in novelty detection 187, 198, 220, spatial memory 188, 221, 222, social recognition memory, and 
aggression 187, 223, 224, 225. The social and aggression behaviors have been linked to the 
localization of several social neuropeptide receptors in CA2, eg. oxytocin and vasopressin 203, 226, 
227 and the direct vasopressinergic projection from the PVN to CA2 183, 223. For example, mice 
deficient in RGS14, a protein that is enriched in CA2 and functions to restrict synaptic plasticity, 
also display enhanced novel object recognition memory and faster learning acquisition in the 
Marris water maze 198. Moreover, mice deficient in the vasopressin receptor and oxytocin 
receptor (both social neuropeptide receptors high in CA2) have deficits in social recognition 
memory and aggression 227-229. Interestingly, re-expression of the vasopressin receptor in dorsal 
CA2 neurons is sufficient to restore normal aggressive behavior 203. Recently, Smith and 
colleauges found that optogenetic excitation of PVN neurons, a pathway known to directly 
innervate CA2, enhanced social memory and the effect was blocked by a vosopressin 1b receptor 
antagonist 205.  Several studies directly manipulate CA2 neuronal activity in vivo and find that 
silencing CA2 neurons impairs social recognition memory 224, 230, and similarly, excitotoxic 
lesion of CA2 neurons also impaired social recognition memory 225. CA2 neurons also display 
place fields (a location in space where a particular neuron will fire) however, unlike CA1, CA2 
neuron ensembles become progressively dissimilar over time, or temporally remap 187, 188. The 
weak spatial coding exhibited by CA2 relative to CA1/3 supports a preferential role for CA2 in 
social, emotional, and temporal function, rather than spatial. Taken together, these data beg the 
question as to what is the function of a critical period in CA2.   
For the most part, hippocampal synaptic plasticity, particularly LTP, is maintained 
throughout adulthood, and this may be one reason synaptic plasticity in the hippocampus is 
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thought to underlie formation of several types of memory 231. However, evidence suggests that 
some critical periods related to hippocampal function do exist.  For example, adult rodents and 
humans are generally unable to recall memories of their early childhood (referred to as infantile 
amnesia), and the ability to maintain long-term declarative-like memory improves with age 232. 
One specific form of hippocampal-dependent memory that is developmentally regulated is 
contextual fear learning 73, 233-237. The age of functional onset of fear learning appears to be 
around P21-P28 in rats, generally after plasticity has matured in CA1 73, 84. Although the exact 
mechanisms regulating the window for fear learning is unknown, a leading explanation for 
infantile amnesia pertains to hippocampal neurogenesis; the developmental decline in 
hippocampal neurogenesis corresponds with the ability to form stable long-term memories 
(humans, nonhuman primates, and rodents) 238-241. Another explanation might be the postnatal 
development of molecular brakes on plasticity, eg. the development of PNNs in CA2, the focus 
of this thesis. These studies are integral to our understanding of the mechanisms underlying fear 
learning and how human childhood trauma has detrimental effects on adult mental health. 
Ultimately, these studies may reveal critical therapeutic windows of intervention in the 
hippocampus that could intervene in the widespread psychological effects of early life trauma.  
 
Dissertation Aims 
This thesis seeks to answer outstanding questions regarding the characterization and 
activity-dependent regulation of perineuronal nets (PNNs) in hippocampal area CA2.  
 
Chapter 1: CA2 PNNs are described using fluorescent and electron microscopy to 
characterize composition and anatomical localization around the cell soma and synapses in 
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pyramidal and SR regions. The cellular origin of PNN synthesis in area CA2 is identified using 
fluorescent in situ hybridization. PNN postnatal development is tracked and tested for 
experience-dependent modulation using an environmental enrichment paradigm. Lastly, the 
functional role of PNNs are tested using electrophysiological techniques in mouse hippocampal 
slices where PNNs are degraded and CA2 intrinsic, synaptic and plasticity properties are 
measured.  
 
Chapter 2: I characterized the development and function of PNNs in a mouse model Rett 
Syndrome, a PNN-associated neurodevelopmental disorder. Using a mouse knockout of MeCP2, 
I quantified the premature development and aberrant increase of PNNs in CA2 compared to 
control mice, and investigated the functional effects of premature PNN development on CA2 
plasticity in slices from young animals. Finally, to study the cell-autonomous effects on PNN 
development, I deleted to Rett gene, MeCP2 (methyl-CpG binding protein 2) from CA2 
pyramidal neurons and quantified changes of PNNs in the hippocampus. 
 
Chapter 3: Finally, PNNs have been strongly implicated in temporal lobe epilepsy (TLE). 
Here I aimed to quantify PNN development in a mouse model of TLE. These Kv1.1 knockout 
mice present with seizure activity starting at P21 and sustain recurrent spontaneous seizures into 
adulthood. This mouse also allows for the study of aberrant activity during adolescence, a 
developmental time point when PNNs are differently regulated by activity 242, 243. To better study 
the effects of PNN regulation in vivo, I also describe the creation of a viral vector system 
designed to conditionally target the degradation of PNNs in CA2 with the enzyme ChABC, with 




CHAPTER II - PERINEURONAL NETS SUPPRESS PLASTICITY AT EXCITATORY 
SYNAPSES ON CA2 PYRAMIDAL NEURONS1 
Overview 
Long-term potentiation of excitatory synapses on pyramidal neurons in the stratum 
radiatum rarely occurs in hippocampal area CA2. Here, we present evidence that perineuronal 
nets (PNNs), a specialized extracellular matrix typically localized around inhibitory neurons, 
also surround mouse CA2 pyramidal neurons and envelop their excitatory synapses. CA2 
pyramidal neurons express mRNA transcripts for the major PNN component aggrecan, 
identifying these neurons as a novel source for PNNs in the hippocampus. We also found that 
disruption of PNNs allows synaptic potentiation of normally plasticity-resistant excitatory CA2 
synapses; thus, PNNs play a role in restricting synaptic plasticity in area CA2. Finally, we found 
that postnatal development of PNNs on CA2 pyramidal neurons is modified by early-life 
enrichment, suggesting that the development of circuits containing CA2 excitatory synapses are 
sensitive to manipulations of the rearing environment. 
 
 
                                                 
1 This chapter previously appeared as an article in the Journal of Neuroscience. The orginal citation is as follows: 
Carstens, K.E., M.L. Phillips, and L. Pozzo-Miller, Perineuronal Nets Suppress Plasticity of Excitatory 





Although components of the extracellular matrix (ECM) have been implicated in 
promoting synaptic plasticity, perineuronal nets (PNNs), a specialized form of ECM typically 
found around inhibitory neurons, are thought to inhibit plasticity 67. We previously identified 
hippocampal area CA2 as a region where synaptic plasticity is limited, even relatively early in 
postnatal development 196. Unlike PNNs in other brain regions, PNNs in area CA2 appear to be 
near excitatory synapses of pyramidal neurons 108, 109, 244, leading us to wonder whether PNNs are 
related to pyramidal neurons in some way.  
PNNs first appear in the brain around postnatal day (PN) 14 in the mouse, and gradually 
increase until they are fully expressed in adulthood, often tracking the end of critical windows of 
synaptic plasticity 1, 2. Interestingly, the onset of PNN expression requires normal early 
experience in several brain regions, including motor, visual, and somatosensory systems, and 
similar manipulations performed in adulthood were without effect 113, 114, 116-118. Because PNN 
deposition is experience-dependent and increases during postnatal development, these structures 
have been hypothesized to function in dampening synaptic plasticity during the closure of critical 
periods. For example, Pizzorusso et al. (2002) demonstrated an association between the presence 
and absence of PNNs in the visual cortex and the closure and reopening of ocular dominance 
plasticity, strongly supporting a role for PNNs in limiting experience-dependent plasticity 134. 
Because PNNs associated with pyramidal (i.e., presumed excitatory) neurons are rare in cortical 
structures  245, the role of this matrix in limiting plasticity is widely thought to be due to their 




 The structural and physiological effects of removing PNNs enzymatically have been well 
studied in inhibitory neurons. Degradation of PNNs around inhibitory neurons in culture (mainly 
PV-positive interneurons) with the bacterial enzyme chondroitinase (ChABC) increases 
interneuron excitability without affecting the number or distribution of perisomatic GABAergic 
presynaptic terminals 148, suggesting that PNNs function to regulate inhibitory neuron activity. 
Interestingly, manipulation of neuronal activity seems to modulate the development of PNNs 
both in culture and in vivo. For example, blocking neuronal activity in culture decreases PNNs 
around inhibitory neurons. Similarly, decreasing activity via dark rearing delays and attenuates 
PNN development around inhibitory neurons in the visual cortex 134. 
Hippocampal area CA2, positioned between areas CA3 and CA1, has recently been 
appreciated as an important module of the hippocampus that is molecularly distinct from its 
neighboring areas 197, 246. CA2 neurons receive excitatory synapses from the dentate gyrus, 
entorhinal cortex, and area CA3, and it is these synapses from CA3 in CA2 stratum radiatum 
(SR) that are highly resistant to plasticity 184, 196, 211. Although we have yet to fully understand the 
mechanism(s) behind this resistance to synaptic plasticity, several genes highly expressed in area 
CA2 are implicated in this lack of plasticity 198, 209, 247, 248. Based on these observations and 
previous studies implicating PNNs in restricting plasticity, we investigated whether PNNs 
around pyramidal neurons in area CA2 play a role in restricting synaptic plasticity of CA2 






Materials and Methods 
Animals 
Animals in all experiments were housed under a 12:12 light/dark cycle with access to 
food and water ad libitum. All procedures were approved by National Institute of Environmental 
Health Sciences, University of Alabama at Birmingham, and University of North Carolina 
Animal Care and Use Committees and were in accordance with the National Institutes of Health 
guidelines for care and use of animals. 
Immunohistochemistry  
Mouse lines expressing enhanced green fluorescent protein (EGFP) were used to label 
hippocampal CA2 pyramidal neurons (Gene Expression Nervous System Atlas, Amigo2-EGFP; 
Tg(Amigo2-EGFP)LW244Gsat/Mmcd) and GABAergic interneurons (Riken BioResource 
Center, Gad67-GFP; Cg-Gad1<tm1.1Tama>). Adult male mice were deeply anesthetized with 
Fatal-Plus and perfused with cold PBS, followed by 4% paraformaldehyde in PBS, pH 7.4. 
Brains were removed and postfixed overnight at 4°C and submerged in 30% sucrose. Forty-
micrometer-thick sections were cut on a sliding microtome, blocked in 5% normal goat serum 
and incubated in biotin-conjugated Wisteria floribunda agglutinin (WFA) lectin (1:1000; Sigma-
Aldrich L1516) or antibodies anti-aggrecan (1:500; Millipore AB1031) or anti-neurocan (1:200; 
R&D Systems AF5800) overnight at 4°C. Sections were washed three times in PBS and 
incubated in secondary antibody at 1:500 for 40 min at room temperature: streptavidin Alexa-
568 (Invitrogen), goat anti-rabbit H+L A568 (Invitrogen), or goat anti-chicken H+L (Invitrogen). 
Alternatively, the biotin-conjugated WFA lectin was amplified with the Vectastain Elite ABC kit 
(Vector Laboratories PK-6100) and reacted with 3,3′-diaminobenzidine (DAB) substrate kit 
(Vector Laboratories SK-4100). Sections were mounted with Vectashield antifade mounting 
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medium with DAPI (Vector Laboratories). Images were acquired on a Zeiss laser scanning 
confocal (LSM510 NLO) or a Zeiss light microscope using controlled camera settings. 
Immunohistochemistry and confocal microscopy of excitatory synapses on dendritic spines 
Adult male mice of the thy1-GFP line M (7–20 months; 249) were anesthetized with a 
mixture of ketamine and xylazine, and perfused as described above. Thirty-micrometer-thick 
coronal sections of the brain at the level of the dorsal hippocampus were made with a vibratome, 
and immunohistochemistry was performed on free-floating sections at room temperature. 
Sections were blocked and permeabilized by incubation in 10% goat serum albumin, 2% bovine 
serum albumin, and 0.4% Triton-X in PBS for 1 h. Sections were incubated with biotin-WFA 
(1:100) and primary antibodies diluted in 5% goat serum albumin, 2% bovine serum albumin, 
and 0.1% Triton-X in PBS for approximately 48 hours. Primary antibodies used were guinea pig 
anti-VGLUT1 (1:1000; EMD Millipore AB5905) and rabbit anti-GFP (1:2000; Abcam 290). 
After washing three times for 5 min in PBS, sections were incubated for 4 h in Streptavidin-594 
(1:1000; Life Technologies) and fluorescently labeled secondary antibodies (anti-rabbit Alexa-
488, 1:500; Jackson ImmunoResearch; anti-guinea pig Alexa-647, 1:500; Jackson 
ImmunoResearch). Sections were washed three times for 5 min in PBS, incubated with DAPI 
(300 nm) for 5 min, and washed with PBS for 5 min before mounting with Vectashield antifade 
mounting media (Vector Laboratories). Sections were imaged in a laser-scanning confocal 
microscope (Zeiss Spectral LSM510-META) equipped with a multiline argon laser (458, 477, 
488, and 514 nm) and two HeNe lasers (543 and 633 nm) using an oil-immersion 100× objective 
(1.4 numerical aperture). Image stacks through the z plane were acquired at 0.1 μm, and 





Adult mice (Charles River) were perfused with 4% paraformaldehyde (0.1 m phosphate 
buffer, pH 7.2) and 0.1% glutaraldehyde for 10 min. Brains were postfixed at 4°C overnight and 
50-μm-thick coronal sections were cut on a vibrating microtome. Sections were stained for PNNs 
following a pre-embedding immunohistochemistry protocol and preincubated in 1% NaBH4, 3% 
hydrogen peroxide, and 10% normal goat serum before overnight incubation in biotinylated 
WFA 8 μg/ml (Sigma-Aldrich L1516). Staining was amplified with a Vectastain Elite ABC kit 
(Vector Laboratories), developed with Ni-DAB and incubated in 1% osmium tetroxide, then in 
1% uranyl acetate. Then sections were embedded in epoxy resin. Hippocampal pieces were cut 
from heat-polymerized wafers, glued to a plastic block, cut at 60 nm with an ultramicrotome, 
collected on copper grids, and stained with uranyl acetate and Sato's lead. Electron micrographs 
were imaged on a Philips Tecnai microscope at 80 kV. 
Electrophysiology  
Mice (Charles River Laboratories), age PN 14–18 of either sex, were deeply anesthetized 
with Fatal-Plus, decapitated, and their brains submerged into oxygenated ice-cold sucrose-
substituted artificial CSF (ACSF), pH 7.4, containing the following (in mm): 240 sucrose, 2.0 
KCl, 1 MgCl2, 2 MgSO4, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3 and 10 glucose. Coronal brain 
slices were cut at 300 μm using a vibrating microtome (Leica VT 1000S) and allowed to recover 
at room temperature in a submersion holding chamber with ACSF containing the following (in 
mm): 124 NaCl, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 17 d-glucose 
bubbled with 95% O2 with 5% CO2. Slices from one hemisphere were incubated in ACSF and 
slices from the other in ACSF with 0.05 U/ml chondroitinase ABC (ChABC; Sigma-Aldrich 
C3667) for ≥2 h until they were transferred to a recording chamber and continuously bathed (at 2 
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ml/min) in normal ACSF at room temperature (137). Effectiveness of the chondroitinase treatment 
was confirmed by staining Amigo2-EGFP slices with WFA as above, except that the 300-μm-
thick slices were cleared using 60% thiodiethanol in PBS before imaging (250). 
Whole-cell recordings were made from pyramidal neurons in either the CA2 or CA1 
regions. CA2 neurons in the pyramidal layer were initially identified using Amigo2-EGFP mice. 
Glass borosilicate pipettes were filled with a potassium gluconate internal solution containing the 
following (in mm): 120 K-gluconate, 10 KCl, 3 MgCl2, 0.5 EGTA, 40 HEPES, 2 Na2-ATP, 0.3 
Na-GTP, pH 7.2. The pipettes had a tip resistance between 2.5 and 4 MΩ. Baseline synaptic 
responses were collected for ≥5 min. For long-term potentiation (LTP) experiments, a pairing 
protocol was used. This protocol consisted of 1.5 min of 3 Hz presynaptic stimulation (270 
pulses) paired with postsynaptic depolarization to 0 mV in voltage-clamp mode. Data were 
collected using Clampex 10.4 and analyzed using Clampfit software (Molecular Devices). Series 
and input resistances were monitored by measuring the response to a 10 mV step at each sweep 
and cells were included for analysis if <25% change in series and input resistance was detected. 
Recordings were not compensated for series resistance. 
To determine action potential threshold, whole-cell recordings were performed in 
current-clamp mode. Current pulses of 180 ms in 0.2 nA steps were delivered and the membrane 
potential at which the cells first fired action potentials was measured. To assess excitatory 
transmission, whole-cell recordings were performed in voltage-clamp mode, and EPSCs were 
isolated using the GABAA receptor antagonist bicuculline (10 μm) in the bath solution. EPSC 
amplitudes were measured at increasing stimulation intensities. Paired-pulse facilitation was 
assessed under similar conditions. 
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To measure the NMDA receptor (NMDAR)-mediated component of the EPSC, a cesium 
internal solution was used to block sodium-dependent action potentials, and 5 
tetraethylammonium chloride was used for whole-cell recordings conducted in the presence of 
glycine (5 μm) and bicuculline (10 μm). The cesium internal solution contained the following (in 
mm): 102 CsOH, 102 d-gluconate, 3.7 NaCl, 10 BAPTA, 0.2 EGTA, 20 HEPES, 4 Mg-ATP, 0.3 
Na-GTP, 5 lidocaine N-ethyl bromide (QX314). EPSCs were measured at −70 and +40 mV 
holding potentials. The AMPA receptor (AMPAR)-mediated component of the EPSC was 
measured 2 ms after stimulation at +40 mV (P1), while the NMDAR-component was measured 
50 ms after the same stimulation (P2; 251). The AMPAR/NMDAR ratio was calculated either as a 
ratio of the P1/P2 responses at +40 mV or as a ratio of P1 at −70 divided by P2 at +40 mV. 
 
Environmental Enrichment (EE) 
One dam (Amigo2-EGFP line) and its litter were singly housed in either standard caging 
(32 × 21 × 19 cm) or environmental enrichment (EE) caging (50 × 30 × 30 cm). Standard caging 
included cotton squares (Enviro-Dri, Shepherd's Specialty Papers) for nesting. EE caging 
consisted of toys of varying shapes and sizes, such as plastic houses and wooden blocks; extra 
bedding material, such as cotton squares; sunflower seeds, and fruit/bacon-flavored rodent treats 
for various forms of sensory stimulation. Objects were repositioned/replaced and treats were 
replenished every other day. Brains were harvested as described above from male mice at ages 
PN 14, PN 21, and PN 45 and analyzed for staining of WFA during the 12 h light cycle. WFA 
staining intensity was quantified using measures of pixel luminescence value on ImageJ software 
(National Institutes of Health) using a region of interest (ROI) contoured around either CA2 
pyramidal neurons in stratum pyramidale (SP) or CA2 apical dendrites using GFP fluorescence 
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in a dorsal hippocampal section. The mean gray value measure of the image background was 
subtracted from the mean gray value of the CA2 ROI. Each data point represents one mouse. 
This study was repeated in a separate cohort of animals and the data combined by normalizing 
each mean gray value–the value for the PN 45 enriched cohort–for each study. For each 
experiment, fluorescence quantification was repeated and analyzed with the experimenter 
blinded to condition. The sample number of mice (N) was 4, 5, 6, 7, 8, and 9 for the following 
groups, respectively: PN 14 standard, PN 14 enriched, PN 45 standard, PN 21 enriched, PN 21 
standard, and PN 45 enriched. 
In situ hybridization 
Adult mouse brains were flash frozen and coronal 20-μm-thick sections were cut on a 
cryostat and mounted on SuperFrost Plus slides (Fisher Scientific 12-550-15). Sections were 
fixed in 4% paraformaldehyde for 1 h at 4°C, dehydrated in 50, 70, and 100% ethanol, and air-
dried at room temperature. Fluorescent RNAscope in situ hybridization (ISH) was performed 
using an RNAscope Fresh Frozen Multiplex Fluorescent kit according to the manufacturer's 
protocol to perform target probe hybridization and signal amplification (Advanced Cell 
Diagnostics). Probes were purchased from Advanced Cell Diagnostics: aggrecan mRNA, mm-
acan-C1 (catalog #300031-C1) and the CA2-marker Purkinje cell protein 4 (PCP4) mRNA, Mm-
Pcp4-C2 (catalog #402311-C2). Fluorescent images were captured on a Zeiss laser-scanning 
confocal microscope (LSM710). 
Statistics 
Data in Figures 3 and 4 are expressed as a mean ± SEM. Data in Figure 3 are expressed 
as a normalized mean ± SEM (the enrichment study was repeated once and data were pooled to 
increase statistical power). Statistical analyses were performed using GraphPad Prism 6.05 
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software, and significance was calculated using an α level of 0.05. The Kolmogorov–Smirnov 
test was used to test normality and variance.  
 
Results 
 PNNs localize to excitatory synapses on CA2 pyramidal neurons 
To confirm our initial impression that PNNs indeed surround CA2 pyramidal neurons and 
their dendrites, we used tissue from mice expressing EGFP under the promoter of Amigo2, a 
gene highly expressed in area CA2 252. Three different PNN markers, WFA, the chondroitin 
sulfate proteoglycans aggrecan and neurocan, labeled select inhibitory interneurons throughout 
the hippocampus  (Fig.1a), but also intensely labeled EGFP-expressing CA2 pyramidal neurons 
(Fig. 1b). The origin of PNN matrix components in area CA2 is unknown, so we used 
fluorescence ISH to determine whether these pyramidal neurons express transcripts for the major 
PNN component aggrecan. We found that CA2 neurons identified by Purkinje cell protein 4 
(PCP4) expression, but not CA1 and CA3 neurons, expressed aggrecan mRNA (Fig. 1c). 
Localization of aggrecan mRNA in the pyramidal cell layer of area CA2 indicates that CA2 
pyramidal neurons synthesize at least one major component of the PNN matrix, identifying such 









Figure 1: PNN markers surround CA2 pyramidal neurons and dendrites. a, Fluorescent labeling 
of WFA (green) localizes with CA2 pyramidal neurons and with GAD67-positive inhibitory 
neurons (red) in hippocampus. b, Anti-aggrecan (top), WFA (middle), and neurocan (bottom), 
indicated in green, label EGFP-expressing CA2 pyramidal neurons and their proximal neurites in 
red (scale bar, 50 μm). c, Fluorescent ISHs showing that aggrecan mRNA (green) and a CA2 
marker, Pcp4 mRNA (red), colocalize to the CA2 pyramidal cell layer. Yellow shows the 








WFA also diffusely labeled the CA2 SR and stratum oriens (Fig. 2a) near the dendritic 
spines of excitatory synapses (as defined by label for VGlut1; Fig. 2b). To more precisely 
characterize this diffuse labeling in the CA2 SR, we turned to electron microscopy. We found 
that electron-dense staining for PNNs appeared around the somata of CA2 pyramidal cells and 
numerous dendritic spines in the CA2 SR, especially around spine necks and in perisynaptic 
regions (Fig. 2c). In contrast, staining for PNNs in the neighboring CA1 SP and SR layers was 



















Figure 2: PNN markers are associated with excitatory synapses in area CA2. a, WFA 
immunoperoxidase staining in area CA2 labels CA2 dendrites in the SR in addition to cell bodies 
in the SP. b, WFA label surrounds excitatory synapses on primary apical dendrites of area CA2 
SR; green is GFP expressed in neurons in tissue from a thy1-GFP-M mouse, red is WFA, purple 
is VGLUT1, and yellow shows where two channels depicted in each panel have overlapped 
(scale bar, 1 μm). c, Electron micrographs showing WFA staining along dendritic spines of CA2 
pyramidal neurons in the SR (top, red arrowheads), and area CA2 somata in the SP (bottom), and 












PNN development is regulated by experience 
Consistent with previous work in other brain regions, including area CA1 242, 253, we 
found that PNN staining in CA2 SP and SR increased with age during early postnatal 
development (Fig. 3a), beginning with minimal WFA fluorescence at PN 14, and increasing in 
intensity with age. Early-life sensory deprivation has been demonstrated to delay and attenuate 
PNN development in several brain regions 114, 118, 134. Moreover, in the visual cortex, early-life 
enrichment has been found to counter effects of dark rearing on PNN development, as well as 
promote cortical maturation and accelerate the closure of the critical period for plasticity 254, 255. 
To investigate whether PNNs are similarly modulated by early-life experience in area CA2, we 
reared mice in EE conditions. We found that WFA staining intensity in the CA2 SP was 
significantly greater in EE-exposed animals than those reared in standard housing at PN 21 and 
PN 45 (p = 0.047 and p = 0.001 respectively; two-way ANOVA, Bonferroni's post hoc test for 
pairwise comparison), but not at PN 14, the earliest age tested (Fig. 3b; p > 0.05). WFA staining 
intensity was similarly significantly greater in the CA2 SR at PN 21 and PN 45 (p = 0.015 and p 












Figure 3: PNNs increase during postnatal development and are increased with experience. a, 
WFA staining in area CA2 is increased in animals reared in an enriched environment, compared 
with animals raised in standard (control) cages. Note that the images have been digitally 
lightened in all panels equally to better display PNNs at PN 14 in area CA2. b, Normalized WFA 
fluorescence intensity was significantly greater in CA2 SP of EE mice compared with control at 
PN 21 (N = 8 and 7 for control and EE respectively) and PN 45 (N = 6 and 9 for control and EE 
respectively; Bonferroni's post hoc test for pairwise comparison after two-way ANOVA,*p < 
0.05, ***p = 0.0008). No significant difference was observed at PN 14 (N = 4 and 5 for control 
and EE respectively). A two-way ANOVA for the two conditions at different ages indicated 
significant main effects of age (F(2,33) = 32.33), condition (F(2,33) = 11.72), and interaction (F(2,33) 
= 3.338). Indicated is the mean ± SEM. c, Normalized WFA fluorescence intensity was similarly 
significantly greater in area CA2 SR at PN 21 and 45 (same N's as reported in b; Bonferroni post 
hoc test for pairwise comparison after two-way ANOVA,*p < 0.05, ***p = 0.0009). A two-way 
ANOVA for the two conditions at different ages indicated significant main effects of age (F(2,33) 











PNNs suppress synaptic plasticity in area CA2 
Excitatory synapses in the CA2 SR fail to express typical LTP 196. To determine whether 
PNNs act to restrict this type of plasticity in area CA2, we degraded PNNs with the enzyme 
ChABC in acute hippocampal slices and attempted to induce LTP at CA2 Schaffer collateral 
synapses. Similar to what has been reported for area CA1 137, we found that PNNs are indeed 
degraded in area CA2 after a 2 h incubation of slices in ChABC (0.05 μl/ml; Fig. 4a). As 
reported previously for untreated slices, synaptic responses recorded from CA2 neurons were not 
potentiated following an LTP “pairing protocol” (92.0 ± 0.1% baseline, n = 10), whereas 
synaptic responses recorded from CA1 neurons showed typical LTP (140 ± 0.1% baseline, n = 
12; Fig. 4b;196). However, a 2 h incubation with ChABC enabled LTP induction of excitatory 
synaptic responses in the CA2 SR (140 ± 0.2% baseline, n = 10), reaching levels comparable to 
that induced at CA1 synapses (p = 0.02, two-tailed unpaired t test compared with untreated 
slices). Similar results were obtained when experiments on ChABC-treated or control-treated 
slices were performed in the presence of the GABAA-receptor blocker bicuculline (significant 
difference between ChABC-treated and untreated slices, p = 0.022 at 10 min, two-tailed unpaired 
t test compared with untreated slices, n = 8 and 4 respectively). Intrinsic properties did not 
change in a way that could explain this newly uncovered plasticity in area CA2 (p > 0.05, two-
way ANOVA, Bonferroni's post hoc test for pairwise comparison; Fig. 4c; Tables 1, 2). 
Furthermore, in the presence of bicuculline, we found no significant differences in basal 
excitatory synaptic transmission (Fig. 4d), paired-pulse facilitation (Fig. 4e), or 
AMPAR/NMDAR ratio (Fig. 4f). These findings are consistent with a previous report showing 
that ChABC treatment had no effect on basal synaptic transmission and paired-pulse facilitation 
in area CA1. However, in contrast to our work in area CA2, PNN degradation resulted in an 
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attenuation of LTP in area CA1 137. These findings indicate that PNNs, or another 
chondroitinase-sensitive component of the ECM, restrict plasticity at the normally plasticity-
























Figure 4: Disruption of PNNs allows for potentiation of EPSCs in CA2 neurons. a, PNNs are 
degraded in 300-μm-thick hippocampal slices cleared with thiodiethanol after a 2 h incubation 
with ChABC compared with control; fluorescent labeling of PNNs with WFA (green) and CA2 
neurons with the Amigo2-EGFP mouse (red). Slices shown are from animals at PN 14. b, 
Plasticity of EPSC amplitudes is enhanced in CA2 neurons treated with the PNN-degrading 
enzyme ChABC, compared with untreated controls. After baseline, an LTP pairing protocol (270 
pulses at 3 Hz paired with postsynaptic depolarization; at time 0), resulted in potentiation of 
EPSCs in CA2 neurons treated with 0.05 U/ml ChABC (mean over 22–28 min, n = 10), but not 
in untreated CA2 controls (n = 10). One-way ANOVA, Bonferroni's post hoc test for pairwise 
comparison, *p < 0.05. Indicated is the mean ± SEM. LTP induced in CA1 neurons is shown for 
comparison. Insets are representative traces of EPSCs from CA2 control and CA2 ChABC-
treated neurons before and 20 min after the LTP pairing protocol. c, ChABC treatment did not 
significantly alter action potential firing frequency in response to indicated current injection (n = 
15 per group; two-way ANOVA, p > 0.05). Example traces show action potential firing of 
control (untreated) CA2 neuron (40 pA current steps from −100 to 180 pA displayed). d, e, 
ChABC did not significantly alter excitatory current amplitude (n = 6 per group) or paired-pulse 
ratio in CA2 neurons (S1, peak of first stimulus response; S2, peak of second stimulus response; 
n = 10 ChABC-treated neurons and n = 5 control; two-way ANOVA, Bonferroni's post hoc test). 
f, ChABC did not significantly alter AMPAR/NMDAR ratio measured at +40 mV (left) or at 
−70 mV (n = 6 ChABC-treated neurons and n = 8 controls; two-tailed unpaired t test). 
Measurements in d–f were made in the presence of a GABAA antagonist bicuculline; see 
Materials and Methods for details. Insets are representative traces of EPSCs from CA2 control 
















Intrinsic properties of CA2 pyramidal neurons in response to PNN degradation. CA2 neuron 
input resistance (Ri) is significantly decreased after 0.05 U/mL ChABC treatment (n=11 per 
group, *P<0.0043, two-tailed unpaired t-test). Significant effects were not detected in other 
properties, including resting membrane potential, membrane capacitance, and decay time. 
Indicated are the means ± SEM. 
 




RMP (mV) Cm (pF) Ri (Mohm) Tau (ms) 
CA2 Control -63.75 (1.048) 143.1 (9.700) 303.5 (9.989) 1.796 (0.08762) 





Properties of action potentials in CA2 pyramidal neurons, including threshold, peak amplitude, 
and decay and rise times (tau), were unchanged after ChABC treatment (n = 12 per group, p > 
0.05, two-tailed unpaired t test). Indicated are the means ± SEM. 
 
Table 2: CA2 action potential firing properties in response to PNN degradation. 
 
Action Potential  
 




Rise Tau (ms) 
CA2 Control -47.98 (1.014) 90.48 (2.707) 22.23 (1.518) 264.3 (16.88) 




PNN degradation can re-open critical windows of plasticity in a number of brain regions, 
but the mechanism of plasticity suppression by PNNs is unclear 134, 170, 256. Because PNNs are 
predominantly associated with inhibitory neurons in the neocortex, it has been suggested that 
plasticity is altered by a disruption of inhibitory transmission 67. However, the lack of LTP in 
area CA2 is unlikely to be due to a disruption of inhibitory transmission, as blockade of 
GABAergic synaptic transmission is insufficient to restore LTP in area CA2 at excitatory 
synapses 196, 216 and was not required for the enabling of LTP reported here. In fact, we present 
evidence that PNNs play a distinct role in suppressing synaptic potentiation at a population of 
excitatory synapses on pyramidal neurons, perhaps in addition to any roles PNNs may have 
related to their expression on inhibitory interneurons. Our findings that PNN degradation enables 
LTP in area CA2 are in contrast with the observation that PNN degradation modestly disrupts 
LTP in area CA1 137.  
PNNs surrounding CA2 neurons are unlikely to be the only factor contributing to the 
plasticity resistance in this region. CA2 neurons express high levels of the protein regulator of G-
protein signaling 14 (RGS 14), which has been implicated in the signaling pathway suppressing 
LTP in area CA2 198. In addition, rodent CA2 neurons have a particularly robust capacity for 
calcium buffering and extrusion. Raising external calcium levels to 4 mm is insufficient to 
induce LTP in area CA2, but the very high concentration of 10 mm allows for the induction of 
LTP, indicating that CA2 synapses have the cellular machinery for LTP, but that calcium is 
limited in the postsynaptic neurons 209. Interestingly, both vasopressin and oxytocin, acting 
through AVPR1b and Oxtr receptors respectively, reinstate ability to induce calcium-dependent 
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LTP in CA2 203. Both receptors are known to be coupled to the ‘Gq’ type G-proteins and 
therefore can take part in regulating calcium levels in CA2 spines. 
PNNs might act through a number of possible plasticity-limiting mechanisms; for 
example, they may provide a physical barrier for new synaptic contacts, restrict surface receptor 
mobility, or buffer ions surrounding fast-firing neurons 140, 257-260. PNN proteoglycans are highly 
negatively charged and may function to buffer and restrict diffusion of cations like calcium 3. 
Taken together, it might not be coincidental that cation binding to PNNs was found to be 
saturated at 10 mM 141, a concentration of extracellular calcium that is able to restore plasticity in 
CA2 neurons 209 Alternatively, PNNs may serve to stabilize the postsynaptic density and limit 
AMPAR insertion into the synapse 140. PNNs have also been linked to neuroprotective functions 
258, 261, and neurons in area CA2 have long been noted as being remarkably resistant to cell death 
from both seizure and ischemic insult 194. The role of PNNs in neuroprotection, however, has 
been less well defined. Therefore, if PNNs act to limit calcium accumulation in CA2 neurons, we 
would predict that their disruption would lead to damage susceptibility in area CA2 similar to 
that in areas CA1 and CA3. 
We have also identified CA2 pyramidal neurons as a novel source for a major component 
of PNNs in the hippocampus, suggesting that these excitatory neurons have the capacity to 
modulate PNN composition throughout development. We show here that PNNs in area CA2 are 
upregulated by early-life exposure to EE. Interestingly, other studies have reported a decrease in 
PNNs after exposure to enrichment in adulthood in several brain regions, suggesting that PNNs 
may be differentially regulated depending on the age that the animal is exposed to enrichment. 
For example, amblyopic rats exposed to EE in adulthood had reduced PNNs in the visual 
cortex262; likewise, adult mice exposed to enrichment had reduced PNN density around 
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cerebellar neurons 263. In contrast, early postnatal enrichment was found to rescue PNN 
development in dark-reared animals and promote critical period maturation 254, similar to the 
findings in this study. Further investigation into intrinsic factors that modulate PNNs, such as 
direct manipulation of CA2 activity, or early-life seizure at different developmental stages 
should provide critical insight into how PNNs in area CA2 may be differentially regulated 
throughout development 242. 
Considering that the development of PNNs in hippocampal area CA2 pyramidal neurons 
parallels the expression timeline of PNNs located in brain regions noted for their critical periods 
for plasticity, our data raise the intriguing possibility of an early critical period for synaptic 
plasticity in area CA2. Although the behavioral functions of area CA2 are only beginning to 
emerge, recent reports implicate area CA2 in social aggression and social recognition memory 
203, 223, 224. Developmental regulation of PNNs in area CA2 may therefore represent a therapeutic 






CHAPTER III– PERINEURONAL NETS PREMATURELY RESTRICT PLASTICITY 
IN HIPPOCAMPAL AREA CA2 IN A RETT SYNDROME MOUSE MODEL 
Introduction 
Rett syndrome is a neurodevelopmental disorder caused by a loss-of-function mutation in 
the gene methyl-CpG-binding protein 2 (MeCP2) 266-268. Mecp2 is located on the X chromosome 
and affects about 1 in 10,000 to 23,000 young girls worldwide 269 270. A defining feature of Rett 
symptomology is the apparent normal development for the first year of life, followed by a rapid, 
profound regression in cognitive function. Rett children progressively lose their motor and 
language abilities, develop stereotypic hand movements, suffer from autonomic dysfunction, and 
7 out of 10 eventually develop seizures 268, 271-275. MeCP2 protein functions as a transcriptional 
activator/ repressor, regulates synaptic plasticity and can regulate gene expression post-
translationally (via micro-RNAs) 276-278. The many cellular functions of MeCP2 is correlated 
with its various binding partners and downstream targets 279. MeCP2 is first expressed during 
embryonic development and increases in expression during postnatal development 280, 281. Early 
studies of postmortem brain tissue from Rett patients reveal reduction in dendritic spine number 
and presynaptic markers; rodent studies reveal deficits in adult neurogenesis and synaptic 
plasticity 270, 282-284. Although symptoms develop approximately one year into postnatal life, 
abnormalities in brain development were discovered earlier (embryonic/ early postnatal stages 
prior to the presentation of symptoms) 285-292. Much effort in the field has been put towards 
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understanding the initiation and progression of the disease, and how a Mecp2 mutation may 
disrupt critical early learning and memory function.  
The specialized extracellular matrix, perineuronal nets (PNNs), are altered in several 
psychiatric and neurological disorders, such as Rett syndrome 265, 293 294. PNNs are activity-
dependent and first appear in the brain during postnatal development and gradually increase until 
they are fully expressed in adulthood 118, 295-297. Staining for PNNs was described as being 
overexpressed in postmortem brain tissue of Rett individuals in motor cortices, but decreased in 
number in frontal and temporal cortices 265. PNNs associated with inhibitory neurons are 
elevated in auditory and visual cortices in the mouse models of Rett, consistent with human Rett 
pathology 298, 299. Because PNNs function to limit plasticity during critical windows of 
development, a recent study looked at the effect of degrading PNNs in the auditory cortex of 
Mecp2-/x mothers, and found improvements in maternal care (pup gathering behavior) 298. PNNs 
however have yet to be described in the hippocampus of either Rett postmortem tissue or mouse 
models or in association with a population of excitatory pyramidal neurons.  
Several transgenic knockout mouse models of Rett have been generated that mimic 
human Rett symptomology, exhibiting both neurological and behavioral impairments 283, 300. The 
MeCP2-null mouse model has been integral in identifying various molecular mechanisms behind 
both structural and plasticity deficits 300, 301. These mice exhibit decreased spine number and 
impairments in excitatory/ inhibitory transmission, neurogenesis, and axonal fiber 
disorganization 286, 302-304. The majority of MeCP2-null studies use Mecp2-/Y males because they 
exhibit more severe behavioral phenotypes and pathology than females, although Mecp2-/x 
females eventually exhibit similar deficits 283. Mecp2-/Y males develop severe neurological 
symptoms around six weeks of age and Mecp2-/x females display behavioral symptoms after 
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several months. The delay in developing neurological deficit in the mouse model nicely mimics 
the apparent normal early development that is characteristic of Rett. Overall, both human and 
rodent studies observe the majority of Rett pathology after infancy ( >5 weeks in the rodent), 
however we and others describe pathology in early neonates 287, 290, 305.   
Disruptions in synaptic plasticity in the mouse MeCP2-null hippocampus is a leading 
candidate underlying the hippocampal-dependent learning deficits in Rett syndrome. In the 
Mecp2-/Y hippocampus, synaptic plasticity is impaired at CA1 Schaffer collateral (SC) synapses 
in an age-dependent manner 286. Electrophysiological measurements synaptic plasticity, long-
term potentiation (LTP) and long-term depression (LTD), at Rett CA1 SC synapses in acute 
hippocampal slices reveal reduced LTP and LTD. In field recordings, basal synaptic 
transmission, as assessed with stimulus-response curves, is unchanged between symptomatic 
mice (18-22 weeks of age) and pre-symptomatic mice (3-5 weeks old); however, more recent 
studies find deficits in both inhibitory and excitatory transmission (more later) 286, 306, 307. 
MeCP2-null mice display significant learning and memory deficits in tasks such as hippocampal-
dependent spatial memory, contextual fear conditioning, and long-term social memory 300, 308, 309 
286. Furthermore, homeostatic synaptic scaling also appears to be disrupted in the Rett 
hippocampus 310 72. Several molecular mechanisms have been proposed to explain these deficits 
in activity-dependent plasticity.  
The plasticity impairment in Rett hippocampus has been linked altered NMDA receptor 
(NMDAR) subunit composition, which may underlie the profound effects on NMDAR-
dependent forms of synaptic plasticity. NR2A levels were significantly decreased and NR2B 
levels were increased in symptomatic mice; NR1 was unaffected 286. During development, NR2A 
subunit gradually replaces the NR2B subunit at the postsynaptic cell in an activity-dependent 
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manner and NR2A functions to drive ‘mature’ NMDAR currents 311-313. Alternatively, or in 
addition, MeCP2 was initially thought to act as a transcriptional repressor of BDNF, a key 
molecule in brain development and plasticity 314, 315. Loss of MeCP2 increased BDNF protein 
levels in the hippocampus (primary cultures) 314, 316; however, others have reported a decrease of 
BDNF in MeCP2 mutant  brain lysates 317, 318. MeCP2 is now thought to also act as an activator 
of Bdnf transcription through binding to the promoter region of Bdnf. Upon neuronal 
depolarization, MeCP2 would be released, allowing Bdnf transcription and subsequent activity-
dependent gene regulation 318, 319 314. Interestingly, overexpression of BDNF rescues locomotor 
and electrophysiology deficits (in cortex) and extended lifespan of MeCP2-null mice 317.  
Electrophysiological studies of the Rett mouse models reveal a critical role for MeCP2 in 
maintaining synaptic excitatory and inhibitory transmission in cortical regions 320. Both enhanced 
inhibition and reduced excitation have been observed in the Rett mouse 303, 321, however the 
effects are complicated because the Rett mouse hippocampus also displays hyperexcitability on a 
global scale 306. Neurological deficits, like seizure, were initially linked to glutamatergic activity 
due to neuronal hyperexcitability 322. More recent work, however, has focused on the role of 
MeCP2 exclusively in inhibitory neurons 323, 324. Targeted expression of MeCP2 in only 
excitatory neurons of a MeCP2-null mouse was unable to rescue most Rett phenotypes 325. 
However, a conditional deletion of MeCP2 in GABAergic inhibitory neurons was sufficient to 
recapitulate most Rett phenotypes 302 and even abolish critical plasticity 326. Overall, the 
variability in cell-type specific deficits associated with the loss MeCP2 suggests that MeCP2 is 
likely acting cell-autonomously in response to activity.  
Although morphological defects have been described in the human Rett hippocampus, 
PNN pathology in human or rodent hippocampus has yet to be studied. In Rett postmortem 
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tissue, hippocampal CA3/4 pyramidal cells neurons appeared hypochromic (described as cellular 
degradation/ ‘ghost cells’) while CA1 cells appeared normal 327. In rodent Mecp2-/Y CA2, neurons 
are reported to be smaller than those in wildtype mice 305, 317, 328, although this decrease in size 
was certainly not limited to neurons in CA2. In this study, I aimed to determine whether PNNs 
associated with a population of excitatory neurons in area CA2 were altered or disrupted in a 
mouse model of Rett. I then investigated whether Mecp2 deletion resulted in any functional 
consequences in CA2, particularly regarding synaptic plasticity. CA2 SC synapses are normally 
resistant to the induction of long-term potentiation (LTP) and as outlined in a previous chapter, I 
identified PNNs as a negative regulator of LTP in acute hippocampal slices of P14-18 day old 
mice. Here I describe experiments showing that PNNs develop prematurely in area CA2 of 
Mecp2-/Y and in a conditional knockout of Mecp2. Furthermore, I found that the plasticity at CA2 
SC synapses prior to the development of PNNs is prematurely restricted at P8-11 in CA2 of a 
MeCP2-null mouse. I also found that normal plasticity in immature CA2 can be rescued by 
degrading PNNs in vitro at P8-11. The results of these studies support the hypothesis that 
MeCP2 can regulate PNNs cell-autonomously in CA2 neurons, and that the premature 
development of PNNs in Rett CA2 results in an early closure of a plasticity ‘critical period’ 
there. The results of these studies are suggestive of a novel critical window of plasticity in CA2 






Materials and Methods 
Animals in all experiments were housed under a 12:12 light/dark cycle with access to 
food and water ad libitum. All procedures were approved by National Institute of Environmental 
Health Sciences Animal Care and Use Committee and were in accordance with the National 
Institutes of Health guidelines for care and use of animals. 
Rett Syndrome mouse model:  
Mice used in this study were hemizygous MeCP2-deficient males (Mecp2-/Y; 
B6.129P2(C) -Mecp2tm1.1Bird , The Jackson Laboratory, stock # 003890, donated by Adrian Bird, 
University of Edinburgh 300). Mecp2-/Y mutant males exhibit severe Rett-like characteristic at 3-8 
weeks of age, whereas heterozygous females exhibit symptoms much later around 6 months of 
age. This mouse line is maintained by breeding heterozygous Mecp2-/x females with C57BL/6 
males. No special breeding conditions were used.  
Conditional deletion of MeCP2:  
For deletion of Mecp2 in CA2 pyramidal neurons, we used commercially available mice 
with an X-linked mutation, loxP sites flanking exons 3-4 of the Mecp2 gene (floxed-MeCP2; 
Mecp2flox ; B6.129P2( C) -Mecp2tm1.1Bird/J , The Jackson Laboratory, stock # 006847, donated by 
Adrian Bird, University of Edinburgh 300) 
This mouse line was maintained by breeding heterozygous Mecp2flox /x with C57BL/6 males; the 
hemizygous males Mecp2flox /y are infertile. To delete MeCP2 in CA2 neurons, we crossed 
heterozygous floxed-MeCP2 females with Amigo2-Cre+ males. MeCP2 is excised upon the 
recombination of the loxP sites in neurons expressing Cre recombinase. 
CA2 Cre-expressing line:  
The Amigo2-Cre mouse line was generated in house at the NIEHS, see Supplemental 
Methods Fig. S13-17 for genetic and histology details 230. The Amigo2 gene (adhesion molecule 
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with Ig like domain 2) is expressed in CA2/3a, the fasciola cinereum, the cerebellum, the 
accessory olfactory bulb, and the premammillary nucleus  (in situ hybridization data, Allen Brain 
Atlas, Seattle, WA; 252 To gain selective genetic access to molecularly-defined CA2, we used an 
Amigo2-Cre line that expresses Cre recombinase predominantly in CA2 neurons in adult mice. 
This mouse was generated from a bacterial artificial chromosome (BAC) transgene (Rp23-
288P18); as in Tg(Amigo2-EGP)LW244Gsat2 (GENSAT2) 329. Amigo2-cre mice were 
maintained as hemizygous by breeding Amigo2-Cre+ mice with C57BL/6 mice. Only Cre+ males 
were used in this study and brains harvested >3 weeks old.   
Immunohistochemistry: 
Mice were deeply anesthetized with Fatal-Plus and perfused with cold phosphate-
buffered saline (PBS), followed by 4% paraformaldehyde in PBS (pH 7.4). Brains were removed 
and post-fixed overnight at 4°C and submerged in 30% sucrose. Forty μm-thick sections were 
cut on a sliding microtome, blocked in 5% normal goat serum and incubated in biotin-conjugated 
WFA lectin (1:1000, Sigma Aldrich L1516), or rabbit anti-MeCP2 (07-013, Millipore, 1:500), or 
mouse anti-STEP (Cell Signaling, 4817, 1:500), or mouse anti-regulator of G-protein signaling 
14 (UC Davis/NIH NeuroMab Facility, AB_10698026, 1:1,000), or rabbit anti-PCP4 (SCBT, sc-
74186, 1:500 overnight at 40 C. Sections were washed 3 times in PBS and incubated in secondary 
antibody at 1:500 for 40 minutes at room temperature: streptavidin Alexa-568, or goat anti-rabbit 
H+L A568, or goat anti-mouse Alexa-568 (Invitrogen). Sections were mounted with Vectashield 
anti-fade mounting medium with DAPI (Vector laboratories). Images were acquired on a Zeiss 
laser scanning confocal (LSM510 NLO) or a Zeiss light microscope using controlled camera 
settings. 
                                                 
2 The Gene Expression Nervous System Atlas (GENSAT) Project, NINDS Contracts N01NS02331 & 




Mice (Charles River Laboratories, Raleigh, NC) were deeply anesthetized with Fatal-
Plus, decapitated, and their brains removed and submerged into oxygenated ice-cold sucrose-
substituted artificial cerebrospinal fluid (ACSF) of pH 7.4 (in mM): 240 sucrose, 2.0 KCl, 1 
MgCl2, 2 MgSO4, 1 CaCl2, 1.25 NaH2PO4, 26 NaHCO3 and 10 glucose. Brain slices were cut 
coronally at 300 μm using a vibrating microtome (Leica VT 1000S) and allowed to recover at 
room temperature in a submersion holding chamber with artificial cerebral spinal fluid (ACSF) 
(in mM): 124 NaCl, 2.5 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 17 D-glucose 
bubbled with 95% O2 with 5% CO2.  
Whole-cell recordings were made from pyramidal neurons in area CA2, which were 
identified visually using differential interference contrast (DIC) optics (CA2 neurons were 
verified in earlier, separate experiments using a CA2-specific fluorescent reporter mouse line, 
see methods 295). Glass borosilicate pipettes were filled with a potassium gluconate internal 
solution (in mM) 120 K-gluconate, 10 KCl, 3 MgCl2, 0.5 EGTA, 40 HEPES, 2 Na2-ATP, 0.3 
Na-GTP, pH 7.2), with a tip resistance between 3-4.5 MOhms. Data were collected using 
Clampex 10.4 and analyzed using Clampfit software (Axon Instruments). Series and input 
resistances were monitored by measuring the response to a 10mV step at each sweep and cells 
were included for analysis if <30% change in series and input resistance. Recordings were not 
compensated for series resistance.  
To assess excitatory transmission in P14-18 slices, whole-cell recordings were performed 
in voltage-clamp mode, and postsynaptic currents (PSCs) were evoked with a bipolar stimulating 
electrode placed in the stratum radiatum. Excitatory PSCs (EPSCs) were isolated using the 
GABAA receptor antagonist bicuculline in the bath solution. Paired-pulse facilitation (PPF) was 
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assessed under similar conditions. Inhibitory transmission was not blocked in P8-11 slices 
because pilot experiments with bicuculline in the bath solution resulted in epileptic activity 
during recordings (data not shown). To determine action potential threshold, whole-cell 
recordings were performed in current-clamp mode. Current pulses of 180 ms in 0.2 nA steps 
were delivered and the membrane potential at which the cells first fired action potentials was 
measured.   For long-term potentiation (LTP) experiments, baseline EPSCs were collected every 
15 seconds for at least 5 minutes after which a pairing protocol was used, consisting of 1.5 
minutes of 3 Hz presynaptic stimulation (270 pulses) paired with postsynaptic depolarization to 0 
mV in voltage-clamp mode 330, 331. Data were averaged and normalized to baseline.  
Immunoblotting: 
Neurons in single hippocampal hemispheres were lysed with RIPA buffer (Thermo) with 
HaltTM protease/phosphatase inhibitor cocktail (Thermo). Lysate was briefly sonicated and 
incubated on ice for 30 minutes while rocking. The lysate was centrifuged and resolved by gel 
electrophoresis and transferred to a nitrocellulose membrane using the iBlot gel transfer 
apparatus (Invitrogen). Immunoblots were incubated with primary antibody overnight, washed 
3X in PBS with 0.01% Tween for five minutes each and incubated in secondary for two hours. 
They were again washed 3X in PBS with 0.01% Tween for five minutes each. Blots were 
visualized with an Odyssey infrared scanner (Li-COR Biosciences) after immunolabeling 
primary antibodies with infrared fluorophore–tagged secondary antibody (LiCor). Images were 
analyzed using the ImageJ; the mean gray value of the band of interest was measured and 
background was subtracted (defined as a region in close proximity to the band of interest). 
Equal amounts of protein (25 ug) from each sample were loaded on 4-12% bis-tris 
NuPage gels (Invitrogen) and transferred to nitrocellulose membranes. The following antibodies 
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were used: rabbit antibody to NR2A (04-901, Millipore, 1:4000), rabbit antibody to glutamate 
receptor 1 protein (GluR1) (ab1504, Millipore, 1:1000), rabbit antibody to MMP-9 (PA5-13199, 
Invitrogen, 1:1000), rabbit antibody to meCP2 (07-013, Millipore, 1:500), mouse antibody to β-
actin (MA5-15739, Invitrogen, 1:10,000), donkey secondary antibody to rabbit IgG 
IRDye680RD® (925-68073, LiCor, 1:500), and goat secondary antibody to mouse IgG (H+L) 
IRDye800CW® (924-32210, LiCor). 
 
Results 
LTP is expressed at CA2 SR synapses at P8-11 
Excitatory synapses in CA2 stratum radiatum (SR) of P14-18 acute hippocampal slices 
normally fail to express typical LTP, but PNN degradation in vitro enables LTP 295. Whether 
LTP can be induced at CA2 SR synapses at an age prior to PNN development (<P14) has yet to 
be tested. First, I characterized the expression of several putative negative regulators of plasticity 
in CA2 at P10 compared to P60. I found RGS14, which had been shown to inhibit LTP in CA2, 
was minimally detected at P10 and strongly expressed at P60, consistent with a previous study 
198. Similarly, STEP, WFA and PCP4 were either not detected (WFA) or minimally detectable at 
P10 (Fig. 3.1a), and highly expressed at P60. Next, I tested whether LTP could be induced at 
CA2 SR synapses at an age when PNNs as assessed with WFA staining, and these other proteins 
are not yet detectable (P8-11) compared to P14-18 when PNNs have begun to develop (Fig. 
3.1b). Stimulating CA2 SR synapses with an LTP pairing protocol (3 Hz stimulation while 
depolarizing the cell to 0 mV) was sufficient to induce LTP at P8-11 CA2 SR synapses (143 ± 
0.2% baseline, *P=0.0011, two-tailed unpaired t-test at 25-30 min. Fig. 3.1c).  
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Intrinsic properties did not change in a way that could explain LTP in at P8-11 (Table 
3.1, unpaired t-test, P>0.05). I found no significant differences in paired-pulse facilitation (Fig. 
3.1d), but did observe higher basal excitatory transmission at P8-11 compared to P14-18 CA2 
neurons (**P= 0.0011 at the highest current stimulation intensity, 320 uA, two-way ANOVA, 
Bonferroni post-hoc test, Fig. 3.2d). Because inhibitory transmission was not blocked during P8-
11 recordings, I repeated EPSC stimulus-response and PPF experiments without inhibitory 
blockers and replicated results in Fig. 3.2d (data not shown). The action potential firing 
frequency of CA2 neurons was also higher at P14-18 compared to P8-11 (**P= 0.0036 at 180 pA 
of injected current, Bonferroni post hoc test for pairwise comparison, two-way ANOVA, Fig. 
3.1d). Developmental changes in CA2 action potential firing frequency at P8-11 does not explain 
the LTP in CA2. The enhanced excitatory transmission (stimulus-response curve) at high 
intensity stimuli at P8-11 CA2 SR synapses compared to P14-18 is similarly unlikely to a factor 
because the LTP experiments were typically performed using stimulation intensities between 15-
30 µA. 
PNNs are increased in CA2 of a mouse model of Rett Syndrome  
Previous work has shown that PNNs, presumably around PV neurons, are higher in brain 
tissue from both individuals with Rett Syndrome and Mecp2-/Y mice 265. To determine whether 
PNN maturation is also altered in hippocampal area CA2 in postnatal development, I quantified 
PNNs at P14, 21 and 45 in a Mecp2-/Y mice. I found that staining for the PNN marker, WFA, is 
increased in P14, 21 and 45 in CA2 stratum pyramidale (SP) of Mecp2-/Y compared to wildtype 
littermates (Fig. 3.2a), Bonferroni post hoc test for pairwise comparison, two-way ANOVA, 
**P< 0.005, ***P<0.0001. WFA staining was however unchanged around PNN+ inhibitory 
neurons in area CA1 and in overlying somatosensory cortex, P > 0.05 (Fig. 3.2a). This finding in 
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somatosensory cortex was in contrast to the results reported in another study looking at PNNs in 
somatosensory cortex in a MeCP2-null mice, which showed PNN staining to be increased 284. 
We also investigated whether another CA2 plasticity inhibitor may be increased in the MeCP2-
null mouse, RGS14. Staining for RGS14 protein was unchanged in CA2 SP at P14, 21, and P45 
of the MeCP2-null males compared to wildtype littermates, P > 0.05 (Fig. 3.2b). I next sought to 
determine whether this premature overexpression of PNNs in CA2 prematurely inhibits synaptic 
plasticity.  
PNNs in CA2 are increased in a targeted deletion of MeCP2 in CA2 
Lastly, I sought to determine whether the increase in PNNs in CA2 of Rett is cell-
autonomous to pyramidal neurons, or is dependent on a global loss of MeCP2 in the 
hippocampus, perhaps by way of glial cells or inhibitory network properties 302, 325.To test this, 
we ablated MeCP2 from CA2 neurons and quantified PNN expression levels in the 
hippocampus. We used a mouse strain expressing Cre recombinase (Cre) in CA2/3 neurons, 
Amigo2-Cre+, to gain selective genetic access to molecularly-defined CA2 pyramidal cells. To 
conditionally delete MeCP2 from CA2 neurons, we crossed Amigo2-Cre+ mice with a Cre-
dependent MeCP2 mouse line, floxed-MeCP2 (Mecp2flox/x) (Fig. 3.3a). The loss of MeCP2 
protein was observed in all CA2 pyramidal neurons and sparsely in CA3 pyramidal neurons and 
dentate gyrus (DG). No apparent loss of MeCP2 protein was observed in extra-hippocampal 
brain structures, however it is likely that regions where Amigo2 is expressed were also affected 
(eg. Cerebellum; 252. MeCP2 protein was not altered in Amigo2-Cre-; floxed-MeCP2 animals 
compared to C57BL/6 (data not shown). Staining for PNNs revealed a greater staining intensity 
of WFA in CA2 SP compared to three different controls: Cre+ WT, Cre-Floxed, Cre+ WT (***P 
= 0.0001, one-way ANOVA, Tukey for post-hoc test, Fig. 3.3b), replicating the findings in the 
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global Mecp2-/Y mouse (Fig. 3.2a). We also found that PNNs were not different around PNN+ 
neurons in CA1 or overlying somatosensory cortex (Fig. 3.3b). These data support the idea that 
MeCP2 is likely acting cell-autonomously in pyramidal neurons to upregulate PNNs in CA2.  
LTP is prematurely restricted at CA2 SR synapses in a mouse model of Rett and 
degradation of PNNs restores plasticity 
Because we found that LTP is expressed at CA2 SR synapses at P8-11 before PNNs are 
detectable, we next asked whether the higher expression of PNNs in Rett CA2 may disrupt the 
potentiation we can induce at early postnatal ages. We quantified WFA staining intensity in CA2 
at P11 in MeCP2-null males compared to age-matched wildtype littermates. WFA staining was 
indeed was higher in CA2 at P11 in the MeCP2-null compared with WT littermates at that age 
(**P=0.0043, two-tailed, unpaired t-test, Fig. 3.4a). Note: to capture optimal images of WFA 
fluorescence at P11, I had increased the camera exposure settings (relative to settings for P14-45 
images in Fig. 3.1a). Next, I tested whether LTP could be induced at CA2 SR synapses in P8-11 
MeCP2-null males like in wildtype animals. Consistent with the idea that premature PNN 
development interferes with LTP, I found that LTP is indeed prematurely restricted at P8-11 
CA2 SR synapses in Mecp2-/Y compared to wildtype littermates (111 ± 0.1% baseline at 20 
minutes versus 1670.1%  ± 0.3% baseline in wildtype baseline at 20 minutes), **P= 0.005, two-
tailed unpaired t-test, Fig. 3.4b. Intrinsic properties did not differ in a way that could explain the 
premature restriction of plasticity in CA2 (Table 3.1, P>0.05, unpaired t-test). I also found no 
significant differences in action potential firing frequency or paired-pulse facilitation at P8-11 
between Mecp2-/Y and wildtype littermates (p>0.05, two-way ANOVA, Fig. 3.4c). Basal 
excitatory transmission, as assessed with a stimulus-response curve, was however smaller at P8-
11 CA2 synapses of Mecp2-/Y compared to wildtype littermates (*P= 0.014  at 320pA current 
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stimulation, two-way ANOVA,  Bonferroni post-hoc test, Fig. 3.4c). This may provide a possible 
explanation for the premature loss of LTP at P8-11 CA2 Rett synapses if synapses were 
‘maximally potentiated’ prior to slice preparation, as proposed by Pozzo-Miller and colleagues 
332. To determine whether it is indeed the aberrant PNNs that are functioning to prematurely 
restrict LTP in Rett CA2, I degraded PNNs in an acute hippocampal slice with the exogenous 
enzyme chondroitinase (ChABC). I found that degradation of PNNs with ChABC apparently 
restored the ability to induce LTP at CA2 SR synapses of P8-11 MeCP2-null males to the level 
of wildtype littermates (178 ± 0.4% baseline versus 1.11 ± 0.4% baseline of WT 20 minutes, *P= 
0.038, two-tailed unpaired t-test, Fig. 3.4d).  
Global loss of MeCP2 alters plasticity-regulating molecules in the hippocampus 
I next explored a few other possible mechanisms that may explain PNN upregulation and 
disrupted plasticity in the Rett syndrome mouse model. One endogenous ECM-degrading 
enzyme, MMP-9, was worth investigating as it has been shown to regulate structural and 
functional plasticity in the visual cortex and postnatal reduction of MMP-9 levels promotes PNN 
formation 160, 166, 333-335. Immunoblot analyses of MMP-9 protein levels in the adult hippocampus 
revealed a significant decrease in MMP-9 in MeCP2-null males compared to wildtype littermates 
(*P=0.034, one-tailed, unpaired, t-test, Fig. 3.5b). Note that we confirmed a complete loss of 
MeCP2 protein in Mecp2-/Y  hippocampal lysate (Fig. 3.5a). Furthermore, glutamatergic receptor 
subunits GluR-1 (AMPAR) and NR2a (NMDAR) have been implicated as a mechanism for 
disrupted plasticity in CA1 hippocampal neurons of the MeCP2-null mouse 286. Consistent with 
previous reports, we show that NR2a protein is decreased in the Mecp2-/Y males compared to 
wildtype littermates (Fig. 3.4c) and GluR-1 is unchanged (Fig. 3.5d). The critical next 
experiments, though, will be to measure these plasticity-associated molecules (and the CA2 
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plasticity-restricting molecules) in the hippocampus of pre-symptomatic P8-11 Mecp2-/Y mouse. 
These future experiments will provide valuable insight into the mechanisms underlying 


























Figure 5- Fig. 3.1 
Figure 3.1: LTP is expressed at CA2 SR synapses at P8-11 
a) CA2 markers RGS14, STEP, PCP4, WFA at P10 and P60 in the hippocampus. At P10, WFA 
staining in CA2 is the weakest relative to staining of RGS14, STEP and PCP4, which area also 
show weak staining. At the adult age of P60, staining for all four protein markers are strongly 
expressed in CA2.  b) WFA staining at P11 and P14 in the hippocampus; the age of acute slices 
used in electrophsyiology recorings in c). Staining for WFA immunofluorescence is detectable 
and morphologically mature in area CA2 at P14 but not at P11 (left). Image of a 300-µm 
hippocampal slice where a CA2 neuron is patched with a glass recording electrode and a 
stimulating electrode is placed in CA SR. c)  LTP is expressed at CA2 SR synapses in early 
postnatal development in a hippocampal slice, before PNNs are detectable in CA2. Plasticity of 
excitatory postsynaptic current (EPSC) amplitudes is present in CA2 neurons at PN 8-11, but 
disappears by the second postnatal week. After baseline, an LTP pairing protocol (270 pulses at 
3 Hz paired with postysnpatic depolarization; at time 0), resulted in potentiation of EPSCs in P8-
11 CA2 neurons. Right: mean over 22-28 minutes of recovery, *P=0.0011, two-tailed unpaired t-
test (n=8 and 9 for P14-18 and P9-11 respectively). Arrow indicates induction of the LTP pairing 
protocol. Indicated is the mean +/- SEM, normalized to baseline. d) Excitatory postsynaptic 
currents in response to indicated current stimulation is increased at P11 CA2 synapses compared 
to P14, **P= 0.0011 at 320pA current stimulation, two-way ANOVA, Bonferroni post-hoc test 
(n=9 and 8, P8-11 and P14-18, respectively). Paired-pulse ratio at CA2 synapses is unchanged 
(S1= peak of first stimulus response, S2= peak of second stimulus response). Action potential 
firing frequency of P11 CA2 neurons is increased compared to P14, **P= 0.0036 at 180pA of 







Figure 6- 3.2 
Figure 3.2: PNNs are increased in CA2 of a mouse model of Rett Syndrome during postnatal 
development  
a) Staining for PNN marker WFA (green) is increased in CA2 of Mecp2-/Y males compared to 
wildtype littermates. Top) Normalized WFA fluorescence intensity was signficatly greater in 
CA2 SP of Mecp2-/Y males (N=4, 4, 5 for ages P14, 21, 45 respectivietly), compared to wildtype 
littermates (N=4, 3, 5 for ages P14, 21, 45 respectivietly), Bonferroni post hoc test for pairwise 
comparison after two-way ANOVA, **P< 0.005, ***P<0.001. A two-way ANOVA for the two 
conditions at different ages indicated significant main effects of age F(2,19)=194.8, condition 
F(1,19)=110.5, and interaction F(2,19)=4.913.) WFA surrounding PNN+ inhibitory neurons in 
CA1 was unchanged in Mecp2-/Y males compared to wildtype littermates, (P>0.05). WFA 
staining in overlying somatosensory cortex was unchanged in Mecp2-/Y males compared to 
wildtype littermates, (P>0.05). Indicated is the mean ± SEM. b) RGS14 staining in CA2 is 
unchanged in MeCP2 compared to wildtype littermates. Normalized RGS14 fluorescence 
intensity was not significantly different in CA2 SP at any age (Bonferroni post hoc test for 











Figure 7- 3.3 
Figure 3.3: PNNs in CA2, not in CA1 or overlying cortex, are increased in a targeted deletion of 
MeCP2 in CA2. 
a) To conditionally delete MeCP2 from CA2 neurons, we crossed Amigo2-Cre+ mice with a Cre-
dependent MeCP2 mouse line, floxed-MeCP2 (Mecp2flox /x). Staining for the MeCP2 protein 
(red) is absent from the CA2 SP and attenuated in CA3 and DG of the Amigo2-Cre+; floxed-
MeCP2 mouse. The PNN marker WFA appears increased in area CA2 in the Amigo2-Cre+; 
floxed-MeCP2 mouse compared to control (Amigo2-Cre-; Mecp2flox/Y).  b) Quantification of 
WFA fluoresence in CA2 SP, PNN+ neurons in CA1, and overlying somatosensory cortex of 
Amigo2-Cre+; floxed-MeCP2 mouse compared to controls, Cre- wildtype, Cre+ wildtype, 
Amigo2-Cre-; floxed-MeCP2. WFA fluorescence intensity is significantly increased in the 
Amigo2-Cre+; floxed-MeCP2 mouse in CA2 SP compared to controls, ***P = 0.0001, one-way 
ANOVA, Tukey for post-hoc test, (N= 3 per group). All other regions were not significant, 






Figure 8- 3.4 
Figure 3.4: Plasticity of excitatory postsynaptic current (EPSC) amplitudes is prematurely 
restricted at P8-11 CA2 SR synapses of Mecp2-/Y neurons and restored upon PNN degradation.  
a) Staining for WFA is detecable and increased in area CA2 of Mecp2-/Y at P11 compared to 
wildtype littermate, **P=0.0043, two-tailed, unpaired t-test, (N= 6 and 4, wildtype littermate and 
Mecp2-/Y respectively). Note that fluorescent intensity was amplified by camera expsoure settings 
for quantification purposes.  b) LTP is restricted at CA2 SR synpases in P8-11 Mecp2-/Y (red) in 
acute hippocampal slices compared to wildtype littermates (gray). Right: mean at 20 minutes of 
recovery, **P= 0.005, two-tailed unpaired t-test, (n= 14 and 16, wildtype littermate and Mecp2-/Y 
respectively). Arrow indicates induction of the LTP pairing protocol. Indicated is the mean +/- 
SEM, normalized to baseline. c) Excitatory postsynaptic currents in response to indicated current 
stimulation is decreased at P8-11 Mecp2-/Y CA2 synapses compared to wildtype littermate, two-
way ANOVA,  Bonferroni post-hoc test, *P= 0.014 at 320pA current stimulation (n= 9 and 6, 
wildtype littermate and Mecp2-/Y, respectively). Paired-pulse ratio at CA2 synapses and action 
potential firing frequency is unchanged, p>0.05. d) Degradation of PNNs after a 2-hour ChABC 
treatment restores EPSC potentiation in P8-11 CA2 MeCP2-/Y neurons (pink) compared to 
controls of the same age (red). Right: mean at 20 minutes of recovery, *P= 0.038, two-tailed 
unpaired t-test (n= 16 and 11, Mecp2-/Y and +ChABC Mecp2-/Y). Arrow indicates induction of the 












Table 3.1: CA2 P8-11 intrinsic properties including RMP, Cm and Ri, as well as action potential 
threshold are unchanged in MeCP2-null males compared to widtype littermates (n=17 and 13, 
respectively), P>0.05, two-tailed unpaired t-test. CA2 P14-18 intrinsic properties including 
RMP, Cm, Ri, and action potential threshold are unchanged in MeCP2-null males compared to 
widtype littermates (n=23 and 8), P>0.05, two-tailed unpaired t-test. Indicated is the mean ± 











P8-11 Intrinsic Properties   
 
RMP (mV) Cm (pF) Ri (Mohm) AP threshold 
(mV) 
CA2 Control -64.33 (1.97) 115.7 (5.812) 337.3 (16.49) -20.6 (1.907) 
CA2 Mecp2-/Y -66.44 (1.464) 120.5 (5.912) 317.7 (24.32) -16.32 (1.46) 
P14-18  
CA2 Control -65.66 (1.575) 179.8 (12.26) 174.5 (14.38) -16.29 (1.85) 
CA2 Mecp2-/Y -64.05 (0.8062) 186.5 (7.605) 223 (14.99) -12.01 (1.145) 
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Figure 9- 3.5 
Figure 3.5: Global loss of MeCP2 alters plasticity-regulating molecules in the hippocampus. 
a) Immunoblot of MeCP2 protein (75 kDa) in Mecp2-/ compared to wildtype littermate (left). The 
ratio of MeCP2 protein over loading control is signficantly decreased in Mecp2-/Y compared to 
wildtype littermate (right). ***P=0.0003, two-tailed, unpaired, t-test, n=3 for each group. b) 
Immunoblot of MMP-9 protein (92 kDa) in Mecp2-/ compared to wildtype littermate (left). The 
ratio of MMP-9 protein over loading control is decreased, in Mecp2-/ compared to wildtype 
littermate (right). *P=0.034, one-tailed, unpaired, t-test, n=3 for each group. c) Immunoblot of 
NR2a protein (170 kDa) in Mecp2-/ compared to wildtype littermate (left). The ratio of NR2a 
protein over loading control is signficantly decreased in Mecp2-/ compared to wildtype littermate 
(right). *P=0.024, two-tailed, unpaired, t-test, n=3 for each group. d) GluR-1 protein (107 kDa) 
in Mecp2-/ compared to wildtype littermate (left). The ratio of GluR-1 protein over loading 












A key challenge for understanding the pathogenesis of Rett syndrome is identifying 
molecular targets and understanding when and how they cause synaptic dysfunction. PNNs are 
functionally implicated in inhibiting structural and synaptic plasticity in the developing brain 296. 
Moreover, PNNs are elevated in several cortical regions in postmortem Rett individuals, as well 
as in the mouse model of Rett, MeCP2-null 265, 284, 336, 337. Because, PNNs have yet to be 
described in the hippocampus or during early postnatal life, I characterized the development of 
PNNs in the hippocampus between ages P11 to P45 in Mecp2-/Y males. I found that staining for 
PNNs develops prematurely and is increased in adulthood in hippocampal area CA2 of Mecp2-/Y 
males compared to wildtype littermates. Because the maturation of PNNs closely track the 
closing of critical windows of plasticity, I reasoned that the normal absence of PNNs at P11 in 
CA2 may be correlated with a yet-to-be described developmental window of plasticity at CA2 
synapses.  
In the visual system, PNNs first appear around inhibitory neurons after eye opening, 
~P15 and are fully matured by P30, tracking the closure of critical period plasticity in mice 298. 
PNNs first develop in area CA2 around P14 in the rodent. Hippocampal CA2 neurons are 
normally resistant to LTP induction at CA2 SR synapses in mice older than P14 196. Because I 
previously found that degrading PNNs in an acute hippocampal slice was sufficient to enable 
plasticity in CA2 at P14-18 295, I tested whether I could induce plasticity in CA2 at in P8-11, an 
age before PNNs develop in CA2. I found that potentiation could indeed be induced at CA2 SR 
synapses in the neonatal hippocampus, discovering a previously unknown window of synaptic 
plasticity in the hippocampus that correlates precisely with the onset of PNN appearance. Next, I 
investigated whether PNNs and/or plasticity may be altered in the developing brain at P8-11 in 
Rett CA2 neurons. 
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I hypothesized that because PNNs are at least one brake on CA2 plasticity, premature 
development of PNNs may be correlated with premature restriction of plasticity at CA2 SR 
synapses. Indeed, I found that plasticity is suppressed prematurely in CA2 of a mouse model of 
Rett (at P8-11). Premature restriction of CA2 LTP may be due to. An alternative hypothesis 
could be that, because others have found inhibitory transmission developing prematurely, as in 
the visual system; LTP in CA2 may be prematurely restricted by inhibition 298. However, this is 
unlikely considering GABA transmission is normally excitatory at P8-11 105, although not 
validated at CA2 synapses. Our data rules out CA2 excitability as a possible explanation because 
action potential firing frequency is unchanged in Mecp2-/Y males. Moreover, I found that 
degradation of PNNs in vitro with ChABC rescues early plasticity restriction, strongly 
implicating PNNs as a regulator of premature plasticity in Mecp2-/Y CA2. To explain the 
ChABC-induced LTP restoration, I proposed to examine whether ChABC treatment at P8-11 in 
Mecp2-/Y hippocampi enhances CA2 excitatory synaptic strength or increases intrinsic 
excitability. Overall, the restoration of CA2 plasticity by ChABC treatment in the Rett mouse 
hippocampus convincingly point to PNNs as a premature molecular brake on plasticity in CA2.  
PNNs function to stabilize synapses in the developing brain, therefore premature PNN 
maturation in Rett CA2 may be disrupting normal synapse/ circuit development 296. PNN 
development is activity-dependent and is modulated by normal experience in early-life in several 
brain regions including motor 116 and visual 113, 117, 118 systems. In general, sensory deprivation 
from birth delays and attenuates PNN maturation but are unaffected by similar manipulations in 
adulthood. This begs the question, could pathological increases in activity explain the premature 
development of PNNs in Rett CA2? Although we did not directly test this, a recent study would 
suggest that indeed aberrant activity in early life can increase PNN expression levels. A single 
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seizure at P10 increases PNNs around inhibitory neurons in the hippocampus 242; whereas a 
single seizure in adulthood reportedly attenuates PNNs 243. In contrast to pathological activity, I 
report that PNNs are increased at P21 and P45 but not at P14 in CA2 after rearing mice in an 
enriched environment (EE) 295. In fact, PNNs may even be lower in CA2 at P14 (see Fig. 3, 
Chap. 2). In future experiments, I propose to characterize the effects of EE on PNN expression at 
P14, and earlier, to better understand how aberrant versus ‘appropriate’ activity may differently 
regulate PNNs during neonatal development of normal and Mecp2-/Y brains.  
Approximately 70% of Rett children develop partial and generalized convulsive seizures 
by the age of 7 266, 270. In symptomatic Mecp2-/Y males, pyramidal neurons in the somatosensory 
cortex and thalamus of Mecp2-/Y males have reduced excitatory synaptic transmission 303, 306, 320, 
338, 339. However, the hippocampus in Rett model mice is reported to be hyper-excitable and more 
susceptible to seizure 306. Voltage sensitive dye experiments in acute hippocampal slices reveal 
increased neuronal depolarizations in response to SR electrical stimulation in Rett CA1 and CA3 
regions compared to control 306. The hyper-excitably is thought to originate from a higher 
frequency of spontaneous activity in CA3 pyramidal neurons and impaired synaptic inhibition 
(smaller mIPSC amplitude) 306, 339. These data indicate that both excitatory and inhibitory 
impairments contribute to overall hippocampal hyperexcitability observed in symptomatic Rett 
mice, however this pathophysiology has yet to be studied in the neonate hippocampus. 
I found that excitatory synaptic transmission is decreased at CA2 SR synapses in P8-11 
Mecp2-/Y males compared to wildtype littermates, but only at high stimulation intensities. 
Interestingly, I also found that excitatory transmission is increased by P14-18 in MeCP2 mice 
(data not shown), which is consistent with previous reports of hippocampal hyperexcitability in 
Mecp2-/Y males. These data indicate a possible abnormal weakening and subsequent 
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strengthening of CA2 synapses during Mecp2-/Y postnatal development. Interestingly, Mecp2-/Y 
CA1 neurons display a 46% reduction in excitatory synaptic response at 2 weeks of age, which 
has been attributed to a reduction in glutamatergic terminals on CA1 pyramidal neurons (note-
glutamatergic release probability is unchanged) 303. I did not observe any differences in PPF, 
suggesting that at least with this measure, presynaptic release properties are normal. In future 
experiments, I propose to measure mEPSC frequency to determine whether the number of 
glutamatergic terminals may be similarly reduced. Taken together, these findings demonstrate 
abnormal strengthening of excitatory synapses in CA2 (and CA1) during early postnatal 
development in Mecp2-/Y hippocampus.  
Glutamate receptor subunits have been identified as one possible mechanism underlying 
the CA1 plasticity deficit in the Rett mouse model 286. During the critical period in mouse visual 
cortex, NR2A subunit expression is modulated by visual experience, leading to the hypothesis 
that the developmental switch from NR2B to NR2A may act to close critical period plasticity 38, 
39, 54 55, 340. Interestingly, AMPA and NMDA receptor densities were increased in young Rett 
brains (< 8 years old) but dramatically decreased in older patients 341, 342. It remains unclear as to 
whether the abnormality in subunit expression in postmortem Rett tissue is a cause or 
consequence of developmental defects in Rett, therefore a developmental characterization of 
glutamatergic subunits in the developing Mecp2-/Y brain would be hugely informative. We, and 
others, show that NR2A expression is high in the symptomatic Mecp2-/Y hippocampus. In  
Mecp2-/Y CA1, high NR2A and low NR2B is thought to contribute to LTP deficits, because 
NR2A is more efficient than NR2B in generating NMDAR-dependent LTP in adult CA1 
synapses 343. NR2B subunit is normally highly expressed at embryonic ages in the cortex, while 
NR2A appears in the cortex a few days after birth in the rodent 312, 344. As an example of NMDA 
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subunit regulation in early windows of plasticity, LTP at thalamocortical synapses in the 
somatosensory cortex at P3-7 is dependent on NR2B, not on NR2A 345. Note- LTP is expressed 
between P8-11 at thalamocortical synapses in somatosensory cortex, at which point LTP is not 
inducible >P11 345.  Because LTP in CA2 is NMDAR-dependent, P8-11 LTP at CA2 SR 
synapses may similarly be NR2B-dependent, in which case alterations in NR2B subunit in 
neonates of MeCP2-null animals could explain the lack of LTP in CA2 of MeCP2-null animals 
203.  To our knowledge, though, the level of NR2b in Mecp2-null mouse hippocampus has only 
been measured in symptomatic adult animals 286.  
Finally, the idea of a premature closure of plasticity is not new to the Rett field. Mecp2-/Y 
visual acuity is comparable to that of WT at the time of eye opening (P13), however rapid and 
progressive deficits in morphology, connectivity and physiological properties occur by 2-3 days 
later 299, 346-348. Krishnan and colleagues also note that PNNs are enhanced at P15 and P30, 
similarly suggesting an early closure of the critical period. Indeed they found an early onset and 
closure of ocular dominance plasticity, as well as deficits in visual function, and attribute these 
findings to a precocious  maturation of PV neurons 298. Interestingly, the loss of MeCP2 from 
only PV inhibitory neurons abolishes experience-dependent plasticity, but a loss of MeCP2 from 
glutamatergic cells or somatostatin+ inhibitory neurons has no effect on critical period 
plasticity326. I found that knock-down of MeCP2 in CA2 was sufficient to replicate the 
overexpression of PNNs. These data would suggest that although loss of MeCP2 in 
glutamatergic cells in the visual cortex did not alter critical period plasticity, our observation of 
increased PNNs in CA2 would suggest that selective loss of MeCP2 in glutamatergic CA2 
neurons may ultimately be sufficient to prematurely restrict plasticity in CA2. In future 
experiments, I propose to characterize PNNs in a PV-targeted MeCP2 knock-down mouse, 
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where an increase in CA2 PNNs would suggest that MeCP2 is not acting cell-autonomously, but 
instead is regulating PNNs on a global scale of hippocampal activity changes. Either way, these 
findings ultimately beg the question, what might be the long-term effects on disrupting an early 
window of critical hippocampal-dependent learning? 
Overall, my findings indicate that synaptic function appears to be pre-symptomatically 
impaired in the hippocampus, particularly in CA2. Interestingly, dendritic spines are reportedly 
decreased in CA1 Mecp2-/Y at P7 but not at P15. Taken together with our findings, the study of 
plasticity in the Mecp2-/Y neonatal hippocampus is critical 332. Future experiments focusing on the 
pathophysiology in the pre-symptomatic mouse, as well as developmental studies of MeCP2-
reinstatement will be imperative to better understand the timepoint at which cognition declines 
and, ultimately, identifying an optimal therapeutic window for therapeutic intervention. Taken 
together, the presence of PNNs in CA2 is highly suggestive of an unknown critical window of 
plasticity in the hippocampus that may ultimately shed light on hippocampal-dependent learning 













CHAPTER IV–SEIZURE ACTIVITY ALTERS PERINEURONAL NETS IN THE 
HIPPOCAMPUS OF A MOUSE MODEL OF TEMPORAL LOBE EPILEPSY 
Introduction 
Temporal lobe epilepsy (TLE) affects an estimated 50 million people worldwide and is 
among the most difficult form of epilepsy to treat 349, 350. Epileptogenesis refers to the process 
whereby a normal brain becomes epileptic and is thought to reflect aberrant plasticity, however, 
little is known about the underlying mechanisms 351. Thus, understanding more about the 
remodeling that takes place during epileptogenesis should lead to more effective therapeutic 
targets for TLE. During epileptogenesis, massive hippocampal remodeling occurs, including 
mossy fiber sprouting and long-term changes in functional plasticity 352, 353. Another observation 
is that the extracellular matrix (ECM), specifically the specialized ECM perineuronal nets 
(PNNs), are altered in the hippocampus of humans with epilepsy and in rodent models of 
seizures 294, 354, 355 356. TLE patients typically develop recurrent seizures during childhood and 
studies of human adult post-mortem TLE tissue reveal massive hippocampal synaptic 
reorganization. Loss of ECM components are thought to be one mechanism by which the cellular 
environment could become permissive for this axonal remodeling 354, 357.  
In rodents, a single prolonged seizure can lead to extensive structural and functional 
synaptic changes in the adult hippocampus, including mossy fiber sprouting, neuronal cell death 
and aberrant synaptic plasticity  353, 358-360. Interestingly, PNNs have be reported to be down-
regulated in the rodent hippocampus after an acute seizure in adulthood 243. One mechanism by 
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which the seizure-induced degradation of PNNs is that endogenous proteases, enzymes that 
degrade the ECM, dramatically increase, and have been shown to play a prominent role in 
modulating epileptogenesis 165, 361, 362 351. Many rodent seizure models, however, have neglected 
to mimic the effects of recurrent seizures that are characteristic of TLE. Because PNNs are 
implicated in epilepsy and are densely localized to hippocampal region CA2, I sought to 
characterize the development and plasticity of PNNs around this population of excitatory 
pyramidal neurons in a mouse model of TLE.   
CA2 neurons have been long appreciated as resistant to seizure-induced cell death in 
TLE individuals and rodents 191, 363-365. Post-mortem analysis of sclerotic hippocampi of TLE 
individuals reveals widespread cell death in areas CA1/ 3 and DG but not in are CA2 191, 363, 
366. The effect of pathological increases in activity on PNN formation in CA2, however, is 
unknown. Interestingly, PNNs in the hippocampus appear to be differently regulated by acute 
seizure in the developing brain compared to adulthood; McRae and colleagues found a 
persistent decrease of PNNs staining around inhibitory neurons in the hippocampus one week 
to two months after a single seizure that persisted into adulthood 243. Moreover, the same 
group found that a single seizure in a neonatal rat (age P10) caused an increase in PNN+ 
inhibitory neurons four days post status-seizure 242. Because we previously found that PNN 
degradation enables potentiation in the normally plasticity-resistant CA2 pyramidal neurons, 
I reasoned that PNN degradation in response to recurrent seizures in adulthood may alter 
plasticity there. Interestingly, a recent study in mice reported mossy fiber sprouting in the 
CA2 region following seizure, suggesting that seizures may allow for a permissive 
environment in CA2 for aberrant plasticity to occur 367.  
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To identify the effect of early-onset seizures on PNN expression levels in hippocampal 
CA2, I used Kv1.1-null mice, in which the Kv1.1 potassium channel gene has been deleted. 
Kv1.1-null mice display frequent spontaneous seizures beginning early in development and 
continuing into adulthood. The seizures exhibited by these mice have been characterized 
behaviorally and electrographically, and mimic limbic seizures observed in human TLE 368. 
Homozygous Kv1.1-null mice on a B6/129S genetic background develop seizures around P21, 
and progress in severity over time limiting the life span to approximately 2 months of age 368. 
This TLE mouse model has allowed me to study the effects of early-life seizure on CA2 PNN 
development, as well as the effects of long-term recurrent seizures on PNNs in adult 
hippocampus. In addition, this model will help us to disentangle the effects of seizure activity 
and MeCP2 depletion, as seizures are common in Rett syndrome 282.  
The dense localization of PNNs in CA2, CA2’s particular resistance to both plasticity and 
damage from seizure, and the region’s central location in hippocampal excitatory circuity make 
CA2 a compelling region to study how PNNs may be developmentally disrupted in epilepsy. In 
this section I report that PNNs are indeed attenuated in area CA2 of adult Kv1.1-null mouse, but 
are unaffected by early-life seizure in these mice. I will also describe a dramatic increase in 
PNNs in dentate gyrus, which is inconsistent with another study that found aggrecan is decreased 
in DG after a single seizure 243. Future investigation into how recurrent seizures modulate PNNs 
in a mouse model of TLE and subsequently, how alterations of PNNs modulate hippocampal 
plasticity will be critical for our understanding of the long-term effects of epileptogenesis on 
hippocampal function.   
Next, we sought to investigate how PNNs are regulated by artificial manipulation of CA2 
neuronal activity in the adult brain. PNNs are indeed susceptible to damage from injury like 
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seizure or ischemia in the adult brain; however, non-pathological forms of activity such as 
environmental enrichment or other learning tasks appear sufficient to also alter expression 125, 295, 
369-371. For example, PNNs in the adult auditory cortex were enhanced 4 hours after tone-shock-
paired fear conditioning but returned to baseline after 24 hours in mouse 174. I previously found 
enhanced PNNs in area CA2 at P45 in mice reared in an enriched environment, suggesting that 
PNN modifications can persist on a longer timescale 295. The age, duration, and degree of 
neuronal activity changes all appear to be variables in regulating PNNs throughout development.   
Here I describe experiments where we directly manipulated CA2 activity using a 
chemogenetic approach. Chemogenetics is a method by which proteins are engineered to interact 
with small molecule chemical actuators 372. One class of engineered proteins that was designed 
to manipulate neuronal activity is G-coupled Designer Receptors Exclusively Activated by 
Designer Drugs (DREADDs) 372. DREADD receptors are activated by their designer drug 
clozapine N-oxide (CNO) 230, 373, 374. Depending on the class of DREADDs, activation of the 
receptor can either increase (Gq-coupled) or decrease (Gi-coupled) neuronal activity by either 
depolarizing or hyperpolarizing the cell 372. CNO has been reported to have lasting effects for up 
to 6-10 hours post administration 374. Using DREADDs, we increased or decreased activity of 
CA2 neurons persistently for 5 days and compared PNN levels to that of the TLE mouse model. 
We found that PNNs staining was significantly lower in CA2 after 5 days of increased activity in 
CA2 compared to control animals.  
Finally, the current methods of experimentally degrading PNNs have several limitations. 
First, a knockout of the major ECM component, aggrecan, during embryonic development is 
lethal and is therefore limited to in vitro studies 375. Moreover, loss of a single PNN component, 
such as tenascin-R, is typically insufficient to fully reduce staining for this matrix, which is 
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likely due to the redundancy of proteoglycan components 138, 168, 376, 377. Note however that these 
mice do exhibit aberrant synaptic and structural plasticity 138, 168, 376. The chondroitinase enzyme 
itself is promiscuous in the mammalian brain; direct injection of the enzyme effects a large 
diffuse area surrounding the site of injection 134, 256. This commonly used approach also lacks 
cell-type specificity, considering that all PNN+ neurons within the ChABC-injected area are 
affected. ChABC has previously been successfully expressed in mammalian neurons using AAV 
and lentiviral vectors, however the effect has still been diffuse and not cell-type specific 259, 378, 
379. Ultimately, cell-type specific degradation of PNNs would allow for studies of cell-
autonomous regulation of PNNs and potentially allow us to better understand whether PNNs are 
a cause or an effect of pathological changes in activity. Here I describe preliminary data 
suggesting that targeting PNN-degradation with cell-type specificity in vivo is indeed possible. 
This novel approach will allow me to study PNN function with cell-type selectivity in vivo and 
may ultimately reveal how long-term loss of PNNs (associated with several neurodevelopmental 
disorders) may disrupt learning and memory processes 265, 380, 381.   
 
 
Materials and Methods 
Animals: 
Animals in all experiments were housed under a 12:12 light/dark cycle with access to 
food and water ad libitum. All procedures were approved by National Institute of Environmental 
Health Sciences NIEHS and were in accordance with the National Institutes of Health guidelines 




Adult male mice were deeply anesthetized with Fatal-Plus and perfused with cold PBS, 
followed by 4% paraformaldehyde in PBS, pH 7.4. Brains were removed and postfixed overnight 
at 4°C and submerged in 30% sucrose. Forty-micrometer-thick sections were cut on a sliding 
microtome, blocked in 5% normal goat serum and incubated in biotin-conjugated Wisteria 
floribunda agglutinin (WFA) lectin (1:1000; Sigma-Aldrich L1516), rabbit anti-PCP4 (1:500, 
SCBT, sc-74186), rabbit anti-MMP-14  (1:500, Abcam, ab51074), guinea pig anti-ZNT3 
antibody (Synaptic systems #197 004, 1:500), overnight at 4°C. Sections were washed three 
times in PBS and incubated in secondary antibody at 1:500 for 40 min at room temperature: 
streptavidin Alexa-568 (Invitrogen #S11226) or goat anti-rabbit H+L A568 (Invitrogen). 
Sections were mounted with Vectashield antifade mounting medium with DAPI (Vector 
Laboratories). Images were acquired on a Zeiss laser scanning confocal (LSM510 NLO) or a 
Zeiss light microscope using controlled camera settings. 
WFA quantification and statistical analysis: 
PNNs were stained and imaged using the protocol described above in the 
immunohistochemistry section. WFA staining intensity was quantified using measures of pixel 
luminescence value on ImageJ software (National Institutes of Health) using a region of interest 
(ROI) contoured around either CA2 pyramidal neurons in stratum pyramidale (SP), PNN+ 
neurons in CA1 or a square ROI spanning all layers of overlying cortex. This cortical region is 
defined as primary somatosensory cortex according to an anatomical reference from the Allen 
Mouse Brain Atlas (Allen Institute, Seattle, WA). The mean gray value measure of background 
(defined as a region in a fixed anatomical location in the fimbria of each section) was subtracted 
from the mean gray value of each ROI. Each data point represents one mouse. Fluorescence 
quantification was repeated and analyzed with the experimenter blinded to condition.  
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Data in figures are expressed either as a mean ± SEM or a normalized mean ± SEM. 
Statistical analyses were performed using GraphPad Prism 6.05 software, and significance was 
calculated using an α level of 0.05. The Kolmogorov–Smirnov test was used to test normality 
and variance.  
 
Aim 1: PNN regulation in a temporal lobe epilepsy (TLE) mouse mode. 
TLE mouse model:  
Kv1.1-null mouse (also known as Kcna1 knock-out mouse), C3HeB.129S7-
Kcna1tm1Tem/J, The Jackson Laboratory, stock # 003532, donated by Bruce L. Tempel, University 
of Washington School of Medicine 368. We crossed heterozygous Kv1.1+/- mice and used 
homozygous male and female Kv1.1-/-  knock-out mice to measure in vivo electrophysiology and 
to quantify PNN staining.  
Electrode implantation of a Kv1.1 KO mouse: 
A P40 Kv1.1 null mouse was implanted with an electrode wire bundle for in vivo 
electrophysiology recordings to measure potential ictal activity. The mouse was anesthetized 
with ketamine (100mg/kg, IP) and xylazine (7mg/kg, IP) and placed in a stereotaxic apparatus. 
An incision was made in the scalp and a hole was drilled over the target region for recording. 
One ground screw was positioned approximately 4 mm posterior and 2 mm lateral to Bregma 
over the right hemisphere. The electrode was lowered and implanted in the left dorsal 
hippocampus targeting CA3 (-2.06 AP, -2.2 ML, -2.1 DV from Bregma). The electrode consisted 
of one bundle of 8 stainless steel wires (44-µm) with polyimide coating (Sandvik Group, 
Stockholm, Sweden). The wires were then connected to a printed circuit board (San Francisco 
Circuits, San Mateo, CA), which was connected to a miniature connector (Omnetics Connector 
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Corporation, Minneapolis, MN).  Electrode placement was confirmed via wire bundle tracks 
during histological analysis. 
Electrophysiology data acquisition: 
Five days following electrode implantation, the null mouse underwent 
electrophysiological recording in the awake, behaving state for a duration of one hour on two 
consecutive days, and local field potential (LFP) data were analyzed for bouts of ictal activity. 
Neural activity was transmitted via a 32-channel wireless 10x gain headstage (Triangle 
BioSystems International, Durham, NC) and was acquired using the Cerebus acquisition system 
(Blackrock Microsystems, Salt Lake City, UT). Continuous LFP data were band-pass filtered at 
0.3-500 Hz and stored at 1,000 Hz. Neurophysiological recordings were referenced to a silver 
wire connected to the ground screw. 
Maximal electroconvulsive Shock (MECS) protocol:  
Unanesthetized adult male mice were given a single maximal electroconvulsive shock 
(MECS) by delivering alternating current through ear clips (60Hz, 45mA for 0.2s with 0.5ms 
pulse width, UGO BASILE ECT UNIT cat # 57800-001). MECS was characterized by full 
extension of the hind limbs (tonic phase) for 10–15 sec, followed by repetitive flexion–extension 
of the forelimbs for 5–10 sec (clonic phase). Sham animals were handled identically except that 
no current was passed. See Farris et al. (2014) for extended methods 382. One hour after seizure 
induction, mice received a lethal dose of fatal plus and the brains were removed and flash frozen 
in isopentane (chilled to −20°C in a dry ice and ethanol bath) for RNA analysis (below). 
In situ hybridization 
Adult mouse brains were flash frozen and coronal 20-μm-thick sections were cut on a 
cryostat and mounted on SuperFrost Plus slides (Fisher Scientific 12-550-15). Sections were 
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fixed in 4% paraformaldehyde for 1 h at 4°C, dehydrated in 50, 70, and 100% ethanol, and air-
dried at room temperature. Fluorescent RNAscope in situ hybridization (ISH) was performed 
using an RNAscope Fresh Frozen Multiplex Fluorescent kit according to the manufacturer's 
protocol to perform target probe hybridization and signal amplification (Advanced Cell 
Diagnostics). Probes were purchased from Advanced Cell Diagnostics: aggrecan mRNA, mm-
acan-C1 (catalog #300031-C1) and the immediate early gene Rn-Arc-3p (catalogue number 
317076) (see design methods187. Fluorescent images were captured on a Zeiss laser-scanning 
confocal microscope (LSM710). 
Cell death Staining:  
Cell death and degenerating neurons were visualized using the FD Neurosilver kit (FD 
Neurotechnologies) on 40-μm sections. Tissue was prepped as described in 
immunohistochemistry manual. See FD Neurotechnologies for protocol, but in brief, the 
NeuroSilver stain uses diaminobenzodine as a chromogen, which stains degenerating neurons the 
color silver. Sections were slide-mounted and washed in tap water, dehydrated through a series 
of ethanol washes (70%, 90%, 100%), for 5-min each, and then finished in a xylene solution. We 
visually inspected the hippocampus in coronal slices for neuronal damage. 
http://www.fdneurotech.com/item/0/41/0/732/FD_NeuroSilver_Kit_II_small 
 
Aim 2: PNN regulation by chemogenetic manipulation of CA2 activity 
Animals:  
To gain selective genetic access to molecularly-defined CA2, we generated a tamoxifen-
inducible mouse line, Amigo2-icreERT2. Expression of Cre in CA2 was validated by crossing 
Amigo2-icreERT2+ with a Cre-dependent tdTomato reporter mouse line 383. Mice expressed 
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tdTomato in CA2 of Amigo2-icreERT2+; ROSA-tdTomato+/- treated with tamoxifen (see Fig. 
S1 of Alexander et al. (2017) for expression of the Cre indicator 230). The localization to CA2 
pyramidal neurons was characterized by co-labeling with the CA2 pyramidal cell marker, PCP4, 
and an inhibitory neuron marker, GAD. The expression of Cre was indeed localized to CA2 
pyramidal neurons and not inhibitory neurons in the hippocampus. To chemogenetically 
manipulate CA2 activity, Cre-dependent AAVs encoding either excitatory Gq-coupled or 
inhibitory Gi-coupled Designer Receptors Exclusively Activated by Designer Drugs 
(DREADDs) were infused into hippocampi of adult Amigo2-icreERT2+ or Amigo2-icreERT2- 
mice. Mice were group housed until the time of the AAV infusion, at which point they were 
singly housed and monitored during recovery from surgery. All procedures were approved by the 
National Institute of Environmental Health Sciences Animal Care and Use Committee 
and were in accordance with the National Institutes of Health guidelines for care and use of 
animals. 
Animal numbers:  
WFA staining intensity was quantified to measure changes in response to chemogenetic 




Mice Infusion hM3Dq Infusion hM4Di No virus infusion 
Amigo2-icreERT2+  (4 mice) (6 mice) 1 







In vivo chemogenetics: 
Gq- or Gi-coupled DREADD AAV (hSyn-DIO-hM3D(Gq)-mCherry or hSyn-DIO-
hM4D(Gi)-mCherry, respectively; serotype 5) was delivered to hippocampus near CA2 in 
Amigo2-icreERT2 mice to selectively target CA2 pyramidal neurons. Expression of each 
DREADD virus was validated previously using the mCherry reporter that is encoded in the AAV 
construct 230. The mCherry expressing cells also expressed the CA2 marker PCP4 and pyramidal 
cell marker CaMKII but not the inhibitory marker GAD.  
Virus infusion and tamoxifen treatment: 
Viruses listed above were obtained from the viral vector core at the University of North 
Carolina at Chapel Hill. To prepare mice for the virus-infusion, mice were anesthetized with 
ketamine (100 mg/kg, IP) and xylazine (7 mg/kg, IP) and placed in a stereotaxic apparatus. An 
incision was made in the scalp and a hole was drilled over the CA2 target region for AAV 
infusion. A 27 guage cannula connected to a Hamilton syringe was lowered into the 
hippocampus (in mm: -2.3 AP, +/-2.5 ML, -1.9mm DV from bregma). Virus were infused 
unilaterally on the left side for hM3Dq and bilaterally for hM4Di AAV at a rate of 0.1 µl/min for 
a total of 0.5 µl. The cannula was then left in place for an additional 10 min before removing. 
Once removed, the scalp was sutured and animals were returned to their cages. Animals were 
administered buprenorphine (0.1 mg/kg, SQ) for pain preoperatively.  
Protocol timeline:  
After Amigo2-icreERT2+ and Amigo2-icreERT2- adult mice were infused with Gq or Gi-
coupled DREADD AAV, the animals recovered from surgery for 2 weeks. The mice were given 
daily treatments of tamoxifen (100 mg/kg, IP) for 7 days. One week after the last tamoxifen 
injection, the mice were administered the DREADD ligand (“designer drug”) clozapine N-oxide 
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(CNO) subcutaneously (1 mg/kg for Gq DREADD infused mice and 5 mg/kg for Gi DREADD 
infused mice) twice daily (at 10:00 AM and 2:00 PM) for four days. On the fifth day, mice 






















Figure 10- Method 4.1 
Methods Figure 4.1: 
a) Histology of the CA2 marker PCP4 (green) was used to demarcate CA2 SP and SR regions. b) 
b) The DG ROI was created using a reference atlas, where DG is highlighted in purpose (Allen 
Brain Instittue, Seattle, WA). Below:  
c, d) Example images of WFA fluorescnet staining (white) with ROIs for CA2 SP or SR 











Aim3: Selective degradation of PNNs in CA2 in vivo with a Cre-dependent AAV; a pilot 
study  
Generation of AAV-ChABC 
To degrade PNNs with cell-type selectively, I sought to create a Cre-dependent AAV that 
encodes the PNN-degrading enzyme ChABC. AAV and lentiviral vectors encoding a modified 
ChABC gene have previously been generated, and infusion into the mouse brain has previously 
been shown to successfully degrade PNNs around the injection site 384, 385. These viruses for 
expressing ChABC were not cell-type specific and PNN degradation was widespread around the 
injection site. They also lacked a tag or reporter to validate expression localization.  
Chondroitinase gene:  
For the ChABC gene insert, we used the synthetic chondroitinase gene sequence ‘Y1330’ 
that was published in lentiviral-ChABC studies 385 and originally optimized for enzymatic 
secretion from mammalian cells in vitro and in tissue culture 386. The ChABC sequence 
containing a P2A processing sequence at its 3’ end (Methods Fig. 4.1) was cloned into vector 
pUC57 at the Xba I site (GenScript, Piscataway, NJ). 
AAV vector:  
A shuttle plasmid containing a double floxed mCherry under the control of human 
synapsin promoter was used for the viral vector backbone, pAAV-hSyn-DIO-mCherry (courtesy 
of the Bryan Roth lab at the University of North Carolina Chapel Hill, also commercially 
available at Addgene, plasmid #50459-AAV5). The ChABC cDNA and P2A sequence were 
subcloned into the AAV shuttle vector as an Xba I restriction fragment and verified for correct 
orientation by PCR. DNA sequencing was carried out to assure fidelity of the shuttle plasmid 
with the original sequence of the vector and insert. AAV particles were generated by 
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cotransfection of HEK 293 cells with the ChABC shuttle vector, a helper plasmid and capsid 
encoding plasmid according to a system originally purchased from Agilent Technologies (AAV 
Helper-Free System Catalog #240071). Viral particles were harvested from HEK 293 cells, 
purified and concentrated by ultracentrifugation, and the viral pellet was resuspended in 1x 
PBS/5% glycerol and stored in aliquots at -80 ̊C at a titer of 4.16E13 GC (genome copies)/ml 
(Methods Fig. 4.2). 
Virus infusion and tamoxifen treatment: 
To express ChABC selectively in CA2 pyramidal neurons, I injected the ChABC-AAV 
into the left hippocampus of mice expressing Cre in only CA2 neurons, Amigo2-iCreERT2+ 
mice (See Aim 2). Saline was injected into the right hemisphere for a within-subject control. To 
prepare mice for the virus infusion, mice were anesthetized with ketamine (100 mg/kg, IP) and 
xylazine (7 mg/kg, IP) and placed in a stereotaxic apparatus. An incision was made in the scalp 
and a hole was drilled over the hippocampal target region for AAV infusion, adjacent to CA2. A 
27-gauge cannula connected to a Hamilton syringe was lowered into the hippocampus (in mm: -
2.3 AP, +/-2.5 ML, -1.9mm DV from Bregma). The AAV was infused unilaterally at a rate of 0.1 
µl/min for a total of 0.5 µl. Saline was infused with the same parameters into the right 
hemisphere as a control comparison within mouse. The cannula was then left in place for an 
additional 10 minutes before removing, at which point the scalp was sutured and animals were 
returned to their cages, singly housed. Mice were administered buprenorphine (0.1 mg/kg, SQ) 
for pain preoperatively.  
After the virus infusion surgery, mice recovered from surgery for 2 weeks. Mice were 
then administered tamoxifen for either 1 or 3 days (100 mg/kg, IP) to induce recombination. Two 
animals per group were used or a preliminary qualitative analysis of ChABC-AAV expression 
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and PNN degradation. This dosing was based on findings from an earlier pilot study in which we 
found that 7 days of tamoxifen treatment resulted in a diffuse loss of PNNs that reached 
extrahippocampal regions. Mice were perfused two weeks after the last tamoxifen injection, and 






























Figure 11- Method 4.2 
Method Figure 4.2: ChABC cDNA sequence 
Synthetic ChABC cDNA sequence, 3162 base pairs, containing Xba I restriction sties, KOZAK 




















































































Figure 12- Method 4.3 
Method Figure 4.3: Cre-dependent AAV-ChABC construct 
A shuttle plasmid containing a double floxed mCherry under the control of human synapsin 














 Aim 1: PNN regulation in a temporal lobe epilepsy (TLE) mouse mode. 
Spontaneous electrographic seizures were detected in vivo in the hippocampus of a Kv1.1-
null mouse. 
 Prior to characterizing PNNs in our TLE mouse model, we examined electrographic 
seizure activity recorded from the hippocampus of an adult Kv1.1-null mouse and compared our 
findings to previously reported  electroencephalographic (EEG) data recorded from this mouse 
strain 368. We measured local field potential (LFP) data by placing a wire-bundle electrode in 
area CA3 of a Kv1.1-null mouse (age P40). We recorded hippocampal LFP data for one hour 
while the mouse was awake and behaving. We observed three episodes of ictal activity (Fig. 
4.1a) from the LFP recordings, interspersed between long periods (15 minutes) of non-ictal 
activity (Fig. 4.1b). Each episode of spontaneous ictal activity lasted approximately 25-30 
seconds and was characterized by sudden onset of large amplitude population spikes, polyspikes 
and burst activity patterns that reversed in polarity and terminated in post-ictal depression 350. 
Our observations of three electrographic seizures over the course of a one-hour recording session 
suggests that at the age of P40, Kv1.1-null mice may have spontaneous seizures approximately 
every 15-20 minutes. This frequency of seizure activity is consistent with EEG findings from the 
first Kv1.1-null mutant mouse characterization study 368. 
PNNs are altered in the hippocampus in a developmental mouse model of TLE, Kv1.1 
mouse  
 Kv1.1-null mice develop seizures around 21 days old and have spontaneous recurrent 
seizures into adulthood. Staining for PNN marker WFA is altered in the hippocampus of Kv1.1-
null mutant at P60 compared to WT littermates but not at age P28 (Fig. 4.2a). WFA staining is 
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significantly decreased in area CA2 (compared to WT littermates, *P < 0.05, Bonferroni post hoc 
test for pairwise comparison after two-way ANOVA, Fig. 4.2b) and is robustly increased in DG 
of P45-60 Kv1.1-null compared to control (***P= 0.0002, Bonferroni post hoc test for pairwise 
comparison after two-way ANOVA, Fig 4.2b). Upon closer inspection, the PNN effect is even 
more robust if data points are separated by ages P45 and P56-60 (.***P= <0.0001, *P= 0.033, 
Bonferroni post hoc test for pairwise comparison after two-way ANOVA, Fig 4.3). CA2 SP, SR 
and DG regions of interest (ROI) are outlined in Methods Fig. 4.1.  
Molecular indicators of TLE pathology 
 I next characterized TLE pathology in the Kv1.1 mouse model compared to WT 
littermate by staining for TLE-associated proteins at P60. Endogenous matrix metalloproteinases 
(MMPs) are modulated by seizure in human and rodent 163, 164, 333, 334, 361, 387. MMP-9 protein is 
increased in young and adult human epilepsy patients, specifically in sclerotic hippocampi 388. I 
observe a similar increase in MMP-14 protein levels in the hippocampus, specifically in CA1 
and CA2 SP layers (Fig. 4.4a). Mossy fiber sprouting is a classic pathology in the hippocampus 
of TLE patients 350, 358, 389. Mossy fibers, labeled with an antibody against zinc transporter 3 
(ZNT3), indeed appear increased in surface area in SR region of CA2/ 3 and also in the hilus of 
the Kv1.1-null mouse compared to WT littermate. Finally, neuronal loss in the TLE 
hippocampus is another common histopathology (hippocampal sclerosis), where cell death is 
typically observed in CA1/ 3 and the hilus cells of DG 193, 366. CA2 neurons are typically resistant 
to seizure-induced cell death 191, 194, 366. To stain for cell death and degenerating neurons, we used 
the proprietary ‘NeuroSilver’ kit (FD Neurotechnologies). Neurons positive for silver stain 
indicate cell death or degeneration. Only CA1 neurons in the Kv1.1-null hippocampus were 
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labeled silver (Fig. 4.4c). No other neurons in the Kv1.1-null mouse or WT littermate show 
indication of cell death at P60 (Fig. 4.4c).  
PNNs appear unaltered in adult WT hippocampus after an acute MECS-induced seizure  
 I sought to compare the modulation of PNNs in our TLE mouse model (long-term 
recurrent seizures) to an acute seizure mouse model, a single maximal electroconvulsive shock 
(MECS)-induced seizure. Note: only mice that exhibited full tonic/ clonic seizure behavior were 
included. I observed no difference in PNNs in area CA2 or DG in adult MECS hippocampus 18-
hours after seizure (Fig. 5a), unlike our adult Kv1.1-null mouse (Fig. 4.1a,b). Furthermore, we 
probed for transcripts of the immediate early gene arc and the major PNN-component aggrecan 
1-hour after acute seizure. Arc expression reflects regions of increased neuronal activity and 
aggrecan synthesis in activity-dependent 114, 390. As expected, arc mRNA is increased in DG 
neurons 1-hour post seizure (Fib. 4.5b). Transcripts for aggrecan appear increased in DG 
neurons and weakly attenuated in CA2 (Fig. 4.5b). Although PNNs appear unaltered 18-hours 
post seizure, the transcript data would suggest that PNNs may be modulated immediately after a 
single seizure, perhaps on an undetectable protein level. These data give insight into how PNNs 
may be temporally regulated after a single seizure, versus long-term recurrent seizures exhibited 








Figure 13- 4.1 
Figure 4.1: Spontaneous electrographic seizures were detected in vivo in the hippocampus of a 
Kv1.1-null mouse. 
Electrographic seizure activity was detected by LFP recordings from hippocampal area CA3 
during a one-hour recording session in a P40 Kv1.1-null male mouse. Three episodes of ictal 
activity were identified, each lasting 25-30 seconds and followed by non-ictal activity for 
approximately 15-20 minutes. Traces represent LFP data recorded from a wire-bundle electrode 
(scale bar indicates time on the x-axis (seconds) and voltage on the y-axis (mV)) (a). 
Electrographic seizure activity was characterized by large amplitude population spikes, 
polyspikes and burst activity patterns that reversed in polarity and terminated in post-ictal 
depression 350. A period of non-ictal activity during the same recording session is shown for 
























Figure 14- 4.2 
Figure 4.2: PNNs are altered in the hippocampus in a developmental mouse model of TLE, 
Kv1.1 mouse.  
a) Staining for PNN marker WFA (green) is altered in the hippocampus of Kv1.1-null mutant at 
P60 compared to WT littermates but not at P28. CA2 pyramidal neurons are identified with the 
CA2-marker PCP4 (red).  
b) Normalized WFA fluorescence intensity was decreased at P45-60 in CA2 SP (N=4, 4, 3, and 5 
for ages P14, 22, P28 and 45 respectively, per group), compared to WT littermates, *P < 0.05, 
Bonferroni post hoc test for pairwise comparison after two-way ANOVA. No significant 
difference in WFA staining in CA2 SR compared to wildtypes or primary somatosensory cortex 
(P > 0.05). WFA fluorescence intensity was however sinficantly increased at P45-60 in DG 
compared to WT littermates, ***P= 0.0002, Bonferroni post hoc test for pairwise comparison 







Figure 15- 4.3 
Figure 4.3: PNNs in DG in a P56-60 Kv1.1-null are dramatically increased relative to P45 
mutant. 
WFA intensity in DG analyzed in Fig. 4.1 shows a large spread of WFA staining in the P45-60 
group. Upon closer inspection, the P60 Kv1.1-null mice have the strongest increase in WFA 
staining compared to a still significant increase at P45. ***P= <0.0001, *P= 0.033, Bonferroni 
post hoc test for pairwise comparison after two-way ANOVA. Indicated is the mean ± SEM 













Figure 16- 4.4 
Figure 4.4: Molecular indicators of TLE pathology 
a) Immunofluorescent staining for the endogenous matrix metalloproteinase, MMP-14 (green), 
appears increased in CA1 and CA3 SP regions of the Kv1.1-null mouse compared to WT 
littermate.  
b) Staining for mossy fibers with the antibody,  anti-ZNT3 (green), reveals mossy fiber sprouting 
in DG and SR of CA2/ 3 regions. Staining for ZNT3 is increased in area in CA2/ 3 SR region, 
and in the the hilus. CA2 neurons are labeled with with anit-PCP4 antibody (red).  
c) Hippocampal sections of a P60 Kv1.1-null mouse and WT littermate were stained with the 
‘NeuroSilver’ kit to label cell death and degenerating neurons. CA1 neurons in the Kv1.1-null 
were labeled with silver stain, indicating cell death and degeneration. No neurons were positive 








Figure 17- 4.5 
Figure 4.5: PNNs appear unaltered in WT hippocampus after an acute MECS-induced seizure 
a) PNNs in CA2 are unchanged 18 hours after an acute seizure induced by MECS treatment in an 
adult WT. WFA staining (green) in CA2 or DG is not observabley different in MECS-treated 
versus sham control mouse.  CA2 neurons are labeled with anit-PCP4 (red). 
b) Transcripts for thhe PNN-component aggrecan and the immediate early gene arc were 
visualized 1 hour after an acute MECS seizure (RNAscope fluorescence in situ hybridization). 
Wildtype controls represent a sham-treated mouse of the same age. Aggrecan mRNA (red) is 
increased in DG and decreased in CA2 in the seizure mouse compared to sham-treated control. 
Furthermore, the efficacy of the seizure was validated with an expected robust increase in arc in 












Aim 2: PNN regulation by chemogenetic manipulation of CA2 activity 
We previously demonstrated that PNNs are regulated by experience in CA2 during early 
development 295. We also found that PNNs are decreased in CA2 but increased in DG in a 
developmental TLE mouse model (Fig. 4.2b). In this study, we sought to determine whether 
selectively increasing activity in CA2 over several days is sufficient to change PNNs in CA2. To 
do so, we used chemogenetics to either increase or decrease CA2 activity for 5 days in an adult 
mouse. A Cre-dependent AAV expressing either the excitatory Gq- or inhibitory Gi-coupled 
DREADD was infused into CA2 of mice expressing Cre in CA2, such that DREADDs were 
selectively express in CA2 neurons (Fig. 4.6a). Cre-negative littermates were also infused with 
DREADD AAVs. The localized expression of Cre and DREADDs to CA2 was validated 
previously in our lab with a Cre-dependent reporter mouse and with mCherry-DREADD 
histology 230. Importantly, DREADD expression is indeed only expressed in CA2 pyramidal 
neurons and not in inhibitory neurons; mCherry was not observed in GAD+ neurons.  
 Mice expressing Gq- and Gi-coupled DREADDs were treated with CNO twice a day for 
5 days. Gq/ Gi DREADD activation by CNO has been previously reported to have lasting effects 
for up to 6-10 hr post administration 230, 373, 374. I then analyzed regulation of PNNs by 
quantifying staining intensity of the lectin WFA in the Cre+ Gq and Gi DREADD mice 
compared to Cre- control animals. I found that PNNs appeared to be increased in CA2 of the Gi 
DREADD-expressing animals and decreased in the Gq DREADD-expressing animals compared 
to controls (Fig. 4.6b). Two separate cohorts of mice were tested and data were analyzed and 
grouped together.  
Quantification of WFA florescence intensity revealed that WFA staining intensity was 
significantly increased in CA2 of Gi DREADD-expressing animals compared to Cre- control 
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animals (*P= 0.015, one-way ANOVA, multiple comparisons, Tukey post-hoc, Fig. 4.7a). WFA 
staining in CA2 of Gq Cre+ mice showed a downward trend compared to Gq Cre- controls but 
was not significant by multiple comparisons, (P< 0.0.5, one-way ANOVA, multiple 
comparisons, Tukey post-hoc, Fig. 4.7a). Direct comparison of Cre+ Gq-DREADD expressing 
mice with Cre- mice infused with Gq DREADD revealed a significant decrease in WFA intensity 
among Cre+ mice P=0.0111; two-tailed t-test). Note: when Gq Cre+ mice were compared to Gq 
Cre- controls with an unpaired, two-tailed t-test, Gq DREADD Cre+ animals are significantly 
decreased compared to Cre- controls in CA2 (*P= 0.0111). We also measured WFA expressing 
in inhibitory neurons in CA1 and CA3. We found that PNN expressing in these neurons was not 
significantly changed in Gi DREADD or Gq DREADD expressing mice (P > 0.05, one-way 
ANOVA, Tukey’s post hoc test for pairwise comparison, Fig. 4.7b, c). Finally, I quantified WFA 
staining intensity in the cortical region overlying CA2, primary somatosensory cortex, to assess 
effects of modifying CA2 activity on an extrahippocampal brain region. Animals expressing Gi 
DREADD had no change in WFA staining in primary somatosensory cortex compared to Cre- 
negative controls (P=0.005, one-way ANOVA, multiple comparisons, Tukey post-hoc, Fig. 
4.7d). Surprisingly, Gq DREADD mice show a significant increase in WFA staining intensity 








Figure 18- 4.6 
Figure 4.6: Gq-DREADD AAV was selectively expressed unilaterally in CA2 neurons.  
a) Gq-DREADD was infused unilaterally into hippocampus (left side). Immunofluorescent 
staining of whole brain sections shows mCherry-Gq DREADD only in CA2 neurons; mCherry-
Gq DREADD (red) overlaps with the CA2 marker PCP4 (magenta).  
b) Images representative of 6 animals showing WFA fluorescence intensity in the hippocampus 
after 5 days of CNO treatment in Gi and Gq DREADD mice. In total, 8 Amigo2-icreERT2+ mice 
infused with either Gi or Gq DREADD virus and 12 Amigo2-icreERT2- mice infused. Top row 
shows WFA fluorescence in green and DREADD expression in red, bottom row shows WFA 







Figure 19- 4.7 
Figure 4.7: CA2 neuronal activity negatively regulates PNN staining in adulthood  
a) WFA staining in CA2 is increased in neurons expressing Gi DREADD compared to Cre- Gi 
control (p= 0.015) and WFA staining in CA2 of neurons expressing Gq DREADD compared to 
Cre- Gq control is trending downward (not significant, p> 0.05, Tukey’s post hoc test for 
pairwise comparison). A one-way ANOVA indicated significant main effects of treatment (F(3,17) 
= 10.19, P=0.0005).   
b, c) WFA staining surround PNN+ neurons in CA1(b) and CA3 (c) are unchanged in Cre+ Gi 
and Gq DREADD mice compared to Cre- mice (P>0.05), one-way ANOVA, Tukey’s post hoc 
test for pairwise comparison.  
d) WFA staining in overlying primary somatosensory cortex was unchanged in Cre+ Gi 
DREADD compared to Cre- Gi (P> 0.05) but increased in Cre+ Gq compared to Cre- Gq (*P= 
0.0012, one-way ANOVA, Tukey’s post hoc test for pairwise comparison). A one-way ANOVA 






















Aim3: Selective degradation of PNNs in CA2 in vivo with a Cre-dependent AAV; a pilot 
study  
To degrade PNNs selectively in area CA2, ideally only around pyramidal neurons, we 
generated a Cre-dependent AAV to express the PNN-degrading enzyme ChABC with cell-type 
specificity.  We infused the AAV into hippocampus of CA2 inducible Cre-expressing mice, 
Amigo2-iCreERT2+ mice (See Aim 2). As a pilot characterization of the expression of ChABC 
with the AAV-ChABC virus, we tested two different dosing regimens of tamoxifen: 1/day for 
either 1-day or 3-days. This protocol was based on findings from a previous pilot study in which 
we administered 7 days of tamoxifen and observed extensive degradation of PNNs in the 
hippocampus of the contralateral hemisphere (saline-injected side) and ipsilateral 
extrahippocampal regions (data not shown).  
Two weeks after a 1-day treatment with tamoxifen, I observed degradation of PNNs in 
CA2 of the ChABC-AAV injected (left) hemisphere (Fig. 4.8a). Accordingly, WFA staining was 
undetectable in the ChABC-AAV injected hippocampus but appeared to be at normal levels in 
the contralateral saline-injected hemisphere (Fig. 4.8a; see also Fig. 4.8b for another example of 
PNN degradation in a different mouse treated with 1-day tamoxifen). In comparison, 3 days of 
tamoxifen treatment resulted in widespread loss of WFA staining in the entire AAV-injected 
hippocampus, as well as in the saline injected hippocampus (Fig. 4.8c). Similar results were 
observed in a second mouse treated with tamoxifen for 3 days. I also validated ChABC 
expression in CA2 neurons using the mCherry reporter that is encoded in the AAV construct. 
Only CA2 pyramidal neurons (labeled with the CA2 marker PCP4) were fluorescently labeled 
with mCherry in the hippocampus, indicating successful expression of ChABC in CA2 neurons, 
as well as CA2 specificity of expression (Fig. 4.8c). However, the effects of the ChABC 
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expression (i.e. loss of WFA) spread well outside of CA2, indicating a still-too-robust 
degradation of PNNs. Dosing with a lower concentration of tamoxifen will likely be required to 
keep the effects of ChABC restricted to CA2. 
Finally, I sought to examine an indicator of structural plasticity that may have resulted 
from sustained degradation of PNNs. I chose to examine mossy fiber sprouting, which reflects 
granule cell axons in the DG spreading into the inner molecular layer of the DG and is an 
anatomical pathology that is consistently observed in the hippocampus of postmortem TLE 
tissue, where granule cell axons in the DG spread into the inner molecular layer of the dentate 
gyurs 391, 392. Mossy fiber sprouting has also been linked to ECM components, in that a sustained 
loss of ECM components has been shown to permit mossy fiber sprouting 362. Here, I labeled 
mossy fibers with an anti-ZNT3 antibody and examined the localization of fluorescence in CA2 
and CA1.  I observed mossy fiber sprouting in the SP layer of CA2 in the ChABC-AAV-injected 
hemisphere but not in the vehicle-treated hemisphere, 2 weeks post-injection (Fig. 4.9). No 
obvious mossy fiber sprouting was detected in DG of either hemisphere (Fig. 4.9). Taken 
together, these data present a novel method to degrade PNNs in vivo and suggest that the 









Figure 20- 4.8 
Figure 4.8: ChABC is selectively expressed in CA2 neurons and degrades hippocampal PNNs. 
a) PNNs labeled with the lectin, WFA (green), are undectable in area CA2 and in adjacent CA1 
and CA3 subregions. CA2  neurons are labeled with PCP4 antibody (magenta) and ChABC-
expressing neurons are labeled with the mCherry reporter encoded in the ChABC-AAV (red). 
The mCherry labeling of CA2 neurons is also shown in (c ). Arrows indicate the site of injection 
of the ChABC-AAV in the left hemisphere and saline vehicle in the right hemisphere. 
b, c) Mice received either 1 day (b) or 3 days (c) of tamoxifen treatment to compare the efficacy 
of PNN degradation in area CA2. Both 1- and 3-day treatments of tamoxifen was suffient to 
degrade PNNs in CA2; staining for WFA was undetectable in CA2. However, the radius of 
undetectable WFA staining from the site of injection was larger following 3 days of tamoxifen 
treatment than following 1 day of treatment. Three days of tamoxifen treatment resulted in loss 
of WFA staining from both the ChABC-AAV-injected hemisphere and the vehicle-injected 
hemiphere. Lastly, staing for CA2 pyramidal  neurons, laebled with PCP4 (green), were positive 
for the mCherry reporter (red), validating that CA2 pyramidal neurons selectively express 











Figure 21- 4.9 
Figure 4.9: ChABC-AAV injection in vivo results in mossy fiber sprouting into CA2 stratum 
pyramidale. 
Staining for mossy fibers with an anti-ZNT3 antibody (green) labels a larger area two weeks 
after ChABC-injection compared to vehicle-treated hemisphere (1-day tamoxifen treatment). 
Specifically, ZNT3 staining is evident in CA2 SP in the ChABC-AAV injected hemisphere 
(arrows) but faint in the vehicle-treated CA2. CA2 cell soma and dentrites are labeled with anit-












Temporal lobe epilepsy (TLE), the most common and refractory form of epilepsy, is 
characterized by the onset of focal seizures typically early in life, arising mainly from the 
hippocampus and persisting into adulthood 349, 393. Recurrent seizures are known to cause 
massive synaptic reorganization in select regions of hippocampus however little is known about 
the mechanism behind these changes. Recent studies suggest that these synaptic changes are 
modulated by the extracellular matrix 355, 357, 394, 395. CA2 neurons are uniquely resistant to 
seizure-induced cell death in the hippocampus and have a dense concentration of PNNs 193, 295, 
363, 396. I found that PNNs are reduced in CA2 after prolonged recurrent seizures in our TLE 
mouse model. Moreover, I found that PNNs are attenuated in CA2 in response to 5 days of 
elevated CA2 neuronal activity (chemogenetic) and unaffected in other brain regions. Lastly, I 
generated a Cre-dependent AAV to deliver the PNN-degrading enzyme, chondroitinase 
(ChABC), selectively to CA2 neurons and found that the AAV-ChABC was sufficient to degrade 
PNNs in CA2. I also observed mossy fiber sprouting in area CA2 after PNN-degradation by both 
the AAV-ChABC and in the TLE mouse model. Taken together, these data suggest that 
decreased PNNs in response to elevated CA2 neuronal activity may cause an aberrant ‘opening’ 
of plasticity in the normally plasticity-resistant CA2 region.   
CA2 neurons have been long appreciated for their resistance to seizure-induced cell 
death. Studies of post-mortem hippocampal sclerosis in TLE patients consistently report severe 
neuronal cell loss in areas CA1 and CA3, with CA2 being relatively unaffected 194, 396. In a rat 
model of TLE, electron micrographs confirm that seizure activity damages CA1 and CA3 
pyramidal cells but not CA2 367. CA2 neurons have many unique cellular properties that likely 
play a role in their resistance to excitotoxic damage. For example, calcium buffering and 
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extrusion are both quite robust in CA2 neurons in rodents 209. In addition, staining for 
phosphorylated (i.e. active) ERK in response to seizure is substantially lower in CA2 than in 
neighboring areas of the hippocampus 196. Interestingly, PNNs are thought to be neuroprotective 
397, and may therefore function as an additional mechanism by which CA2 neurons are protected 
from seizure-induced damage. I examined cell death in CA2 of the Kv1.1-null mouse at P60 and, 
as expected, observe indication of cell death in CA1, but not CA2. I also examined cell death in 
hippocampi infused with the CA2-specific AAV-ChABC and observed apparently normal cell 
survival in CA2 two weeks after infusion of the ChABC-AAV (data not shown). These data 
suggest that both a partial and complete loss of PNNs in CA2 are not sufficient to cause CA2 cell 
death and therefore are not consistent with the theory that PNNs are neuroprotective. In future 
experiments, I propose to examine PNNs several months after the ChABC-AAV viral infusion to 
determine whether long-term loss of PNNs may induce CA2 cell death. This experiment 
however would not rule out possible effects of activity changes on CA2 cell survival, 
considering ChABC-induced PNN degradation in the hippocampus in vivo was found to alter 
hippocampal network activity 175. Overall, our findings suggest that PNNs are not functioning to 
protect CA2 neurons from cell death.  
PNNs are reportedly reduced in the hippocampus of adult TLE postmortem tissue and in 
adult rodent seizure models 294, 354, 355 356. One mechanism to explain the seizure-induced 
degradation of PNNs is the dramatic increases in endogenous proteases. Enzymes such as matrix 
metalloproteinases (MMPs) function to post-translationally modify PNNs throughout the brain 
and are critical for normal development and remodeling of synapses 333. Moreover, MMPs are 
activity-regulated in that increased neuronal activity elevates MMP expression, in response to 
both pathological activity and learning, 157, 158 165, 361, 362. We found that MMP-14 appears to be 
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elevated in areas CA1 and CA2 in a P60 Kv1.1-null mouse (N of 1), consistent with other 
seizure models 361. However, MMP-14 protein was not uniquely elevated in CA2 and elevated 
levels around CA1 pyramidal cell somas would suggest that MMP levels are not necessarily 
correlated with PNN+ neurons. To confirm PNNs are not selectively elevated in CA2, in future 
experiments I propose to characterize transcripts for Mmp-9 (the MMP most strongly-implicated 
in seizure and plasticity361, 398) in CA2 of the Kv1.1-null mouse using in situ hybridization 
techniques described in Chapter 2. I would also stain for both the protein and enzymatic activity 
of active MMP-9 using gelatin-substrate zymography techniques. If MMP-9 levels are indeed 
not different in CA2, MMP-9 mRNA localization experiments would still be informative in 
terms of understanding cell-autonomous regulation of PNNs by MMPs in CA2. Taken together, 
these data suggest that MMPs may be at least one mechanism by which seizure-induced PNN 
degradation is regulated in CA2. 
An important outstanding question in the field is whether changes in the ECM are a cause 
or an effect of epileptogenesis. One group found that MMP-9 levels (both protein and enzymatic 
activity) are strongly increased after seizure, suggesting that PNNs are likely degraded, and 
MMP-9 deficient mice are less susceptible to epileptogenesis (pentylenetetrazole (PTZ) model of 
TLE) 361. If PNNs are indeed increased in the MMP-9 deficient mouse (as expected by the loss of 
MMP-9), one could speculate that increased PNNs could also correlate with decreased 
vulnerability to seizure. Indeed, a group recently found that degradation of PNNs with ChABC in 
vivo elevated seizure susceptibility (increased myoclonic seizures in response to PTZ 
administration) 356. Moreover, a PNN component knockout mouse, hyaluronan synthase 3, 
display epileptiform activity in the hippocampus and are more prone to seizure 399. Although a 
direct relationship between seizure susceptibility and PNN loss has yet to be identified, these 
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data provide compelling evidence to further study the role of PNNs in epileptogenesis. In future 
experiments, I propose to use the Cre-dependent AAV-ChABC to determine whether degrading 
PNNs in CA2 of the Kv1.1-null mutant, or in a healthy mouse, may increase vulnerability to 
seizure. Moreover, a critical question surrounding TLE is whether traumatic early-life brain 
injury is correlated epileptogenesis later in life 349. To address this, I would conduct a 
developmental study to determine whether degrading PNNs in early development (using the 
ChABC-AAV) may increase vulnerability to seizure in adulthood. Taken together, these data 
suggest that PNNs may play a role both the cause and effect of epilepsy and future 
developmental studies are needed to determine the exact timing and degree to which aberrant 
PNNs may be involved in epileptogenesis.  
I also compared the Kv1.1-null TLE mouse model to an acute seizure model. One hour 
after a single MECS-induced seizure, aggrecan mRNA is increased in DG but appears decreased 
in CA2. ECS depolarizes nearly 100% of hippocampal pyramidal cells therefore it is a reliable 
method to study how activity may affect gene and protein expression 382 {Cole, 1990 #731, 400. 
Interestingly, I found that PNNs are not altered in CA2 18 hours after this same seizure protocol. 
In a recent study, a decrease in aggrecan protein expression around PNN+ PV neurons in the 
hippocampus was reported 48 hours to 2 months following a single seizure 243, 294. Interestingly, 
they also found that the reduction in aggrecan protein precedes a decrease in aggrecan mRNA in 
the hippocampus (whole hippocampal lysates), such that they found no change in aggrecan 
mRNA 48 hours or one week after seizure but a significant decrease in aggrecan mRNA 2 
months later 114. These data are not consistent with our finding that aggrecan mRNA is altered 
immediately after seizure however this difference is likely attributable to ‘wash out’ effects from 
whole hippocampal lysate analysis.  
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Although seizure onset is around P21 in the Kv1.1-null mouse, we did not observe altered 
PNNs (compared to wildtype) in CA2/ DG until P45. One possible factor is the degree to which 
activity is pathologically altered at these different ages. Kv1.1-null seizures progress in severity 
with age therefore epileptiform activity during the third postnatal week may be insufficient to 
alter PNNs. Moreover, dramatic increases in excitability by the sixth week of life appear to be 
sufficient to alter ECM. Our in vivo recordings indeed validate that these mice have classic 
spontaneous electrographic seizures at P40. We observed three ictal episodes over one hour that 
each lasted approximately 25-30 seconds, indicating that the Kv1.1-null mouse likely has 
spontaneous recurrent seizures every 15-20 minutes at P40. Note: A previous Kv1.1-null 
characterization study reported that ictal EEG patters in the cerebral cortex were observed in the 
absence of apparent seizure behavior 368. In future experiments, recordings of hippocampal 
activity in the developing brain before seizure-onset would provide valuable insight into whether 
pathological activity in TLE may precede seizure initiation. Using methods outlined in Aim 1 of 
this chapter, I propose to measure LFPs in P14-21 hippocampi to identify possible aberrant 
activity. Because we found that PNNs are unchanged after the onset of seizure (P21) in the 
Kv1.1-null mouse, I conclude that either the degree of pathological activity is insufficient to alter 
PNNs or alternatively, that PNNs are differently regulated by pathological activity in early 
development, as was previously discussed (Chapter 3).  
As an alternative approach, electrophysiological manipulation of activity in acute 
hippocampal slices could provide valuable insight into the development and mechanism of 
pathological activity in Kv1.1-null mice. CA3 pyramidal neurons in the Kv1.1-null mouse were 
previously reported to produce a late burst discharge in response to mossy fiber stimulation 368. 
Intrinsic cellular properties, such as resting membrane potential, input resistance, and action 
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potential amplitude, were unchanged 368. The generation of epileptiform activity, or ictogenesis, 
has been proposed to arise from aberrant synchronous activity in CA3, subsequently spreading to 
other subregions, causing over-synchronous activity of hippocampal pyramidal cell networks 401, 
402 403. In future experiments, I propose to study CA2 intrinsic and synaptic properties in the 
Kv1.1-null mouse over development to determine whether CA2 neurons may only be abnormal 
at P45 when PNNs are attenuated.     
To better understand whether loss of CA2 PNNs in a TLE mouse model is an effect of 
global changes in hippocampal activity, or is rather a cell-autonomous effect, we directly 
manipulated CA2 activity. We show that PNNs are altered in area CA2 in both hM3Dq/ hM4Di-
expressing mice after 5 days of twice daily CNO treatment, but that PNNs in CA1 are unaltered, 
suggesting that targeted manipulation of PNNs in CA2 is sufficient to inversely regulate PNNs in 
CA2. In future experiments, I propose to test how the age, duration and degree of activity 
changes in CA2 affect PNN expression in the brain. For example, the duration of changes in 
CA2 activity can be tested by treating mice with CNO for different lengths of time. Moreover, 
DREADD-induced voltage changes are CNO dose dependent 230, 374, therefore the degree of 
activity, although subtle, could be manipulated by altering the dose of CNO. Overall, these future 
experiments would provide insight into how age, duration and degree of activity changes may 
differently regulate PNNs and, ultimately, may reveal whether aberrant PNNs are a causative 







CHAPTER V – CONCLUSION 
Summary of Conclusions: 
▪ PNN in area CA2 function as at least one negative regulator of plasticity in hippocampal 
CA2 neurons (P14-18 mice). 
▪ LTP is inducible at CA2 SR synapses at an age prior to PNN maturation (P8-11 mice), 
identifying a novel window of plasticity in CA2. 
▪ In a mouse model of Rett syndrome, PNNs are aberrantly increased and develop 
prematurely in CA2 during postnatal development. 
▪ LTP is prematurely restricted in CA2 of a Rett mouse model and degradation of PNNs in 
acute hippocampal slices reinstates LTP in Rett CA2 neurons (P8-11 mice). 
▪ Pathological and chemogenetic increases in CA2 neuronal activity appears to 
downregulate PNN expression in adult CA2.  





I describe a function for PNNs in restricting plasticity in a population of excitatory pyramidal 
neurons. Moreover, I discovered a novel window of early plasticity at CA2 SR synapses in P8-11 
mice, an age before PNNs are detectable in CA2. Because PNN degradation with the enzyme 
ChABC reinstates LTP in CA2 at P8-11, I postulate that the maturation of PNNs functions to, at 
least in part, close an unknown window of plasticity in CA2. These data are consistent with 
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previous studies that identify PNNs as a molecular brake on several other windows of plasticity 
in the brain 113, 114, 116. The exact behavioral function of area CA2 is not clear, however recent 
studies find a role for CA2 in social memory and behavior 205, 224, 227-230. Moreover, a critical 
window of learning in the hippocampus has yet to be identified, however one specific form of 
hippocampal-dependent memory that is developmentally regulated is contextual fear learning 73,  
233-237. Fear learning is clinically relevant because childhood trauma has detrimental effects on 
adult mental health 23. Understanding the molecular mechanism underlying this potential 
hippocampal critical period, such as PNNs in CA2, could potentially unveil a therapeutic 
window of intervention. Moreover, based on findings in this study, developmental regulation of 
PNNs in area CA2 may represent a therapeutic target for neurodevelopmental disorders, such as 
TLE and Rett syndrome 264, 265, 349, 350. 
A recent focus in the ECM field has been on PNN sulfation patterns, which appear to 
shift during postnatal development. CSPGs are known to be a class of molecules that are both 
inhibitory or permissive, depending on their biochemical properties 132, 404.The ratio of carbon 4-
sulfated (4S) to 6-sulfated (6S) CSPGs increases in development 405, such that 4S is more 
prevalent in the PNN matrix in adult rodents while 6S is more strongly expressed in early 
development. One study found that the transgenic overexpression of 6S in adulthood (decreasing 
the 4S/ 6S ratio) extended the window of ocular dominance plasticity 405, implicating 6S as an 
important component of critical period plasticity in the visual cortex. In the future, I propose to 
characterize the 4S/ 6S ratio in area CA2 to validate a possible window of plasticity. I would 
predict the 4S/ 6S ratio is low at P8-11 but high by P14-18 in mouse, tracking the closing 
plasticity in CA2. I would also propose to examine how this ratio may be altered in 
neurodevelopmental disorders such as Rett syndrome.  
132 
 
As another area of study, I propose to determine whether PNNs in CA2 are distinctly 
associated with excitatory or inhibitory terminals in CA2 SR. PNNs are enriched along the 
membrane of CA2 neuron cell bodies and perisynaptically around dendritic spines according to 
electron micrograph data presented in this study. Interestingly, one study found the PNN marker, 
WFA, frequently localizes with inhibitory neuron terminal staining, Kv3.1b (voltage-gated 
potassium channel subunit), in cortical layer V 406. Using similar methods, I propose to 
determine whether the PNN-associated terminals along CA2 soma and proximal dendrites are 
similarly inhibitory, or alternatively excitatory. To determine whether synaptic terminals in CA2 
SR are inhibitory or excitatory, I propose to use EM and double-labeling of the PNN marker 
WFA using the antibody against Kv3.1b and the antibody against VGLUT1 (a vesicular 
glutamate transporter marking excitatory terminals). I would use peroxidase methods and silver-
intensified streptavidin-gold particles (demonstrated in Chapter 2) such that I can distinguish the 
pattern of WFA-immunogold particles from KV 3.1b or VGLUT1 staining in adult CA2. Unlike 
cortical layer V, I predict that PNNs will be associated with excitatory terminals based on my 
findings that suggests PNNs function to regulate excitatory plasticity in CA2. 
Degrading PNNs with ChABC is a reliable therapeutic approach in spinal cord injury, 
allowing axon regeneration at the site of injury 378. However, whether PNNs degradation 
could serve as a viable therapeutic target in the brain is unclear. Several studies found a 
correlation between cell survival and PNN+ neurons in a normal brain and in Alzheimer’s 
disease 141, 258. My data would suggest that PNNs are not playing a neuroprotective role in 
area CA2 in both a normal mouse brain and in a TLE mouse model. The modulation of PNNs 
is complicated; they are both overexpressed and ‘under-expressed’ in several neurological 
diseases other than Rett syndrome and TLE, eg. schizophrenia, bipolar, prion disease, and 
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Creutzfeldt-Jakob disease 265, 327, 407. It is unclear whether alterations in PNNs precedes or 
follows the onset of disease; however, my findings (PNNs are not altered in the TLE mouse 
model until two weeks after seizure-onset) would make a case for the latter. In the case of the 
Rett model mouse, my data show that PNNs are aberrant prior to the onset of symptomology 
such as behavioral seizures 269 270. One hypothesis to explain these discrepancies is that the 
role of PNNs in CA2 is multi-functional, in that their presence is neuroprotective but their 
degradation may also be critical in recovery from injury. 
Overall, the findings presented in this thesis demonstrate a critical role for PNNs in 
restricting LTP at CA2 synapses. We also identify an undefined window of plasticity in area 
CA2. The behavioral function of this critical period is unclear. Because CA2 appears to regulate 
social memory 205, 224, 227-230, this early critical window of plasticity in postnatal may be critical 
for early social learning. Social deficits are prevalent in many neurodevelopmental disorders, 
such as in Rett syndrome, where girls display a loss of social interaction and communication 408. 
Mouse models of Rett also display sociability impairments 409. Area CA2 may serve as an 
integral region for studying mechanisms behind social learning deficits during early development 
in the Rett brain. Overall, the experience-dependent development of PNNs in CA2 is highly 
suggestive of an unknown critical period of plasticity in the hippocampus and may ultimately 
reveal a mechanism behind the severe hippocampal-dependent learning impairments that emerge 










1. Hensch, T.K. Critical period regulation. Annu Rev Neurosci 27, 549-79 (2004). 
2. Horii-Hayashi, N., Sasagawa, T., Matsunaga, W. & Nishi, M. Development and 
Structural Variety of the Chondroitin Sulfate Proteoglycans-Contained Extracellular 
Matrix in the Mouse Brain. Neural Plast 2015, 256389 (2015). 
3. Bruckner, G. et al. Perineuronal nets provide a polyanionic, glia-associated form of 
microenvironment around certain neurons in many parts of the rat brain. Glia 8, 183-200 
(1993). 
4. Pyka, M. et al. Chondroitin sulfate proteoglycans regulate astrocyte-dependent 
synaptogenesis and modulate synaptic activity in primary embryonic hippocampal 
neurons. Eur J Neurosci 33, 2187-202 (2011). 
5. Hebb, D.O. The Organization of Behavior (ed. Wiley) (New York, 1949). 
6. Bliss, T.V. & Lomo, T. Long-lasting potentiation of synaptic transmission in the dentate 
area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol 232, 
331-56 (1973). 
7. Bliss, T.V. & Gardner-Medwin, A.R. Long-lasting potentiation of synaptic transmission 
in the dentate area of the unanaestetized rabbit following stimulation of the perforant 
path. J Physiol 232, 357-74 (1973). 
8. Katz, L.C. & Shatz, C.J. Synaptic activity and the construction of cortical circuits. 
Science 274, 1133-8 (1996). 
9. Martin, S.J., Grimwood, P.D. & Morris, R.G. Synaptic plasticity and memory: an 
evaluation of the hypothesis. Annu Rev Neurosci 23, 649-711 (2000). 
10. Kirkwood, A., Lee, H.K. & Bear, M.F. Co-regulation of long-term potentiation and 
experience-dependent synaptic plasticity in visual cortex by age and experience. Nature 
375, 328-31 (1995). 
11. Komatsu, Y., Fujii, K., Maeda, J., Sakaguchi, H. & Toyama, K. Long-term potentiation 
of synaptic transmission in kitten visual cortex. J Neurophysiol 59, 124-41 (1988). 
12. Perkins, A.T.t. & Teyler, T.J. A critical period for long-term potentiation in the 
developing rat visual cortex. Brain Res 439, 222-9 (1988). 
13. Kato, N., Artola, A. & Singer, W. Developmental changes in the susceptibility to long-
term potentiation of neurones in rat visual cortex slices. Brain Res Dev Brain Res 60, 43-
50 (1991). 
14. Crair, M.C. & Malenka, R.C. A critical period for long-term potentiation at 
thalamocortical synapses. Nature 375, 325-8 (1995). 
135 
 
15. Dudek, S.M. & Bear, M.F. Bidirectional long-term modification of synaptic effectiveness 
in the adult and immature hippocampus. J Neurosci 13, 2910-8 (1993). 
16. Dudek, S.M. & Friedlander, M.J. Developmental down-regulation of LTD in cortical 
layer IV and its independence of modulation by inhibition. Neuron 16, 1097-106 (1996). 
17. Blundon, J.A. & Zakharenko, S.S. Presynaptic gating of postsynaptic synaptic plasticity: 
a plasticity filter in the adult auditory cortex. Neuroscientist 19, 465-78 (2013). 
18. Jaynes, J. Imprinting: the interaction of learned and innate behavior. II. The critical 
period. J Comp Physiol Psychol 50, 6-10 (1957). 
19. Hubel, D.H. & Wiesel, T.N. The period of susceptibility to the physiological effects of 
unilateral eye closure in kittens. J Physiol 206, 419-36 (1970). 
20. Lorenz, K. The companion in the bird's world (Auk, 1937). 
21. Bateson, P. Sexual imprinting and optimal outbreeding. Nature 273, 659-60 (1978). 
22. Bornstein, M.H. Sensitive periods in development: structural characteristics and causal 
interpretations. Psychol Bull 105, 179-97 (1989). 
23. De Bellis, M.D. & Zisk, A. The biological effects of childhood trauma. Child Adolesc 
Psychiatr Clin N Am 23, 185-222, vii (2014). 
24. Harrison, E.L. & Baune, B.T. Modulation of early stress-induced neurobiological 
changes: a review of behavioural and pharmacological interventions in animal models. 
Transl Psychiatry 4, e390 (2014). 
25. Wiesel, T.N. & Hubel, D.H. SINGLE-CELL RESPONSES IN STRIATE CORTEX OF 
KITTENS DEPRIVED OF VISION IN ONE EYE. J Neurophysiol 26, 1003-17 (1963). 
26. Romens, S.E., McDonald, J., Svaren, J. & Pollak, S.D. Associations between early life 
stress and gene methylation in children. Child Dev 86, 303-9 (2015). 
27. Sperry, R. Optic nerve regeneration with return of vision in anurans. Journal of 
Neurophysiology, 57-69 (1944). 
28. Pettigrew, J.D. The effect of visual experience on the development of stimulus specificity 
by kitten cortical neurones. J Physiol 237, 49-74 (1974). 
29. Wiesel, T.N. & Hubel, D.H. Comparison of the effects of unilateral and bilateral eye 
closure on cortical unit responses in kittens. J Neurophysiol 28, 1029-40 (1965). 
30. Fagiolini, M. et al. Separable features of visual cortical plasticity revealed by N-methyl-
D-aspartate receptor 2A signaling. Proc Natl Acad Sci U S A 100, 2854-9 (2003). 
31. Lewis, T.L. & Maurer, D. Multiple sensitive periods in human visual development: 
evidence from visually deprived children. Dev Psychobiol 46, 163-83 (2005). 
136 
 
32. Bienenstock, E.L., Cooper, L.N. & Munro, P.W. Theory for the development of neuron 
selectivity: orientation specificity and binocular interaction in visual cortex. J Neurosci 2, 
32-48 (1982). 
33. Shatz, C.J. & Stryker, M.P. Ocular dominance in layer IV of the cat's visual cortex and 
the effects of monocular deprivation. J Physiol 281, 267-83 (1978). 
34. Frenkel, M.Y. & Bear, M.F. How monocular deprivation shifts ocular dominance in 
visual cortex of young mice. Neuron 44, 917-23 (2004). 
35. Kirkwood, A., Rioult, M.C. & Bear, M.F. Experience-dependent modification of synaptic 
plasticity in visual cortex. Nature 381, 526-8 (1996). 
36. Smith, G.B., Heynen, A.J. & Bear, M.F. Bidirectional synaptic mechanisms of ocular 
dominance plasticity in visual cortex. Philos Trans R Soc Lond B Biol Sci 364, 357-67 
(2009). 
37. Gordon, J.A. & Stryker, M.P. Experience-dependent plasticity of binocular responses in 
the primary visual cortex of the mouse. J Neurosci 16, 3274-86 (1996). 
38. Philpot, B.D., Espinosa, J.S. & Bear, M.F. Evidence for altered NMDA receptor function 
as a basis for metaplasticity in visual cortex. J Neurosci 23, 5583-8 (2003). 
39. Philpot, B.D., Cho, K.K. & Bear, M.F. Obligatory role of NR2A for metaplasticity in 
visual cortex. Neuron 53, 495-502 (2007). 
40. LeVay, S., Wiesel, T.N. & Hubel, D.H. The development of ocular dominance columns 
in normal and visually deprived monkeys. J Comp Neurol 191, 1-51 (1980). 
41. Mioche, L. & Singer, W. Chronic recordings from single sites of kitten striate cortex 
during experience-dependent modifications of receptive-field properties. J Neurophysiol 
62, 185-97 (1989). 
42. Doshi, N.R. & Rodriguez, M.L. Amblyopia. Am Fam Physician 75, 361-7 (2007). 
43. Trachtenberg, J.T. & Stryker, M.P. Rapid anatomical plasticity of horizontal connections 
in the developing visual cortex. J Neurosci 21, 3476-82 (2001). 
44. Antonini, A. & Stryker, M.P. Rapid remodeling of axonal arbors in the visual cortex. 
Science 260, 1819-21 (1993). 
45. Bear, M.F. & Colman, H. Binocular competition in the control of geniculate cell size 
depends upon visual cortical N-methyl-D-aspartate receptor activation. Proc Natl Acad 
Sci U S A 87, 9246-9 (1990). 
46. Mataga, N., Mizuguchi, Y. & Hensch, T.K. Experience-dependent pruning of dendritic 
spines in visual cortex by tissue plasminogen activator. Neuron 44, 1031-41 (2004). 
137 
 
47. Oray, S., Majewska, A. & Sur, M. Dendritic spine dynamics are regulated by monocular 
deprivation and extracellular matrix degradation. Neuron 44, 1021-30 (2004). 
48. Antonini, A., Fagiolini, M. & Stryker, M.P. Anatomical correlates of functional plasticity 
in mouse visual cortex. J Neurosci 19, 4388-406 (1999). 
49. Alvarez, V.A. & Sabatini, B.L. Anatomical and physiological plasticity of dendritic 
spines. Annu Rev Neurosci 30, 79-97 (2007). 
50. Djurisic, M. et al. PirB regulates a structural substrate for cortical plasticity. Proc Natl 
Acad Sci U S A 110, 20771-6 (2013). 
51. Kelly, E.A., Russo, A.S., Jackson, C.D., Lamantia, C.E. & Majewska, A.K. Proteolytic 
regulation of synaptic plasticity in the mouse primary visual cortex: analysis of matrix 
metalloproteinase 9 deficient mice. Front Cell Neurosci 9, 369 (2015). 
52. Vidal, G.S. & Djurisic, M. Cell-Autonomous Regulation of Dendritic Spine Density by 
PirB.  3 (2016). 
53. Grutzendler, J., Kasthuri, N. & Gan, W.B. Long-term dendritic spine stability in the adult 
cortex. Nature 420, 812-6 (2002). 
54. Philpot, B.D., Sekhar, A.K., Shouval, H.Z. & Bear, M.F. Visual experience and 
deprivation bidirectionally modify the composition and function of NMDA receptors in 
visual cortex. Neuron 29, 157-69 (2001). 
55. Quinlan, E.M., Olstein, D.H. & Bear, M.F. Bidirectional, experience-dependent 
regulation of N-methyl-D-aspartate receptor subunit composition in the rat visual cortex 
during postnatal development. Proc Natl Acad Sci U S A 96, 12876-80 (1999). 
56. Carmignoto, G. & Vicini, S. Activity-dependent decrease in NMDA receptor responses 
during development of the visual cortex. Science 258, 1007-11 (1992). 
57. Malinow, R., Mainen, Z.F. & Hayashi, Y. LTP mechanisms: from silence to four-lane 
traffic. Curr Opin Neurobiol 10, 352-7 (2000). 
58. Shi, S., Hayashi, Y., Esteban, J.A. & Malinow, R. Subunit-specific rules governing 
AMPA receptor trafficking to synapses in hippocampal pyramidal neurons. Cell 105, 
331-43 (2001). 
59. Takahashi, T., Svoboda, K. & Malinow, R. Experience strengthening transmission by 
driving AMPA receptors into synapses. Science 299, 1585-8 (2003). 
60. Rumpel, S., LeDoux, J., Zador, A. & Malinow, R. Postsynaptic receptor trafficking 
underlying a form of associative learning. Science 308, 83-8 (2005). 
61. Turrigiano, G.G., Leslie, K.R., Desai, N.S., Rutherford, L.C. & Nelson, S.B. Activity-
dependent scaling of quantal amplitude in neocortical neurons. Nature 391, 892-6 (1998). 
138 
 
62. Mataga, N., Nagai, N. & Hensch, T.K. Permissive proteolytic activity for visual cortical 
plasticity. Proc Natl Acad Sci U S A 99, 7717-21 (2002). 
63. Maffei, A., Nelson, S.B. & Turrigiano, G.G. Selective reconfiguration of layer 4 visual 
cortical circuitry by visual deprivation. Nat Neurosci 7, 1353-9 (2004). 
64. Maffei, A., Nataraj, K., Nelson, S.B. & Turrigiano, G.G. Potentiation of cortical 
inhibition by visual deprivation. Nature 443, 81-4 (2006). 
65. Morishita, H., Miwa, J.M., Heintz, N. & Hensch, T.K. Lynx1, a cholinergic brake, limits 
plasticity in adult visual cortex. Science 330, 1238-40 (2010). 
66. Beurdeley, M. et al. Otx2 binding to perineuronal nets persistently regulates plasticity in 
the mature visual cortex. J Neurosci 32, 9429-37 (2012). 
67. Dityatev, A., Schachner, M. & Sonderegger, P. The dual role of the extracellular matrix 
in synaptic plasticity and homeostasis. Nat Rev Neurosci 11, 735-46 (2010). 
68. Greenberg, M.E., Xu, B., Lu, B. & Hempstead, B.L. New insights in the biology of 
BDNF synthesis and release: implications in CNS function. J Neurosci 29, 12764-7 
(2009). 
69. Dudek, S.M., Bowen, W.D. & Bear, M.F. Postnatal changes in glutamate stimulated 
phosphoinositide turnover in rat neocortical synaptoneurosomes. Brain Res Dev Brain 
Res 47, 123-8 (1989). 
70. Dudek, S.M. & Bear, M.F. A biochemical correlate of the critical period for synaptic 
modification in the visual cortex. Science 246, 673-5 (1989). 
71. Kirkwood, A., Dudek, S.M., Gold, J.T., Aizenman, C.D. & Bear, M.F. Common forms of 
synaptic plasticity in the hippocampus and neocortex in vitro. Science 260, 1518-21 
(1993). 
72. Turrigiano, G.G. & Nelson, S.B. Homeostatic plasticity in the developing nervous 
system. Nat Rev Neurosci 5, 97-107 (2004). 
73. Raineki, C. et al. Functional emergence of the hippocampus in context fear learning in 
infant rats. Hippocampus 20, 1037-46 (2010). 
74. Rudy, J.W. & Morledge, P. Ontogeny of contextual fear conditioning in rats: implications 
for consolidation, infantile amnesia, and hippocampal system function. Behav Neurosci 
108, 227-34 (1994). 
75. Esmoris-Arranz, F.J., Mendez, C. & Spear, N.E. Contextual fear conditioning differs for 
infant, adolescent, and adult rats. Behav Processes 78, 340-50 (2008). 
76. Bayer, S.A. Development of the hippocampal region in the rat. II. Morphogenesis during 
embryonic and early postnatal life. J Comp Neurol 190, 115-34 (1980). 
139 
 
77. Johnson, M.H. Functional brain development in humans. Nat Rev Neurosci 2, 475-83 
(2001). 
78. Bekenstein, J.W. & Lothman, E.W. An in vivo study of the ontogeny of long-term 
potentiation (LTP) in the CA1 region and in the dentate gyrus of the rat hippocampal 
formation. Brain Res Dev Brain Res 63, 245-51 (1991). 
79. Harris, K.M. & Teyler, T.J. Developmental onset of long-term potentiation in area CA1 
of the rat hippocampus. J Physiol 346, 27-48 (1984). 
80. Wilson, D.A. A comparison of the postnatal development of post-activation potentiation 
in the neocortex and dentate gyrus of the rat. Brain Res 318, 61-8 (1984). 
81. Kudryashov, I.E. & Kudryashova, I.V. Ontogeny of synaptic transmission in the rat 
hippocampus. Brain Res 892, 263-8 (2001). 
82. Michelson, H.B. & Lothman, E.W. An in vivo electrophysiological study of the ontogeny 
of excitatory and inhibitory processes in the rat hippocampus. Brain Res Dev Brain Res 
47, 113-22 (1989). 
83. Swann, J.W., Smith, K.L. & Brady, R.J. Neural networks and synaptic transmission in 
immature hippocampus. Adv Exp Med Biol 268, 161-71 (1990). 
84. Muller, D., Oliver, M. & Lynch, G. Developmental changes in synaptic properties in 
hippocampus of neonatal rats. Brain Res Dev Brain Res 49, 105-14 (1989). 
85. DiScenna, P.G. & Teyler, T.J. Development of inhibitory and excitatory synaptic 
transmission in the rat dentate gyrus. Hippocampus 4, 569-76 (1994). 
86. Liao, D., Hessler, N.A. & Malinow, R. Activation of postsynaptically silent synapses 
during pairing-induced LTP in CA1 region of hippocampal slice. Nature 375, 400-4 
(1995). 
87. Yasuda, H., Barth, A.L., Stellwagen, D. & Malenka, R.C. A developmental switch in the 
signaling cascades for LTP induction. Nat Neurosci 6, 15-6 (2003). 
88. Lisman, J., Schulman, H. & Cline, H. The molecular basis of CaMKII function in 
synaptic and behavioural memory. Nat Rev Neurosci 3, 175-90 (2002). 
89. Smith, G.B. & Bear, M.F. Bidirectional ocular dominance plasticity of inhibitory 
networks: recent advances and unresolved questions. Front Cell Neurosci 4, 21 (2010). 
90. Nicoll, R.A. Expression mechanisms underlying long-term potentiation: a postsynaptic 
view. Philos Trans R Soc Lond B Biol Sci 358, 721-6 (2003). 
91. Busetto, G., Higley, M.J. & Sabatini, B.L. Developmental presence and disappearance of 
postsynaptically silent synapses on dendritic spines of rat layer 2/3 pyramidal neurons. J 
Physiol 586, 1519-27 (2008). 
140 
 
92. Abrahamsson, T., Gustafsson, B. & Hanse, E. AMPA silencing is a prerequisite for 
developmental long-term potentiation in the hippocampal CA1 region. J Neurophysiol 
100, 2605-14 (2008). 
93. Isaac, J.T., Nicoll, R.A. & Malenka, R.C. Evidence for silent synapses: implications for 
the expression of LTP. Neuron 15, 427-34 (1995). 
94. Malinow, R. & Malenka, R.C. AMPA receptor trafficking and synaptic plasticity. Annu 
Rev Neurosci 25, 103-26 (2002). 
95. Hanse, E. & Gustafsson, B. Quantal variability at glutamatergic synapses in area CA1 of 
the rat neonatal hippocampus. J Physiol 531, 467-80 (2001). 
96. Elias, G.M. et al. Synapse-specific and developmentally regulated targeting of AMPA 
receptors by a family of MAGUK scaffolding proteins. Neuron 52, 307-20 (2006). 
97. Kolleker, A. et al. Glutamatergic plasticity by synaptic delivery of GluR-B(long)-
containing AMPA receptors. Neuron 40, 1199-212 (2003). 
98. Flint, A.C., Maisch, U.S., Weishaupt, J.H., Kriegstein, A.R. & Monyer, H. NR2A subunit 
expression shortens NMDA receptor synaptic currents in developing neocortex. J 
Neurosci 17, 2469-76 (1997). 
99. Nase, G., Weishaupt, J., Stern, P., Singer, W. & Monyer, H. Genetic and epigenetic 
regulation of NMDA receptor expression in the rat visual cortex. Eur J Neurosci 11, 
4320-6 (1999). 
100. Hayashi, Y. et al. Driving AMPA receptors into synapses by LTP and CaMKII: 
requirement for GluR1 and PDZ domain interaction. Science 287, 2262-7 (2000). 
101. Esteban, J.A. et al. PKA phosphorylation of AMPA receptor subunits controls synaptic 
trafficking underlying plasticity. Nat Neurosci 6, 136-43 (2003). 
102. Yuste, R. & Katz, L.C. Control of postsynaptic Ca2+ influx in developing neocortex by 
excitatory and inhibitory neurotransmitters. Neuron 6, 333-44 (1991). 
103. Cherubini, E., Rovira, C., Gaiarsa, J.L., Corradetti, R. & Ben Ari, Y. GABA mediated 
excitation in immature rat CA3 hippocampal neurons. Int J Dev Neurosci 8, 481-90 
(1990). 
104. Ganguly, K., Schinder, A.F., Wong, S.T. & Poo, M. GABA itself promotes the 
developmental switch of neuronal GABAergic responses from excitation to inhibition. 
Cell 105, 521-32 (2001). 
105. Cherubini, E., Gaiarsa, J.L. & Ben-Ari, Y. GABA: an excitatory transmitter in early 
postnatal life. Trends Neurosci 14, 515-9 (1991). 
141 
 
106. Rivera, C. et al. The K+/Cl- co-transporter KCC2 renders GABA hyperpolarizing during 
neuronal maturation. Nature 397, 251-5 (1999). 
107. Dityatev, A. & Rusakov, D.A. Molecular signals of plasticity at the tetrapartite synapse. 
Curr Opin Neurobiol 21, 353-9 (2011). 
108. Celio, M.R. Perineuronal nets of extracellular matrix around parvalbumin-containing 
neurons of the hippocampus. Hippocampus 3 Spec No, 55-60 (1993). 
109. Costa, C. et al. Mapping of aggrecan, hyaluronic acid, heparan sulphate proteoglycans 
and aquaporin 4 in the central nervous system of the mouse. J Chem Neuroanat 33, 111-
23 (2007). 
110. Yamamoto, M., Marshall, P., Hemmendinger, L.M., Boyer, A.B. & Caviness, V.S., Jr. 
Distribution of glucuronic acid-and-sulfate-containing glycoproteins in the central 
nervous system of the adult mouse. Neurosci Res 5, 273-98 (1988). 
111. Drake, C.T., Mulligan, K.A., Wimpey, T.L., Hendrickson, A. & Chavkin, C. 
Characterization of Vicia villosa agglutinin-labeled GABAergic interneurons in the 
hippocampal formation and in acutely dissociated hippocampus. Brain Res 554, 176-85 
(1991). 
112. Bruckner, G., Grosche, J., Hartlage-Rubsamen, M., Schmidt, S. & Schachner, M. Region 
and lamina-specific distribution of extracellular matrix proteoglycans, hyaluronan and 
tenascin-R in the mouse hippocampal formation. J Chem Neuroanat 26, 37-50 (2003). 
113. Lander, C., Kind, P., Maleski, M. & Hockfield, S. A family of activity-dependent 
neuronal cell-surface chondroitin sulfate proteoglycans in cat visual cortex. J Neurosci 
17, 1928-39 (1997). 
114. McRae, P.A., Rocco, M.M., Kelly, G., Brumberg, J.C. & Matthews, R.T. Sensory 
deprivation alters aggrecan and perineuronal net expression in the mouse barrel cortex. J 
Neurosci 27, 5405-13 (2007). 
115. Bruckner, G. et al. Postnatal development of perineuronal nets in wild-type mice and in a 
mutant deficient in tenascin-R. J Comp Neurol 428, 616-29 (2000). 
116. Kalb, R.G. & Hockfield, S. Molecular evidence for early activity-dependent development 
of hamster motor neurons. J Neurosci 8, 2350-60 (1988). 
117. Guimaraes, A., Zaremba, S. & Hockfield, S. Molecular and morphological changes in the 
cat lateral geniculate nucleus and visual cortex induced by visual deprivation are revealed 
by monoclonal antibodies Cat-304 and Cat-301. J Neurosci 10, 3014-24 (1990). 
118. Kind, P.C., Beaver, C.J. & Mitchell, D.E. Effects of early periods of monocular 
deprivation and reverse lid suture on the development of Cat-301 immunoreactivity in the 
dorsal lateral geniculate nucleus (dLGN) of the cat. J Comp Neurol 359, 523-36 (1995). 
142 
 
119. Novak, U. & Kaye, A.H. Extracellular matrix and the brain: components and function. J 
Clin Neurosci 7, 280-90 (2000). 
120. Nicholson, C. & Sykova, E. Extracellular space structure revealed by diffusion analysis. 
Trends Neurosci 21, 207-15 (1998). 
121. Golgi, C. Intorno alla struttura delle cellule nervose. Med-chir Pavia, 1-14 (1898). 
122. Neame, P.J. & Barry, F.P. The link proteins. Exs 70, 53-72 (1994). 
123. Binette, F., Cravens, J., Kahoussi, B., Haudenschild, D.R. & Goetinck, P.F. Link protein 
is ubiquitously expressed in non-cartilaginous tissues where it enhances and stabilizes the 
interaction of proteoglycans with hyaluronic acid. J Biol Chem 269, 19116-22 (1994). 
124. Watanabe, E., Fujita, S.C., Murakami, F., Hayashi, M. & Matsumura, M. A monoclonal 
antibody identifies a novel epitope surrounding a subpopulation of the mammalian 
central neurons. Neuroscience 29, 645-57 (1989). 
125. Galtrey, C.M. & Fawcett, J.W. The role of chondroitin sulfate proteoglycans in 
regeneration and plasticity in the central nervous system. Brain Res Rev 54, 1-18 (2007). 
126. Yamaguchi, Y. Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 
57, 276-89 (2000). 
127. Kwok, J.C., Carulli, D. & Fawcett, J.W. In vitro modeling of perineuronal nets: 
hyaluronan synthase and link protein are necessary for their formation and integrity. J 
Neurochem 114, 1447-59 (2010). 
128. Asher, R.A. et al. Neurocan is upregulated in injured brain and in cytokine-treated 
astrocytes. J Neurosci 20, 2427-38 (2000). 
129. Moon, L.D. & Fawcett, J.W. Reduction in CNS scar formation without concomitant 
increase in axon regeneration following treatment of adult rat brain with a combination of 
antibodies to TGFbeta1 and beta2. Eur J Neurosci 14, 1667-77 (2001). 
130. Lin, R., Rosahl, T.W., Whiting, P.J., Fawcett, J.W. & Kwok, J.C. 6-Sulphated 
chondroitins have a positive influence on axonal regeneration. PLoS One 6, e21499 
(2011). 
131. Milev, P. et al. Differential regulation of expression of hyaluronan-binding proteoglycans 
in developing brain: aggrecan, versican, neurocan, and brevican. Biochem Biophys Res 
Commun 247, 207-12 (1998). 
132. Rauch, U. Extracellular matrix components associated with remodeling processes in 
brain. Cell Mol Life Sci 61, 2031-45 (2004). 
133. Bandtlow, C.E. & Zimmermann, D.R. Proteoglycans in the developing brain: new 
conceptual insights for old proteins. Physiol Rev 80, 1267-90 (2000). 
143 
 
134. Pizzorusso, T. et al. Reactivation of ocular dominance plasticity in the adult visual cortex. 
Science 298, 1248-51 (2002). 
135. Dityatev, A. & Schachner, M. Extracellular matrix molecules and synaptic plasticity. Nat 
Rev Neurosci 4, 456-68 (2003). 
136. Evers, M.R. et al. Impairment of L-type Ca2+ channel-dependent forms of hippocampal 
synaptic plasticity in mice deficient in the extracellular matrix glycoprotein tenascin-C. J 
Neurosci 22, 7177-94 (2002). 
137. Bukalo, O., Schachner, M. & Dityatev, A. Modification of extracellular matrix by 
enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially affects 
several forms of synaptic plasticity in the hippocampus. Neuroscience 104, 359-69 
(2001). 
138. Geissler, M. et al. Primary hippocampal neurons, which lack four crucial extracellular 
matrix molecules, display abnormalities of synaptic structure and function and severe 
deficits in perineuronal net formation. J Neurosci 33, 7742-55 (2013). 
139. Klueva, J., Gundelfinger, E.D., Frischknecht, R.R. & Heine, M. Intracellular Ca(2)(+) 
and not the extracellular matrix determines surface dynamics of AMPA-type glutamate 
receptors on aspiny neurons. Philos Trans R Soc Lond B Biol Sci 369, 20130605 (2014). 
140. Frischknecht, R. et al. Brain extracellular matrix affects AMPA receptor lateral mobility 
and short-term synaptic plasticity. Nat Neurosci 12, 897-904 (2009). 
141. Morawski, M. et al. Ion exchanger in the brain: Quantitative analysis of perineuronally 
fixed anionic binding sites suggests diffusion barriers with ion sorting properties. Sci Rep 
5, 16471 (2015). 
142. Hrabetova, S., Masri, D., Tao, L., Xiao, F. & Nicholson, C. Calcium diffusion enhanced 
after cleavage of negatively charged components of brain extracellular matrix by 
chondroitinase ABC. J Physiol 587, 4029-49 (2009). 
143. Schuster, T. et al. Immunoelectron microscopic localization of the neural recognition 
molecules L1, NCAM, and its isoform NCAM180, the NCAM-associated polysialic acid, 
beta1 integrin and the extracellular matrix molecule tenascin-R in synapses of the adult 
rat hippocampus. J Neurobiol 49, 142-58 (2001). 
144. Bernard-Trifilo, J.A. et al. Integrin signaling cascades are operational in adult 
hippocampal synapses and modulate NMDA receptor physiology. J Neurochem 93, 834-
49 (2005). 
145. Huang, Z. et al. Distinct roles of the beta 1-class integrins at the developing and the 
mature hippocampal excitatory synapse. J Neurosci 26, 11208-19 (2006). 
146. Brown, E.J. Integrin-associated proteins. Curr Opin Cell Biol 14, 603-7 (2002). 
144 
 
147. Huber, K.M., Mauk, M.D. & Kelly, P.T. Distinct LTP induction mechanisms: 
contribution of NMDA receptors and voltage-dependent calcium channels. J 
Neurophysiol 73, 270-9 (1995). 
148. Dityatev, A. et al. Activity-dependent formation and functions of chondroitin sulfate-rich 
extracellular matrix of perineuronal nets. Dev Neurobiol 67, 570-88 (2007). 
149. Kochlamazashvili, G. et al. The extracellular matrix molecule hyaluronic acid regulates 
hippocampal synaptic plasticity by modulating postsynaptic L-type Ca(2+) channels. 
Neuron 67, 116-28 (2010). 
150. Lundell, A. et al. Structural basis for interactions between tenascins and lectican C-type 
lectin domains: evidence for a crosslinking role for tenascins. Structure 12, 1495-506 
(2004). 
151. Briata, P., Ilengo, C., Bobola, N. & Corte, G. Binding properties of the human 
homeodomain protein OTX2 to a DNA target sequence. FEBS Lett 445, 160-4 (1999). 
152. Sugiyama, S. et al. Experience-dependent transfer of Otx2 homeoprotein into the visual 
cortex activates postnatal plasticity. Cell 134, 508-20 (2008). 
153. Vo, T. et al. The chemorepulsive axon guidance protein semaphorin3A is a constituent of 
perineuronal nets in the adult rodent brain. Mol Cell Neurosci 56, 186-200 (2013). 
154. Goretzki, L., Burg, M.A., Grako, K.A. & Stallcup, W.B. High-affinity binding of basic 
fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the 
NG2 proteoglycan. J Biol Chem 274, 16831-7 (1999). 
155. Shen, Y. et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor 
of neural regeneration. Science 326, 592-6 (2009). 
156. Shiosaka, S. & Yoshida, S. Synaptic microenvironments--structural plasticity, adhesion 
molecules, proteases and their inhibitors. Neurosci Res 37, 85-9 (2000). 
157. Meighan, S.E. et al. Effects of extracellular matrix-degrading proteases matrix 
metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. J Neurochem 96, 
1227-41 (2006). 
158. Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R.D. & Kaczmarek, L. Matrix 
metalloproteinase-9 undergoes expression and activation during dendritic remodeling in 
adult hippocampus. J Neurosci 22, 920-30 (2002). 
159. Nagy, V. et al. Matrix metalloproteinase-9 is required for hippocampal late-phase long-
term potentiation and memory. J Neurosci 26, 1923-34 (2006). 
160. Michaluk, P. et al. Matrix metalloproteinase-9 controls NMDA receptor surface diffusion 
through integrin beta1 signaling. J Neurosci 29, 6007-12 (2009). 
145 
 
161. Nagy, V., Bozdagi, O. & Huntley, G.W. The extracellular protease matrix 
metalloproteinase-9 is activated by inhibitory avoidance learning and required for long-
term memory. Learn Mem 14, 655-64 (2007). 
162. Yoshiyama, Y., Asahina, M. & Hattori, T. Selective distribution of matrix 
metalloproteinase-3 (MMP-3) in Alzheimer's disease brain. Acta Neuropathol 99, 91-5 
(2000). 
163. Nagel, S. et al. Focal cerebral ischemia induces changes in both MMP-13 and aggrecan 
around individual neurons. Brain Res 1056, 43-50 (2005). 
164. Sole, S., Petegnief, V., Gorina, R., Chamorro, A. & Planas, A.M. Activation of matrix 
metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion. J Neuropathol 
Exp Neurol 63, 338-49 (2004). 
165. Yuan, W., Matthews, R.T., Sandy, J.D. & Gottschall, P.E. Association between protease-
specific proteolytic cleavage of brevican and synaptic loss in the dentate gyrus of kainate-
treated rats. Neuroscience 114, 1091-101 (2002). 
166. Murase, S. & Lantz, C.L. Light reintroduction after dark exposure reactivates plasticity in 
adults via perisynaptic activation of MMP-9.  6 (2017). 
167. Duffy, K.R. & Mitchell, D.E. Darkness alters maturation of visual cortex and promotes 
fast recovery from monocular deprivation. Curr Biol 23, 382-6 (2013). 
168. Brakebusch, C. et al. Brevican-deficient mice display impaired hippocampal CA1 long-
term potentiation but show no obvious deficits in learning and memory. Mol Cell Biol 22, 
7417-27 (2002). 
169. Zhou, X.H. et al. Neurocan is dispensable for brain development. Mol Cell Biol 21, 5970-
8 (2001). 
170. Gogolla, N., Caroni, P., Luthi, A. & Herry, C. Perineuronal nets protect fear memories 
from erasure. Science 325, 1258-61 (2009). 
171. Sun, Z.Y. et al. Disruption of perineuronal nets increases the frequency of sharp wave 
ripple events.  28, 42-52 (2018). 
172. Schlingloff, D. & Kali, S. Mechanisms of sharp wave initiation and ripple generation.  
34, 11385-98 (2014). 
173. Kim, J.H. & Richardson, R. A developmental dissociation of context and GABA effects 
on extinguished fear in rats. Behav Neurosci 121, 131-9 (2007). 
174. Banerjee, S.B. et al. Perineuronal Nets in the Adult Sensory Cortex Are Necessary for 
Fear Learning. Neuron 95, 169-179.e3 (2017). 
146 
 
175. Lensjo, K.K. & Lepperod, M.E. Removal of Perineuronal Nets Unlocks Juvenile 
Plasticity Through Network Mechanisms of Decreased Inhibition and Increased Gamma 
Activity.  37, 1269-1283 (2017). 
176. Thompson, E.H. et al. Removal of perineuronal nets disrupts recall of a remote fear 
memory. Proc Natl Acad Sci U S A 115, 607-612 (2018). 
177. Cajal, S.R.y. Sobre un ganglio especial de la corteza esfeno-occipital. Trab del Lab de 
invest Biol Univ Madrid 1, 189–201 (1902). 
178. Lorente de Nò, R. Studies on the Structure of the Cerebral Cortex II. Continuation of the 
Study of the Ammonic System. Journal für Psychologie und Neurologie 113-177, 113-
177 (1934). 
179. Bartesaghi, R. & Ravasi, L. Pyramidal neuron types in field CA2 of the guinea pig. Brain 
Res Bull 50, 263-73 (1999). 
180. Gall, C. & Selawski, L. Supramammillary afferents to guinea pig hippocampus contain 
substance P-like immunoreactivity. Neurosci Lett 51, 171-6 (1984). 
181. Zhang, L. & Hernandez, V.S. Synaptic innervation to rat hippocampus by vasopressin-
immuno-positive fibres from the hypothalamic supraoptic and paraventricular nuclei. 
Neuroscience 228, 139-62 (2013). 
182. Llorens-Martin, M., Jurado-Arjona, J., Avila, J. & Hernandez, F. Novel connection 
between newborn granule neurons and the hippocampal CA2 field. Exp Neurol 263, 285-
92 (2015). 
183. Cui, Z., Gerfen, C.R. & Young, W.S., 3rd. Hypothalamic and other connections with 
dorsal CA2 area of the mouse hippocampus. J Comp Neurol 521, 1844-66 (2013). 
184. Kohara, K. et al. Cell type-specific genetic and optogenetic tools reveal hippocampal 
CA2 circuits. Nat Neurosci 17, 269-79 (2014). 
185. Woodhams, P.L., Celio, M.R., Ulfig, N. & Witter, M.P. Morphological and functional 
correlates of borders in the entorhinal cortex and hippocampus. Hippocampus 3 Spec No, 
303-11 (1993). 
186. Hirama, J., Shoumura, K., Ichinohe, N., You, S. & Yonekura, H. Cornu ammonis of the 
cat: lack of a separate field of CA2. J Hirnforsch 38, 487-93 (1997). 
187. Alexander, G.M. et al. Social and novel contexts modify hippocampal CA2 
representations of space.  7, 10300 (2016). 
188. Mankin, E.A., Diehl, G.W., Sparks, F.T., Leutgeb, S. & Leutgeb, J.K. Hippocampal CA2 
activity patterns change over time to a larger extent than between spatial contexts. 
Neuron 85, 190-201 (2015). 
147 
 
189. Boehringer, R. et al. Chronic Loss of CA2 Transmission Leads to Hippocampal 
Hyperexcitability. Neuron 94, 642-655.e9 (2017). 
190. Nicoll, R.A. & Schmitz, D. Synaptic plasticity at hippocampal mossy fibre synapses. Nat 
Rev Neurosci 6, 863-76 (2005). 
191. Steve, T.A., Jirsch, J.D. & Gross, D.W. Quantification of subfield pathology in 
hippocampal sclerosis: a systematic review and meta-analysis. Epilepsy Res 108, 1279-85 
(2014). 
192. Corsellis, J.A. & Bruton, C.J. Neuropathology of status epilepticus in humans. Adv 
Neurol 34, 129-39 (1983). 
193. Maxwell, W.L. et al. There is differential loss of pyramidal cells from the human 
hippocampus with survival after blunt head injury. J Neuropathol Exp Neurol 62, 272-9 
(2003). 
194. Sloviter, R.S., Sollas, A.L., Barbaro, N.M. & Laxer, K.D. Calcium-binding protein 
(calbindin-D28K) and parvalbumin immunocytochemistry in the normal and epileptic 
human hippocampus. J Comp Neurol 308, 381-96 (1991). 
195. Kirino, T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain 
Res 239, 57-69 (1982). 
196. Zhao, M., Choi, Y.S., Obrietan, K. & Dudek, S.M. Synaptic plasticity (and the lack 
thereof) in hippocampal CA2 neurons. J Neurosci 27, 12025-32 (2007). 
197. Dudek, S.M., Alexander, G.M. & Farris, S. Rediscovering area CA2: unique properties 
and functions. Nat Rev Neurosci 17, 89-102 (2016). 
198. Lee, S.E. et al. RGS14 is a natural suppressor of both synaptic plasticity in CA2 neurons 
and hippocampal-based learning and memory. Proc Natl Acad Sci U S A 107, 16994-8 
(2010). 
199. Evans, P.R., Dudek, S.M. & Hepler, J.R. Regulator of G Protein Signaling 14: A 
Molecular Brake on Synaptic Plasticity Linked to Learning and Memory. Prog Mol Biol 
Transl Sci 133, 169-206 (2015). 
200. Evans, P.R. et al. Interactome Analysis Reveals Regulator of G Protein Signaling 14 
(RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) 
Binding Partner. J Proteome Res (2018). 
201. Evans, P.R., Lee, S.E., Smith, Y. & Hepler, J.R. Postnatal developmental expression of 
regulator of G protein signaling 14 (RGS14) in the mouse brain. J Comp Neurol 522, 
186-203 (2014). 
202. Donaldson, Z.R. & Young, L.J. Oxytocin, vasopressin, and the neurogenetics of sociality. 
Science 322, 900-4 (2008). 
148 
 
203. Pagani, J.H. et al. Role of the vasopressin 1b receptor in rodent aggressive behavior and 
synaptic plasticity in hippocampal area CA2. Mol Psychiatry 20, 490-9 (2015). 
204. Young, W.S., Li, J., Wersinger, S.R. & Palkovits, M. The vasopressin 1b receptor is 
prominent in the hippocampal area CA2 where it is unaffected by restraint stress or 
adrenalectomy. Neuroscience 143, 1031-9 (2006). 
205. Smith, A.S., Williams Avram, S.K., Cymerblit-Sabba, A., Song, J. & Young, W.S. 
Targeted activation of the hippocampal CA2 area strongly enhances social memory. Mol 
Psychiatry 21, 1137-44 (2016). 
206. Dasgupta, A. et al. Substance P induces plasticity and synaptic tagging/capture in rat 
hippocampal area CA2.  114, E8741-e8749 (2017). 
207. Choi, W.K. et al. The characteristics of supramammillary cells projecting to the 
hippocampus in stress response in the rat. Korean J Physiol Pharmacol 16, 17-24 (2012). 
208. Ochiishi, T. et al. Cellular localization of adenosine A1 receptors in rat forebrain: 
immunohistochemical analysis using adenosine A1 receptor-specific monoclonal 
antibody. J Comp Neurol 411, 301-16 (1999). 
209. Simons, S.B., Escobedo, Y., Yasuda, R. & Dudek, S.M. Regional differences in 
hippocampal calcium handling provide a cellular mechanism for limiting plasticity. Proc 
Natl Acad Sci U S A 106, 14080-4 (2009). 
210. Kirk, I.J. & McNaughton, N. Supramammillary cell firing and hippocampal rhythmical 
slow activity. Neuroreport 2, 723-5 (1991). 
211. Chevaleyre, V. & Siegelbaum, S.A. Strong CA2 pyramidal neuron synapses define a 
powerful disynaptic cortico-hippocampal loop. Neuron 66, 560-72 (2010). 
212. Piskorowski, R.A. & Chevaleyre, V. Delta-opioid receptors mediate unique plasticity 
onto parvalbumin-expressing interneurons in area CA2 of the hippocampus. J Neurosci 
33, 14567-78 (2013). 
213. Mercer, A., Trigg, H.L. & Thomson, A.M. Characterization of neurons in the CA2 
subfield of the adult rat hippocampus. J Neurosci 27, 7329-38 (2007). 
214. Mercer, A., Eastlake, K., Trigg, H.L. & Thomson, A.M. Local circuitry involving 
parvalbumin-positive basket cells in the CA2 region of the hippocampus. Hippocampus 
22, 43-56 (2012). 
215. Botcher, N.A., Falck, J.E., Thomson, A.M. & Mercer, A. Distribution of interneurons in 
the CA2 region of the rat hippocampus. Front Neuroanat 8, 104 (2014). 
216. Nasrallah, K., Piskorowski, R.A. & Chevaleyre, V. Inhibitory Plasticity Permits the 
Recruitment of CA2 Pyramidal Neurons by CA3(1,2,3). eNeuro 2 (2015). 
149 
 
217. Leroy, F., Brann, D.H., Meira, T. & Siegelbaum, S.A. Input-Timing-Dependent Plasticity 
in the Hippocampal CA2 Region and Its Potential Role in Social Memory. Neuron 95, 
1089-1102.e5 (2017). 
218. Benes, F.M., Kwok, E.W., Vincent, S.L. & Todtenkopf, M.S. A reduction of 
nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol 
Psychiatry 44, 88-97 (1998). 
219. Piskorowski, R.A. et al. Age-Dependent Specific Changes in Area CA2 of the 
Hippocampus and Social Memory Deficit in a Mouse Model of the 22q11.2 Deletion 
Syndrome. Neuron 89, 163-76 (2016). 
220. Wintzer, M.E., Boehringer, R., Polygalov, D. & McHugh, T.J. The hippocampal CA2 
ensemble is sensitive to contextual change. J Neurosci 34, 3056-66 (2014). 
221. Oliva, A., Fernandez-Ruiz, A., Buzsaki, G. & Berenyi, A. Spatial coding and 
physiological properties of hippocampal neurons in the Cornu Ammonis subregions. 
Hippocampus 26, 1593-1607 (2016). 
222. Lu, L., Igarashi, K.M., Witter, M.P., Moser, E.I. & Moser, M.B. Topography of Place 
Maps along the CA3-to-CA2 Axis of the Hippocampus. Neuron 87, 1078-92 (2015). 
223. Smith, A.S., Williams Avram, S.K., Cymerblit-Sabba, A., Song, J. & Young, W.S. 
Targeted activation of the hippocampal CA2 area strongly enhances social memory. Mol 
Psychiatry (2016). 
224. Hitti, F.L. & Siegelbaum, S.A. The hippocampal CA2 region is essential for social 
memory. Nature 508, 88-92 (2014). 
225. Stevenson, E.L. & Caldwell, H.K. Lesions to the CA2 region of the hippocampus impair 
social memory in mice. Eur J Neurosci 40, 3294-301 (2014). 
226. DeVito, L.M. et al. Vasopressin 1b receptor knock-out impairs memory for temporal 
order. J Neurosci 29, 2676-83 (2009). 
227. Chafai, M., Corbani, M., Guillon, G. & Desarmenien, M.G. Vasopressin inhibits LTP in 
the CA2 mouse hippocampal area. PLoS One 7, e49708 (2012). 
228. Wersinger, S.R., Ginns, E.I., O'Carroll, A.M., Lolait, S.J. & Young, W.S., 3rd. 
Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol 
Psychiatry 7, 975-84 (2002). 
229. Wersinger, S.R., Temple, J.L., Caldwell, H.K. & Young, W.S., 3rd. Inactivation of the 
oxytocin and the vasopressin (Avp) 1b receptor genes, but not the Avp 1a receptor gene, 
differentially impairs the Bruce effect in laboratory mice (Mus musculus). Endocrinology 
149, 116-21 (2008). 
150 
 
230. Alexander, G. et al. CA2 Neuronal Activity Controls Hippocampal Oscillations and 
Social Behavior. bioRxiv (2017). 
231. Whitlock, J.R., Heynen, A.J., Shuler, M.G. & Bear, M.F. Learning induces long-term 
potentiation in the hippocampus. Science 313, 1093-7 (2006). 
232. Josselyn, S.A. & Frankland, P.W. Infantile amnesia: a neurogenic hypothesis. Learn Mem 
19, 423-33 (2012). 
233. Fanselow, M.S. Contextual fear, gestalt memories, and the hippocampus. Behav Brain 
Res 110, 73-81 (2000). 
234. Eichenbaum, H. Is the rodent hippocampus just for 'place'? Curr Opin Neurobiol 6, 187-
95 (1996). 
235. Wiltgen, B.J., Sanders, M.J., Anagnostaras, S.G., Sage, J.R. & Fanselow, M.S. Context 
fear learning in the absence of the hippocampus. J Neurosci 26, 5484-91 (2006). 
236. Bourtchuladze, R. et al. Deficient long-term memory in mice with a targeted mutation of 
the cAMP-responsive element-binding protein. Cell 79, 59-68 (1994). 
237. Daumas, S., Halley, H., Frances, B. & Lassalle, J.M. Encoding, consolidation, and 
retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 
hippocampal subregions. Learn Mem 12, 375-82 (2005). 
238. Campbell, B.A. & Spear, N.E. Ontogeny of memory. Psychol Rev 79, 215-36 (1972). 
239. Wiskott, L., Rasch, M.J. & Kempermann, G. A functional hypothesis for adult 
hippocampal neurogenesis: avoidance of catastrophic interference in the dentate gyrus. 
Hippocampus 16, 329-43 (2006). 
240. Treves, A., Tashiro, A., Witter, M.P. & Moser, E.I. What is the mammalian dentate gyrus 
good for? Neuroscience 154, 1155-72 (2008). 
241. Shors, T.J. From stem cells to grandmother cells: how neurogenesis relates to learning 
and memory. Cell Stem Cell 3, 253-8 (2008). 
242. McRae, P.A., Baranov, E., Sarode, S., Brooks-Kayal, A.R. & Porter, B.E. Aggrecan 
expression, a component of the inhibitory interneuron perineuronal net, is altered 
following an early-life seizure. Neurobiol Dis 39, 439-48 (2010). 
243. McRae, P.A., Baranov, E., Rogers, S.L. & Porter, B.E. Persistent decrease in multiple 
components of the perineuronal net following status epilepticus. Eur J Neurosci 36, 
3471-82 (2012). 
244. Fuxe, K., Tinner, B., Staines, W., David, G. & Agnati, L.F. Regional distribution of 
neural cell adhesion molecule immunoreactivity in the adult rat telencephalon and 
151 
 
diencephalon. Partial colocalization with heparan sulfate proteoglycan immunoreactivity. 
Brain Res 746, 25-33 (1997). 
245. Alpar, A., Gartner, U., Hartig, W. & Bruckner, G. Distribution of pyramidal cells 
associated with perineuronal nets in the neocortex of rat. Brain Res 1120, 13-22 (2006). 
246. Caruana, D.A., Alexander, G.M. & Dudek, S.M. New insights into the regulation of 
synaptic plasticity from an unexpected place: hippocampal area CA2. Learn Mem 19, 
391-400 (2012). 
247. Boulanger, L.M. et al. Cellular and molecular characterization of a brain-enriched protein 
tyrosine phosphatase. J Neurosci 15, 1532-44 (1995). 
248. Pelkey, K.A. et al. Tyrosine phosphatase STEP is a tonic brake on induction of long-term 
potentiation. Neuron 34, 127-38 (2002). 
249. Feng, G. et al. Imaging neuronal subsets in transgenic mice expressing multiple spectral 
variants of GFP. Neuron 28, 41-51 (2000). 
250. Aoyagi, Y., Kawakami, R., Osanai, H., Hibi, T. & Nemoto, T. A rapid optical clearing 
protocol using 2,2'-thiodiethanol for microscopic observation of fixed mouse brain. PLoS 
One 10, e0116280 (2015). 
251. Poncer, J.C. & Malinow, R. Postsynaptic conversion of silent synapses during LTP 
affects synaptic gain and transmission dynamics. Nat Neurosci 4, 989-96 (2001). 
252. Laeremans, A. et al. AMIGO2 mRNA expression in hippocampal CA2 and CA3a. Brain 
Struct Funct 218, 123-30 (2013). 
253. Sur, M., Frost, D.O. & Hockfield, S. Expression of a surface-associated antigen on Y-
cells in the cat lateral geniculate nucleus is regulated by visual experience. J Neurosci 8, 
874-82 (1988). 
254. Bartoletti, A., Medini, P., Berardi, N. & Maffei, L. Environmental enrichment prevents 
effects of dark-rearing in the rat visual cortex. Nat Neurosci 7, 215-6 (2004). 
255. Baroncelli, L. et al. Experience Affects Critical Period Plasticity in the Visual Cortex 
through an Epigenetic Regulation of Histone Post-Translational Modifications. J 
Neurosci 36, 3430-40 (2016). 
256. Romberg, C. et al. Depletion of perineuronal nets enhances recognition memory and 
long-term depression in the perirhinal cortex. J Neurosci 33, 7057-65 (2013). 
257. Wang, D. & Fawcett, J. The perineuronal net and the control of CNS plasticity. Cell 
Tissue Res 349, 147-60 (2012). 
258. Morawski, M., Bruckner, M.K., Riederer, P., Bruckner, G. & Arendt, T. Perineuronal 
nets potentially protect against oxidative stress. Exp Neurol 188, 309-15 (2004). 
152 
 
259. Galtrey, C.M., Asher, R.A., Nothias, F. & Fawcett, J.W. Promoting plasticity in the 
spinal cord with chondroitinase improves functional recovery after peripheral nerve 
repair. Brain 130, 926-39 (2007). 
260. Corvetti, L. & Rossi, F. Degradation of chondroitin sulfate proteoglycans induces 
sprouting of intact purkinje axons in the cerebellum of the adult rat. J Neurosci 25, 7150-
8 (2005). 
261. Cabungcal, J.H. et al. Perineuronal nets protect fast-spiking interneurons against 
oxidative stress. Proc Natl Acad Sci U S A 110, 9130-5 (2013). 
262. Sale, A. et al. Environmental enrichment in adulthood promotes amblyopia recovery 
through a reduction of intracortical inhibition. Nat Neurosci 10, 679-81 (2007). 
263. Foscarin, S. et al. Experience-dependent plasticity and modulation of growth regulatory 
molecules at central synapses. PLoS One 6, e16666 (2011). 
264. Mauney, S.A. et al. Developmental pattern of perineuronal nets in the human prefrontal 
cortex and their deficit in schizophrenia. Biol Psychiatry 74, 427-35 (2013). 
265. Belichenko, P.V., Hagberg, B. & Dahlstrom, A. Morphological study of neocortical areas 
in Rett syndrome. Acta Neuropathol 93, 50-61 (1997). 
266. Amir, R.E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding 
methyl-CpG-binding protein 2. Nat Genet 23, 185-8 (1999). 
267. Neul, J.L. et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 
68, 944-50 (2010). 
268. Percy, A.K., Zoghbi, H.Y. & Glaze, D.G. Rett syndrome: discrimination of typical and 
variant forms. Brain Dev 9, 458-61 (1987). 
269. Percy, A.K. et al. Rett syndrome diagnostic criteria: lessons from the Natural History 
Study. Ann Neurol 68, 951-5 (2010). 
270. Armstrong, D.D. Neuropathology of Rett syndrome. J Child Neurol 20, 747-53 (2005). 
271. Percy, A.K., Zoghbi, H. & Riccardi, V.M. Rett syndrome: initial experience with an 
emerging clinical entity. Brain Dev 7, 300-4 (1985). 
272. Schultz, R.J. et al. The pattern of growth failure in Rett syndrome. Am J Dis Child 147, 
633-7 (1993). 
273. Ellison, K.A. et al. Examination of X chromosome markers in Rett syndrome: exclusion 




274. Percy, A.K., Zoghbi, H.Y., Lewis, K.R. & Jankovic, J. Rett syndrome: qualitative and 
quantitative differentiation from autism. J Child Neurol 3 Suppl, S65-7 (1988). 
275. Gilby, K.L. & O'Brien, T.J. Epilepsy, autism, and neurodevelopment: kindling a shared 
vulnerability? Epilepsy Behav 26, 370-4 (2013). 
276. Chahrour, M. et al. MeCP2, a key contributor to neurological disease, activates and 
represses transcription. Science 320, 1224-9 (2008). 
277. Cheng, T.L. et al. MeCP2 suppresses nuclear microRNA processing and dendritic growth 
by regulating the DGCR8/Drosha complex. Dev Cell 28, 547-60 (2014). 
278. Qiu, Z. et al. The Rett syndrome protein MeCP2 regulates synaptic scaling. J Neurosci 
32, 989-94 (2012). 
279. Ebert, D.H. & Greenberg, M.E. Activity-dependent neuronal signalling and autism 
spectrum disorder. Nature 493, 327-37 (2013). 
280. Shahbazian, M.D., Antalffy, B., Armstrong, D.L. & Zoghbi, H.Y. Insight into Rett 
syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with 
neuronal maturation. Hum Mol Genet 11, 115-24 (2002). 
281. Mullaney, B.C., Johnston, M.V. & Blue, M.E. Developmental expression of methyl-CpG 
binding protein 2 is dynamically regulated in the rodent brain. Neuroscience 123, 939-49 
(2004). 
282. Lyst, M.J. & Bird, A. Rett syndrome: a complex disorder with simple roots. Nat Rev 
Genet 16, 261-75 (2015). 
283. Boggio, E.M., Lonetti, G., Pizzorusso, T. & Giustetto, M. Synaptic determinants of rett 
syndrome. Front Synaptic Neurosci 2, 28 (2010). 
284. Belichenko, P.V., Oldfors, A., Hagberg, B. & Dahlstrom, A. Rett syndrome: 3-D 
confocal microscopy of cortical pyramidal dendrites and afferents. Neuroreport 5, 1509-
13 (1994). 
285. Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K. & Goto, Y. Delayed maturation of 
neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J 
Neuropathol Exp Neurol 64, 537-44 (2005). 
286. Asaka, Y., Jugloff, D.G., Zhang, L., Eubanks, J.H. & Fitzsimonds, R.M. Hippocampal 
synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. 
Neurobiol Dis 21, 217-27 (2006). 
287. Medrihan, L. et al. Early defects of GABAergic synapses in the brain stem of a MeCP2 
mouse model of Rett syndrome. J Neurophysiol 99, 112-21 (2008). 
154 
 
288. Belichenko, N.P., Belichenko, P.V. & Mobley, W.C. Evidence for both neuronal cell 
autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral 
cortex of female mice with Mecp2 mutation. Neurobiol Dis 34, 71-7 (2009). 
289. Tropea, D. et al. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant 
mice. Proc Natl Acad Sci U S A 106, 2029-34 (2009). 
290. Zhang, Z.W., Zak, J.D. & Liu, H. MeCP2 is required for normal development of 
GABAergic circuits in the thalamus. J Neurophysiol 103, 2470-81 (2010). 
291. Gantz, S.C., Ford, C.P., Neve, K.A. & Williams, J.T. Loss of Mecp2 in substantia nigra 
dopamine neurons compromises the nigrostriatal pathway. J Neurosci 31, 12629-37 
(2011). 
292. Smrt, R.D. et al. Mecp2 deficiency leads to delayed maturation and altered gene 
expression in hippocampal neurons. Neurobiol Dis 27, 77-89 (2007). 
293. Pantazopoulos, H., Woo, T.U., Lim, M.P., Lange, N. & Berretta, S. Extracellular matrix-
glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with 
schizophrenia. Arch Gen Psychiatry 67, 155-66 (2010). 
294. McRae, P.A. & Porter, B.E. The perineuronal net component of the extracellular matrix 
in plasticity and epilepsy. Neurochem Int 61, 963-72 (2012). 
295. Carstens, K.E., Phillips, M.L. & Pozzo-Miller, L. Perineuronal Nets Suppress Plasticity 
of Excitatory Synapses on CA2 Pyramidal Neurons.  36, 6312-20 (2016). 
296. Sorg, B.A. & Berretta, S. Casting a Wide Net: Role of Perineuronal Nets in Neural 
Plasticity.  36, 11459-11468 (2016). 
297. Hockfield, S., Kalb, R.G., Zaremba, S. & Fryer, H. Expression of neural proteoglycans 
correlates with the acquisition of mature neuronal properties in the mammalian brain. 
Cold Spring Harb Symp Quant Biol 55, 505-14 (1990). 
298. Krishnan, K., Lau, B.Y., Ewall, G., Huang, Z.J. & Shea, S.D. MECP2 regulates cortical 
plasticity underlying a learned behaviour in adult female mice. Nat Commun 8, 14077 
(2017). 
299. Krishnan, K. et al. MeCP2 regulates the timing of critical period plasticity that shapes 
functional connectivity in primary visual cortex. Proc Natl Acad Sci U S A 112, E4782-
91 (2015). 
300. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. & Bird, A. A mouse Mecp2-null 
mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27, 322-6 
(2001). 
301. Pelka, G.J. et al. Mecp2 deficiency is associated with learning and cognitive deficits and 
altered gene activity in the hippocampal region of mice. Brain 129, 887-98 (2006). 
155 
 
302. Chao, H.T. et al. Dysfunction in GABA signalling mediates autism-like stereotypies and 
Rett syndrome phenotypes. Nature 468, 263-9 (2010). 
303. Chao, H.T., Zoghbi, H.Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength 
by regulating glutamatergic synapse number. Neuron 56, 58-65 (2007). 
304. Belichenko, P.V. et al. Widespread changes in dendritic and axonal morphology in 
Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal 
networks. J Comp Neurol 514, 240-58 (2009). 
305. Chen, R.Z., Akbarian, S., Tudor, M. & Jaenisch, R. Deficiency of methyl-CpG binding 
protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27, 327-31 
(2001). 
306. Calfa, G., Hablitz, J.J. & Pozzo-Miller, L. Network hyperexcitability in hippocampal 
slices from Mecp2 mutant mice revealed by voltage-sensitive dye imaging. J 
Neurophysiol 105, 1768-84 (2011). 
307. Moretti, P. et al. Learning and memory and synaptic plasticity are impaired in a mouse 
model of Rett syndrome. J Neurosci 26, 319-27 (2006). 
308. Hao, S. et al. Forniceal deep brain stimulation rescues hippocampal memory in Rett 
syndrome mice. Nature 526, 430-4 (2015). 
309. Lu, H. et al. Loss and Gain of MeCP2 Cause Similar Hippocampal Circuit Dysfunction 
that Is Rescued by Deep Brain Stimulation in a Rett Syndrome Mouse Model. Neuron 91, 
739-747 (2016). 
310. Blackman, M.P., Djukic, B., Nelson, S.B. & Turrigiano, G.G. A critical and cell-
autonomous role for MeCP2 in synaptic scaling up. J Neurosci 32, 13529-36 (2012). 
311. Cull-Candy, S., Brickley, S. & Farrant, M. NMDA receptor subunits: diversity, 
development and disease. Curr Opin Neurobiol 11, 327-35 (2001). 
312. Watanabe, M., Inoue, Y., Sakimura, K. & Mishina, M. Developmental changes in 
distribution of NMDA receptor channel subunit mRNAs. Neuroreport 3, 1138-40 (1992). 
313. Liu, N., He, S. & Yu, X. Early natural stimulation through environmental enrichment 
accelerates neuronal development in the mouse dentate gyrus. PLoS One 7, e30803 
(2012). 
314. Martinowich, K. et al. DNA methylation-related chromatin remodeling in activity-
dependent BDNF gene regulation. Science 302, 890-3 (2003). 
315. Monteggia, L.M. et al. Essential role of brain-derived neurotrophic factor in adult 
hippocampal function. Proc Natl Acad Sci U S A 101, 10827-32 (2004). 
156 
 
316. Larimore, J.L. et al. Bdnf overexpression in hippocampal neurons prevents dendritic 
atrophy caused by Rett-associated MECP2 mutations. Neurobiol Dis 34, 199-211 (2009). 
317. Chang, Q., Khare, G., Dani, V., Nelson, S. & Jaenisch, R. The disease progression of 
Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49, 341-8 
(2006). 
318. Chen, W.G. et al. Derepression of BDNF transcription involves calcium-dependent 
phosphorylation of MeCP2. Science 302, 885-9 (2003). 
319. Zhou, Z. et al. Brain-specific phosphorylation of MeCP2 regulates activity-dependent 
Bdnf transcription, dendritic growth, and spine maturation. Neuron 52, 255-69 (2006). 
320. Dani, V.S. et al. Reduced cortical activity due to a shift in the balance between excitation 
and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 102, 12560-
5 (2005). 
321. Nelson, E.D., Kavalali, E.T. & Monteggia, L.M. MeCP2-dependent transcriptional 
repression regulates excitatory neurotransmission. Curr Biol 16, 710-6 (2006). 
322. Samaco, R.C. et al. Loss of MeCP2 in aminergic neurons causes cell-autonomous defects 
in neurotransmitter synthesis and specific behavioral abnormalities. Proc Natl Acad Sci U 
S A 106, 21966-71 (2009). 
323. Lioy, D.T. et al. A role for glia in the progression of Rett's syndrome. Nature 475, 497-
500 (2011). 
324. Derecki, N.C. et al. Wild-type microglia arrest pathology in a mouse model of Rett 
syndrome. Nature 484, 105-9 (2012). 
325. Alvarez-Saavedra, M., Saez, M.A., Kang, D., Zoghbi, H.Y. & Young, J.I. Cell-specific 
expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about 
pathogenesis. Hum Mol Genet 16, 2315-25 (2007). 
326. He, L.J. et al. Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic 
cells results in the absence of critical period plasticity. Nat Commun 5, 5036 (2014). 
327. Leontovich, T.A., Mukhina, J.K., Fedorov, A.A. & Belichenko, P.V. Morphological 
study of the entorhinal cortex, hippocampal formation, and basal ganglia in Rett 
syndrome patients. Neurobiol Dis 6, 77-91 (1999). 
328. Giacometti, E., Luikenhuis, S., Beard, C. & Jaenisch, R. Partial rescue of MeCP2 
deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci U S A 104, 1931-6 
(2007). 
329. Gong, S., Yang, X.W., Li, C. & Heintz, N. Highly efficient modification of bacterial 
artificial chromosomes (BACs) using novel shuttle vectors containing the R6Kgamma 
origin of replication. Genome Res 12, 1992-8 (2002). 
157 
 
330. Gustafsson, B., Wigstrom, H., Abraham, W.C. & Huang, Y.Y. Long-term potentiation in 
the hippocampus using depolarizing current pulses as the conditioning stimulus to single 
volley synaptic potentials. J Neurosci 7, 774-80 (1987). 
331. Malenka, R.C. & Nicoll, R.A. NMDA-receptor-dependent synaptic plasticity: multiple 
forms and mechanisms. Trends Neurosci 16, 521-7 (1993). 
332. Chapleau, C.A. et al. Hippocampal CA1 pyramidal neurons of Mecp2 mutant mice show 
a dendritic spine phenotype only in the presymptomatic stage. Neural Plast 2012, 976164 
(2012). 
333. Ethell, I.M. & Ethell, D.W. Matrix metalloproteinases in brain development and 
remodeling: synaptic functions and targets. J Neurosci Res 85, 2813-23 (2007). 
334. Reinhard, S.M., Razak, K. & Ethell, I.M. A delicate balance: role of MMP-9 in brain 
development and pathophysiology of neurodevelopmental disorders. Front Cell Neurosci 
9, 280 (2015). 
335. Wen, T.H. et al. Genetic Reduction of Matrix Metalloproteinase-9 Promotes Formation 
of Perineuronal Nets Around Parvalbumin-Expressing Interneurons and Normalizes 
Auditory Cortex Responses in Developing Fmr1 Knock-Out Mice. Cereb Cortex, 1-14 
(2017). 
336. Kaufmann, W.E., Naidu, S. & Budden, S. Abnormal expression of microtubule-
associated protein 2 (MAP-2) in neocortex in Rett syndrome. Neuropediatrics 26, 109-13 
(1995). 
337. Kaufmann, W.E., Taylor, C.V., Hohmann, C.F., Sanwal, I.B. & Naidu, S. Abnormalities 
in neuronal maturation in Rett syndrome neocortex: preliminary molecular correlates. 
Eur Child Adolesc Psychiatry 6 Suppl 1, 75-7 (1997). 
338. Dani, V.S. & Nelson, S.B. Intact long-term potentiation but reduced connectivity 
between neocortical layer 5 pyramidal neurons in a mouse model of Rett syndrome. J 
Neurosci 29, 11263-70 (2009). 
339. Zhang, L., He, J., Jugloff, D.G. & Eubanks, J.H. The MeCP2-null mouse hippocampus 
displays altered basal inhibitory rhythms and is prone to hyperexcitability. Hippocampus 
18, 294-309 (2008). 
340. van Zundert, B., Yoshii, A. & Constantine-Paton, M. Receptor compartmentalization and 
trafficking at glutamate synapses: a developmental proposal. Trends Neurosci 27, 428-37 
(2004). 
341. Blue, M.E., Naidu, S. & Johnston, M.V. Altered development of glutamate and GABA 




342. Blue, M.E., Naidu, S. & Johnston, M.V. Development of amino acid receptors in frontal 
cortex from girls with Rett syndrome. Ann Neurol 45, 541-5 (1999). 
343. Liu, L. et al. Role of NMDA receptor subtypes in governing the direction of hippocampal 
synaptic plasticity. Science 304, 1021-4 (2004). 
344. Kirson, E.D. & Yaari, Y. Synaptic NMDA receptors in developing mouse hippocampal 
neurones: functional properties and sensitivity to ifenprodil. J Physiol 497 ( Pt 2), 437-55 
(1996). 
345. Lu, H.C., Gonzalez, E. & Crair, M.C. Barrel cortex critical period plasticity is 
independent of changes in NMDA receptor subunit composition. Neuron 32, 619-34 
(2001). 
346. Huang, Z.J. et al. BDNF regulates the maturation of inhibition and the critical period of 
plasticity in mouse visual cortex. Cell 98, 739-55 (1999). 
347. Chattopadhyaya, B. et al. Experience and activity-dependent maturation of perisomatic 
GABAergic innervation in primary visual cortex during a postnatal critical period. J 
Neurosci 24, 9598-611 (2004). 
348. Chattopadhyaya, B. et al. GAD67-mediated GABA synthesis and signaling regulate 
inhibitory synaptic innervation in the visual cortex. Neuron 54, 889-903 (2007). 
349. Kwan, P. & Sander, J.W. The natural history of epilepsy: an epidemiological view. J 
Neurol Neurosurg Psychiatry 75, 1376-81 (2004). 
350. Riban, V. et al. Evolution of hippocampal epileptic activity during the development of 
hippocampal sclerosis in a mouse model of temporal lobe epilepsy. Neuroscience 112, 
101-11 (2002). 
351. Lukasiuk, K., Wilczynski, G.M. & Kaczmarek, L. Extracellular proteases in epilepsy. 
Epilepsy Res 96, 191-206 (2011). 
352. Schubert, M., Siegmund, H., Pape, H.C. & Albrecht, D. Kindling-induced changes in 
plasticity of the rat amygdala and hippocampus. Learn Mem 12, 520-6 (2005). 
353. Beck, H., Goussakov, I.V., Lie, A., Helmstaedter, C. & Elger, C.E. Synaptic plasticity in 
the human dentate gyrus. J Neurosci 20, 7080-6 (2000). 
354. Dityatev, A. Remodeling of extracellular matrix and epileptogenesis. Epilepsia 51 Suppl 
3, 61-5 (2010). 
355. Perosa, S.R. et al. Extracellular matrix components are altered in the hippocampus, 
cortex, and cerebrospinal fluid of patients with mesial temporal lobe epilepsy. Epilepsia 
43 Suppl 5, 159-61 (2002). 
159 
 
356. Rankin-Gee, E.K. et al. Perineuronal net degradation in epilepsy. Epilepsia 56, 1124-33 
(2015). 
357. Suzuki, F., Makiura, Y., Guilhem, D., Sorensen, J.C. & Onteniente, B. Correlated axonal 
sprouting and dendritic spine formation during kainate-induced neuronal morphogenesis 
in the dentate gyrus of adult mice. Exp Neurol 145, 203-13 (1997). 
358. Ben-Ari, Y. & Represa, A. Brief seizure episodes induce long-term potentiation and 
mossy fibre sprouting in the hippocampus. Trends Neurosci 13, 312-8 (1990). 
359. Anwyl, R., Walshe, J. & Rowan, M. Electroconvulsive treatment reduces long-term 
potentiation in rat hippocampus. Brain Res 435, 377-9 (1987). 
360. Barr, D.S., Hoyt, K.L., Moore, S.D. & Wilson, W.A. Post-ictal depression transiently 
inhibits induction of LTP in area CA1 of the rat hippocampal slice. Epilepsy Res 27, 111-
8 (1997). 
361. Wilczynski, G.M. et al. Important role of matrix metalloproteinase 9 in epileptogenesis. J 
Cell Biol 180, 1021-35 (2008). 
362. Wu, Y.P. et al. The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic 
system regulates seizure-induced hippocampal mossy fiber outgrowth through a 
proteoglycan substrate. J Cell Biol 148, 1295-304 (2000). 
363. Sloviter, R.S. "Epileptic" brain damage in rats induced by sustained electrical stimulation 
of the perforant path. I. Acute electrophysiological and light microscopic studies. Brain 
Res Bull 10, 675-97 (1983). 
364. Sloviter, R.S. & Damiano, B.P. Sustained electrical stimulation of the perforant path 
duplicates kainate-induced electrophysiological effects and hippocampal damage in rats. 
Neurosci Lett 24, 279-84 (1981). 
365. Hatanpaa, K.J. et al. Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: 
differential vulnerability of hippocampal subfields. J Neuropathol Exp Neurol 73, 136-42 
(2014). 
366. Cavazos, J.E., Das, I. & Sutula, T.P. Neuronal loss induced in limbic pathways by 
kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J 
Neurosci 14, 3106-21 (1994). 
367. Haussler, U., Rinas, K., Kilias, A., Egert, U. & Haas, C.A. Mossy fiber sprouting and 
pyramidal cell dispersion in the hippocampal CA2 region in a mouse model of temporal 
lobe epilepsy. Hippocampus (2015). 
368. Smart, S.L. et al. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. 
Neuron 20, 809-19 (1998). 
160 
 
369. Bidmon, H.J. et al. Structural alterations and changes in cytoskeletal proteins and 
proteoglycans after focal cortical ischemia. Neuroscience 82, 397-420 (1998). 
370. Smith, C.C. et al. Differential regulation of perineuronal nets in the brain and spinal cord 
with exercise training. Brain Res Bull 111, 20-6 (2015). 
371. Hartig, W. et al. Damaged Neocortical Perineuronal Nets Due to Experimental Focal 
Cerebral Ischemia in Mice, Rats and Sheep. Front Integr Neurosci 11, 15 (2017). 
372. Roth, B.L. DREADDs for Neuroscientists. Neuron 89, 683-94 (2016). 
373. Armbruster, B.N., Li, X., Pausch, M.H., Herlitze, S. & Roth, B.L. Evolving the lock to fit 
the key to create a family of G protein-coupled receptors potently activated by an inert 
ligand. Proc Natl Acad Sci U S A 104, 5163-8 (2007). 
374. Alexander, G.M. et al. Remote control of neuronal activity in transgenic mice expressing 
evolved G protein-coupled receptors. Neuron 63, 27-39 (2009). 
375. Giamanco, K.A., Morawski, M. & Matthews, R.T. Perineuronal net formation and 
structure in aggrecan knockout mice. Neuroscience 170, 1314-27 (2010). 
376. Saghatelyan, A.K. et al. Reduced perisomatic inhibition, increased excitatory 
transmission, and impaired long-term potentiation in mice deficient for the extracellular 
matrix glycoprotein tenascin-R. Mol Cell Neurosci 17, 226-40 (2001). 
377. Carulli, D. et al. Animals lacking link protein have attenuated perineuronal nets and 
persistent plasticity. Brain 133, 2331-47 (2010). 
378. Bradbury, E.J. et al. Chondroitinase ABC promotes functional recovery after spinal cord 
injury. Nature 416, 636-40 (2002). 
379. Cafferty, W.B. et al. Chondroitinase ABC-mediated plasticity of spinal sensory function. 
J Neurosci 28, 11998-2009 (2008). 
380. Berretta, S. Extracellular matrix abnormalities in schizophrenia. Neuropharmacology 62, 
1584-97 (2012). 
381. Babb, T.L., Kupfer, W.R., Pretorius, J.K., Crandall, P.H. & Levesque, M.F. Synaptic 
reorganization by mossy fibers in human epileptic fascia dentata. Neuroscience 42, 351-
63 (1991). 
382. Farris, S., Lewandowski, G., Cox, C.D. & Steward, O. Selective localization of arc 
mRNA in dendrites involves activity- and translation-dependent mRNA degradation. J 
Neurosci 34, 4481-93 (2014). 
383. Madisen, L. et al. A robust and high-throughput Cre reporting and characterization 
system for the whole mouse brain. Nat Neurosci 13, 133-40 (2010). 
161 
 
384. Alves, J.N. et al. AAV vector-mediated secretion of chondroitinase provides a sensitive 
tracer for axonal arborisations. J Neurosci Methods 227, 107-20 (2014). 
385. Zhao, R.R. et al. Lentiviral vectors express chondroitinase ABC in cortical projections 
and promote sprouting of injured corticospinal axons. J Neurosci Methods 201, 228-38 
(2011). 
386. Muir, E.M. et al. Modification of N-glycosylation sites allows secretion of bacterial 
chondroitinase ABC from mammalian cells. J Biotechnol 145, 103-10 (2010). 
387. Pollock, E., Everest, M., Brown, A. & Poulter, M.O. Metalloproteinase inhibition 
prevents inhibitory synapse reorganization and seizure genesis. Neurobiol Dis 70, 21-31 
(2014). 
388. Konopka, A. et al. Matrix metalloproteinase-9 (MMP-9) in human intractable epilepsy 
caused by focal cortical dysplasia. Epilepsy Res 104, 45-58 (2013). 
389. Bouilleret, V. et al. Recurrent seizures and hippocampal sclerosis following 
intrahippocampal kainate injection in adult mice: electroencephalography, histopathology 
and synaptic reorganization similar to mesial temporal lobe epilepsy. Neuroscience 89, 
717-29 (1999). 
390. Shepherd, J.D. & Bear, M.F. New views of Arc, a master regulator of synaptic plasticity. 
Nat Neurosci 14, 279-84 (2011). 
391. Shibley, H. & Smith, B.N. Pilocarpine-induced status epilepticus results in mossy fiber 
sprouting and spontaneous seizures in C57BL/6 and CD-1 mice. Epilepsy Res 49, 109-20 
(2002). 
392. Sutula, T., Cascino, G., Cavazos, J., Parada, I. & Ramirez, L. Mossy fiber synaptic 
reorganization in the epileptic human temporal lobe. Ann Neurol 26, 321-30 (1989). 
393. Bell, B., Lin, J.J., Seidenberg, M. & Hermann, B. The neurobiology of cognitive 
disorders in temporal lobe epilepsy. Nat Rev Neurol 7, 154-64 (2011). 
394. Heck, N., Garwood, J., Loeffler, J.P., Larmet, Y. & Faissner, A. Differential upregulation 
of extracellular matrix molecules associated with the appearance of granule cell 
dispersion and mossy fiber sprouting during epileptogenesis in a murine model of 
temporal lobe epilepsy. Neuroscience 129, 309-24 (2004). 
395. Pitkanen, A. & Lukasiuk, K. Molecular and cellular basis of epileptogenesis in 
symptomatic epilepsy. Epilepsy Behav 14 Suppl 1, 16-25 (2009). 
396. de Lanerolle, N.C. et al. A retrospective analysis of hippocampal pathology in human 




397. Suttkus, A. et al. Aggrecan, link protein and tenascin-R are essential components of the 
perineuronal net to protect neurons against iron-induced oxidative stress. Cell Death Dis 
5, e1119 (2014). 
398. Bozdagi, O., Nagy, V., Kwei, K.T. & Huntley, G.W. In vivo roles for matrix 
metalloproteinase-9 in mature hippocampal synaptic physiology and plasticity. J 
Neurophysiol 98, 334-44 (2007). 
399. Arranz, A.M. et al. Hyaluronan deficiency due to Has3 knock-out causes altered neuronal 
activity and seizures via reduction in brain extracellular space. J Neurosci 34, 6164-76 
(2014). 
400. Retchkiman, I., Fischer, B., Platt, D. & Wagner, A.P. Seizure induced C-Fos mRNA in 
the rat brain: comparison between young and aging animals. Neurobiol Aging 17, 41-4 
(1996). 
401. Bragin, A., Wilson, C.L., Almajano, J., Mody, I. & Engel, J., Jr. High-frequency 
oscillations after status epilepticus: epileptogenesis and seizure genesis. Epilepsia 45, 
1017-23 (2004). 
402. Le Van Quyen, M. et al. Cell type-specific firing during ripple oscillations in the 
hippocampal formation of humans. J Neurosci 28, 6104-10 (2008). 
403. Wittner, L. & Miles, R. Factors defining a pacemaker region for synchrony in the 
hippocampus. J Physiol 584, 867-83 (2007). 
404. Jones, P.L. & Jones, F.S. Tenascin-C in development and disease: gene regulation and 
cell function. Matrix Biol 19, 581-96 (2000). 
405. Miyata, S., Komatsu, Y., Yoshimura, Y., Taya, C. & Kitagawa, H. Persistent cortical 
plasticity by upregulation of chondroitin 6-sulfation. Nat Neurosci 15, 414-22, s1-2 
(2012). 
406. Hartig, W. et al. Cortical neurons immunoreactive for the potassium channel Kv3.1b 
subunit are predominantly surrounded by perineuronal nets presumed as a buffering 
system for cations. Brain Res 842, 15-29 (1999). 
407. Moleres, F.J. & Velayos, J.L. Expression of PrP(C) in the rat brain and characterization 
of a subset of cortical neurons. Brain Res 1056, 10-21 (2005). 
408. Kaufmann, W.E. et al. Social impairments in Rett syndrome: characteristics and 
relationship with clinical severity. J Intellect Disabil Res 56, 233-47 (2012). 
409. Veeraragavan, S. et al. Loss of MeCP2 in the rat models regression, impaired sociability 
and transcriptional deficits of Rett syndrome. Hum Mol Genet 25, 3284-3302 (2016). 
 
